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ABSTRACT
The DNA sequence of the gene coding for the OXA-2 
beta-lactamase has been completed. The primary amino acid sequence 
deduced from the DNA sequence was used to study homologies with 
other beta-lactamases; no good homologies were observed with any class 
of beta-lactamase. A more detailed analysis has revealed from 
comparison of both primary and predicted secondary structure, that the 
OXA-2 beta-lactamase may be more closely related to class A enzymes.
Confirmation that the OXA-2 beta-lactamase is a serine enzyme
has come from the DNA sequence and the interaction with mechanism 
based inactivators. Clavulanic acid and a novel beta-lactamase inhibitor, 
BRL36148, both interact specifically with the OXA-2 beta-lactamase by 
branched pathway mechanisms. Analysis of inactivated enzymes by 
peptide mapping and isoelcetric focusing have revealed that more than 
one inactive enzyme species is formed with each inactivator.
A specific DNA probe was designed to come entirely from within 
the coding sequence of the OXA-2 beta-lactamase gene. This probe was 
found to interact only with plasmids specifying the OXA-2 or OXA-3 
type enzymes. These results confirm earlier observations that OXA-2 and 
OXA-3 beta-lactamases are related. Another probe which comprised the 
whole of the OXA-2 beta-lactamase gene as well as segments of DNA on 
either side of the gene, was found to hybridise with a number of 
resistance plasmids. This interaction suggests that multi resistance 
plasmids carry common segments of DNA.
Characterisation of the physical properties of the OXA-2 enzyme
by analytical ultracentrifugation have not only confirmed the dimeric 
nature of this beta-lactamase but have also shown that this enzyme
forms aggregates at high protein concentrations. Probing of the enzyme 
structure with trypsin, strongly points to the OXA-2 beta-lactamase 
having a domain structure.
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Section 1 Beta-Lactamases: Classification and Nomenclature
1.1 Historical Overview of the Beta-Lactamases
The emergence of microbial resistance to antibiotics has stimulated 
research in the antibiotic field for the last 40 years. This interest has 
not diminished, with the current world expenditure on just one group of 
antibiotics, the beta-lactams amounting to £9,000,000,000 (B. Buxton,
personal communication). This high level of interest over the last few 
decades has revealed some of the basic mechanisms of antibiotic 
resistance adopted by bacteria of which one particular mechanism is 
relevant to this project. This mechanism involves the synthesis of an 
enzyme that will inactivate the antibiotic either by modification or 
hydrolysis. An example of such a group of enzymes is the 
beta-lactamases which hydrolyse beta-lactam antibiotics. This class of 
enzymes is very common amongst both Gram-positive and Gram-negative 
organisms and is the most common factor involved in resistance to 
beta-lactam antibiotics (Medeiros, 1984). Beta-lactamases catalyse the 
hydrolysis of the amide bond in the beta-lactam ring to yield the 
corresponding acid (figure 1).
Figure 1: Hydrolysis of Penicillin by Beta-Lactamase.
Benzylpenicillin  Benzylpenicilloic Acid
Beta-lactamases were identified as early as 1940 by Abraham and 
Chain, who noted that a cell extract from Escherichia coli resistant to 
penicillin, destroyed the growth-inhibiting properties of this antibiotic 
(Abraham and Chain, 1940). This enzyme was also present in a 
penicillin-resistant Gram-negative rod found to be contam inating their 
Penicillium cultures but not in a penicillin-sensitive Staphylococcus aureus. 
With the wide spread use of penicillin in the 1950’s, resistance emerged
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rapidly in S. aureus focusing attention on the penicillin hydrolysing 
enzyme from this organism. Isolation of the penicillin nucleus by 
Batchelor et al (1959), opened the door to the synthesis of the 
semisynthetic penicillins such as methicillin and cloxacillin which resisted 
hydrolysis by the staphylococcal beta-lactamase. The treatm ent of
patients infected with the resistant staphylococci became more effective 
with the new semisynthetic antibiotics but a concomitant increase in the 
prevalence of infections due to resistant Gram-negative bacilli was noted 
in hospitals as the usage of these antibiotics increased. It soon became 
apparent that this resistance was associated with the production of
beta-lactamases. The Gram-negative bacilli were found to produce a 
variety of beta-lactamases capable of destroying the newer penicillins and 
also many cephalosporins (Matthew et al, 1975). Furthermore several of 
the most prevalent beta-lactamases were found to be determined by
plasmids and transposons (Datta and Knotomichalou, 1965; Hedges and 
Jacob, 1974), that were capable of transfer to other genera. In addition 
to the plasmid and transposon mediated enzymes, chromosomally mediated 
beta-lactamses have been found in all bacteria (Matthew and Hedges, 
1976). This plethora of penicillin and cephalosporin hydrolysing enzymes 
has led to intensive research within the pharmaceutical industry to find 
new beta-lactams that are both resistant to these enzymes and are potent 
antimicrobial agents. As a result several new classes of clinically useful 
beta-lactam antibiotics have been found which have come into clinical 
use (Brown, 1982). U nfortunately identification of new beta-lactamases 
and other mechanisms of resistance to these antibiotics are being 
reported ensuring that the battle against resistance is a long and ongoing 
process.
1.2 Classification of the Beta-Lactamases
As new beta-lactamases have been discovered and characterised it 
has become apparent that these enzymes can d iffe r significantly in their 
properties. Consequently several attempts have been made to classify the 
d ifferen t enzymes. The earliest classification systems were based on the 
substrate profiles of the different types of beta-lactamase and were based 
on the relative Vmax for the individual substrates (Sawai et al, 1982). 
Enzymes that hydrolysed penicillins more rapidly were referred to as 
penicillinases whereas those that hydrolysed cephalosporins were called 
cephalosporinases. The plasmid mediated penicillinase TEM, hydrolyses 
the cephalosporin cephaloridine, at 76% of the rate of benzylpenicillin.
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Using only Vmax to describe substrate specificity can be misleading 
since the distinction between penicillinases and cephalosporinases is far 
from absolute. Furthermore it is kcat/K m that describes the enzyme 
specificity and not Vmax (Fersht, 1982). For example the chromosomal 
"cephalosporinase" from Pseudomonas aeruginosa has a k ca t/^ m  ^or 
benzylpenicillin 12 times greater than that for cephalosporin C 
(Knott-Hunziker et al, 1982a).
Other properties that have been used to classify beta-lactamases 
include the molecular weight, isoelectric point and susceptibility to 
various inhibitors. Sawai et al, (1982) have proposed a classification that 
incorporates some of these properties but is not as extensive as the 
system proposed by Richmond and Sykes (1973). This latter classification 
system applies prim arily to the enzymes from Gram-negative organisms 
and contains five groups which are defined below.
CLASS I: These are chromosomally mediated "cephalosporinases" that are 
sensitive to inhibition by cloxacillin but are resistant to inhibition by 
PCMB (p-chloromercuribenzoate). They can be fu rther subdivided 
according to their inducibility eg enzymes from P. aeruginosa, Citrobacter 
spp. Constitutive enzymes include those from E. coli and also 
Enterobacter cloacae P99.
CLASS II: Very few enzymes f it into this group which constitutes the 
chromosomally mediated "penicillinases". They include enzymes from 
Proteus mirabilis GN310. The enzymes in this group are cloxacillin 
sensitive but resistant to PCMB.
CLASS III: This group contains the the R plasmid beta-lactamases that 
do not hydrolyse oxacillin. They are constitutive, cloxacillin sensitive 
but PCMB resistant. This group contains the TEM enzyme.
CLASS IV: This comprises the constitutive chromosomally mediated broad 
spectrum beta-lactamases that are generally PCMB sensitive and cloxacillin 
resistant. The main group of enzymes comes from Klebsiella species such 
as Klebsiella aerogenes 1082E.
CLASS V: These are the R plasmid mediated enzymes that hydrolyse 
oxacillin and carbenicillin. They are PCMB resistant and generally 
cloxacillin resistant. Members of this class include the OXA and PSE 
type enzymes.
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This classification system has been useful for introducing order 
into the large variety of enzymes. However, as more enzymes have been 
discovered and characterised, it has become apparent that the scheme has
limitations as a basis for molecular studies. Firstly it refers only to the
enzymes from Gram-negative organisms and does not take into account 
im portant enzymes from Gram-positive cells such as Staphylococcus or the 
mycobacteria, nor the enzymes from Actinomadura R39 and Streptomyces 
which have been well studied at the molecular level (Duez et al, 1982; 
Frere et al, 1982; DeMeester et al, 1987). Secondly some novel enzymes 
have properties that are not readily accomodated within this 
classification system e.g. the plasmid-mediated "cephalosporinase" described 
by Levesque et al (1982). Thirdly some of the methods used to judge
the sim ilarity of the enzymes within classes can be unreliable, a point 
that is also applicable to other classification systems. Using the
molecular weight to judge the relatedness of enzymes can be unreliable 
as shown by the example of the beta-lactamase from Actinomadura R39 
(Duez et al, 1982); the estimate of the molecular weight by gel filtration  
was fa r too large due to the asymmetry of this protein. Another 
example involves TEM beta-lactamase whose original molecular weight was 
determined as 16,700 (Datta and Richmond, 1966) but was then shown to 
be in error due to contamination with other protein (Dale and Smith, 
1971a). The final molecular weight as determined from amino acid 
sequencing, was found to be 28,500 (Ambler and Scott, 1978).
Analytical isoelectric focusing has greatly improved the 
identification of beta-lactamases (Matthew and Harris, 1976) but values 
quoted for the pi of d ifferent enzymes can vary from laboratory to 
laboratory. OXA-2 beta-lactamase is acid labile (Holland, 1983) and 
loading of the protein at the acidic end of an isoelectric-focusing gel 
can give erroneous results. The typical pi of the enzyme obtained in 
this laboratory is 8.6, whereas the value quoted by Matthew (1979), is 
7.9. The Richmond and Sykes classification system has relied on these 
and other parameters that can vary from laboratory to laboratory but 
despite the limitations of this system, Sykes (1982), has argued for its 
continued use due to its extensive citation in the literature and its basis 
for a common reference point for the characterisation of novel 
beta-lactamases.
Ambler (1980), has proposed a new classification system based on 
homology in the primary sequence of the beta-lactamases. This is the 
most definitive way of showing relatedness and serves to highlight the 
evolutionary relationships. The main problem with this classification has
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been in obtaining the primary sequences of the proteins but with rapid 
DNA sequencing and good N-terminal sequencing, it has been possible to 
allocate several beta-lactamases into this classification system.
CLASS A: The four class A beta-lactmases identified by Ambler (1980),
TEM, Bacillus cereus type I, Bacillus licheniformis and S. aureus PCI, 
share 20% homology throughout their primary sequences. When 
individual proteins are compared this homology can be as high as 56% 
for the two Bacillus proteins. Since then four more beta-lactamases have 
been grouped into this class. These include the proteins from K. 
aerogenes 1082E (originally classed in group II of the Richmond and 
Sykes classification scheme), Streptomyces albus G, Rpdo pseudomonas
capsulata SP108 and P. aeruginosa Rmsl49 (Emanuel et al, 1985, 1986;
Dehottay et al, 1986; and Campbell and Ambler, unpublished results).
These proteins are serine enzymes and have similar mechanisms of action.
CLASS B: This group contains only one member, the metallo enzyme 
beta-lactamase II from B. cereus. Bicknell et al (1985), have studied the 
zinc metallo enzyme of Pseudomonas maltophilia but it appears to be 
unrelated to the Bacillus enzyme.
CLASS C: There are currently four members within this group which are 
also serine beta-lactamases. They include E. coli ampC chromosomal 
enzyme, E. cloacae P99 and the chromosomal enzyme from Citrobacter 
freundii (Jaurin and Grundstrom, 1981; Knott-Hunziker et al, 1982a;
Lindberg and Nomark, 1986). The primary sequences of these proteins 
are unrelated to those of the class A enzymes.
1.3 Nomenclature of the Beta-Lactamases
No systematic method has been applied to the nomenclature of 
beta-lactamases, with enzymes being named after their properties, place 
of discovery, species location and even the patients from which they
were originally isolated. Furthermore some enzymes may have one or 
more names which can be exceedingly confusing for someone unfam iliar 
with this group of proteins. To add to the problem names given to 
beta-lactamases can be misleading as to the properties and nature of that 
particular enzyme. The PSE beta-lactamases are plasmid borne serine 
enzymes that can be used as an example to illustrate some of the points
18
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mentioned above. These enzymes were originally identified in
Pseudomonas. Since they were believed to be species specific, the
enzymes were called PSE-1-4 (Matthew, 1979). However some of these 
enzymes such as PSE-1, have since been isolated in other species
including E. coli and Sallmonella (Medeiros et al, 1982). Therefore using 
the term PSE is not strictly correct since it does not accurately reflect 
the properties of these enzymes. An alternative name for these enzymes
has been used by Labia et al (1980), where PSE-1, -3, -4 have been
referred  to as CARB-2, -4, -1 respectively from their ability to hydrolyse
carbenicillin. This again is not helpful since several other 
beta-lactamases are able to hydrolyse carbenicillin such as the OXA-1 
enzyme (Matthew, 1979). The PSE-2 beta-lactamase also has considerable 
activity  against oxacillin and has been refered to as OXA-4 (Phillipon et 
al, 1983) although it is immunologically distinct from any of the OXA
type beta-lactamases (Phillipon et al, 1982). However a new 
beta-lactamase from P. aeruginosa and E. coli that is immunologically 
cross reactive with OXA-1 enzyme, has now been identified and called 
OXA-4 (Medeiros et al, 1985; Phillipon et al, 1986).
As yet there is no systematic method available to describe 
beta-lactamases uniquely and in a definitive way. Such a task may 
prove very d ifficu lt owing to the great diversity of these enzymes and 
the extensive use of the trivial names in the literature. Hence the
success of any system would greatly depend on the consistent use of a 
particular name by all authors.
1.4 The Oxacillin Hvdrolvsing Beta-Lactamases
Enzymes that hydrolyse oxacillin more rapidly than benzylpenicillin 
(section 1.2) have been grouped together as the oxacillin hydrolysing
beta-lactamases. Initial investigations centred on the enzymes specified 
by RGN238 (Yamagishi et al, 1969) and R46 which has also been called 
R-1818 and R-Brighton (Anderson and Datta, 1965). Study of the two 
beta-lactamases enabled them to be differentiated principly on their 
molecular weight; the RGN238 specified beta-lactamase having a
molecular weight of 24,000 daltons and the R46 specified enzyme giving 
an Mr of 45,000 (Dale and Smith, 1972). Further characterisation of 14 
oxacillin hydrolysing beta-lactamases revealed that the enzymes segregated 
into a low and high molecular weight group. The latter could be 
fu rther divided into subgroups that gave Mr’s of 45,000 and 42,000 and 
differed in electrophoretic mobility (Dale and Smith, 1974). These
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enzymes have been designated as OXA-1, OXA-2 and OXA-3 respectively 
(Matthew and Hedges, 1976). These are the second most wide spread 
group of beta-lactamases to be found in clinical isolates after the TEM 
group although their total frequency of occurence is still comparatively 
low at 12% compared to 72% for TEM-1 (Medeiros, 1984). Several new 
OXA type beta-lactamases have been found of which OXA-4, OXA-5 and 
QXA-7 resemble OXA-1 more closely in their low Mr whereas OXA-6 is 
similar to OXA-2 and OXA-3 in having an Mr 40,000 (Medeiros et al, 
1985). The sim ilarity in properties of the OXA-2 and OXA-3 enzymes 
led Dale and Smith (1974), to suggest that the OXA-3 beta-lactamase may 
be a deletion mutant of the OXA-2 enzyme. Hybrid studies between 
OXA-2/OXA-3 suggested that both enzymes may be dimeric, which would 
also resolve the discrepancy in the Mr of denatured and native OXA-2 
beta-lactamases as determined by SDS-polyacylamide gel electrophoresis 
and gel-filtration (Dale and Smith, 1976). At that time it was the only 
report of a dimeric beta-lactamase until Saino et al (1982), reported the 
tetram eric metallo enzyme from P. maltophilia.
The high molecular weight beta-lactamases are fu rther characterised 
by their specific interaction with cibacron blue, a property more 
commonly associated with enzymes that possess a dinucleotide fold 
(Monoghan et al, (1982); the OXA-1 beta-lactamase is not inhibited by 
this dye. The differences between these two types of OXA enzyme 
were illustrated by Holland and Dale (1985), who demonstrated that 
OXA-2 beta-lactamase was immunologically cross reactive with the OXA-3 
enzyme whereas no cross reaction was seen with OXA-1. The work 
presented in this thesis further defines the molecular properties of the 
OXA-2 beta-lactamase.
22
Section 2: Location and Secretion of Beta-Lactamases
Beta-lactamases are secreted proteins in that they are transported 
through the inner membrane of both Gram-positive and Gram-negative 
bacteria (Sykes and Matthew, 1976). The fate of the beta-lactamase is 
then very much dependent on the organism; beta-lactamases in 
Gram-positive organisms are not "trapped" by the presence of an outer 
membrane and so can be either secreted into the surrounding medium or 
be membrane bound. B. cereus produces three types of beta-lactamase, I, 
II and III. Type I and II have been well characterised (Abraham and 
Waley, 1979) and are predominantly extracellular whereas type III is 
predominantly membrane bound and is immunologically distinct from the
class A type I beta-lactamase (Connolly and Waley, 1983; Nielsen and 
Lampen, 1983). It appears to be bound to the inner membrane as a 
cysteine-glyceryl linked lipoprotein.
As a consequence of the presence of an outer membrane in
Gram-negative organisms, beta-lactamases are "trapped" in the periplasmic 
space between the inner and outer membranes. The m ajority of 
beta-lactamases in Gram-negative organisms are sequestered in this 
manner. This is an advantage since they can act as a barrier to the 
beta-lactam antibiotics before they reach their target proteins located
predominantly in the inner membrane (Spratt, 1983). A few exceptions 
to this rule include the class C beta-lactamase from P. aeruginosa which 
appears to "leak" into the surrounding medium after its induction (Sabath 
et al, 1965; Furth, 1979). Beta-lactamase from Gram-negative organisms 
can also be membrane bound such as the LI enzyme from P. maltophilia 
(Bicknell et al, 1985); solubilisation of the LI enzyme is aided by
detergent but the detergent is not needed to m aintain solubility unlike 
the B. cereus III beta-lactamase (Conolly and Waley, 1983).
To date several models for the secretion process have been 
described with varying amounts of evidence presented for each type of 
model, and have been discussed in detail in Benson et al (1985), Pugsley 
and Schwartz (1985) and Oliver (1985). Beta-lactamases have been used 
to study the complex process of secretion in both prokaryotic and 
eukaryotic cells. It is now apparent that the majority of secreted 
proteins are synthesised as precursors containing 20-40 amino acids at the 
N-terminal end that are not found in the mature protein (Oliver, 1985). 
These residues comprise the signal peptide which is cleaved by signal 
peptidases on translocation of the membrane. Beta-lactamases are no
exception and are also synthesised as precursors; with the advent of 
rapid DNA sequencing, several signal peptides of various beta-lactamases
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have now been identified.
Analysis of signal peptides has revealed there is no homology in 
the prim ary sequence but they all share certain common features (Von
Heijne, 1981). These can be summarised:- (a) The amino • acid N-terminus 
contains 1-3 positively charged residues. (b) Following the basic amino 
terminus is a stretch of 14-20 neutral or hydrophobic residues and (c) 
there is a preference for certain amino acids adjacent to the processing 
site with a conserved sequence AXB. B is immediately adjacent to the 
cleavage site and is usually alanine, glycine or serine and A includes 
these residues as well as leucine valine or isoleucine (Von Heijne, 1984; 
Oliver, 1985). It is believed that the signal peptide is only involved in 
the early stages of protein secretion and does not dictate the ultimate 
cellular location. Mutations to the basic amino terminus signal peptide
which cause a blockage in secretion, have shown that the overall charge
of this region is important and not the specific residues present (Inouye 
et aU 1982). Charged amino acids and deletions within the hydrophobic 
core of the signal peptide disrupt secretion (Benson et al, 1985). This
may be due to a change in the secondary structure w ithin the signal
peptide (Emr and Silhavy, 1983) or because the mutant signal peptide 
may be too short to traverse the membrane. Austen (1979), suggests that 
23 amino acids are needed to form an alpha-helix that would span a 
0.36nm membrane or 11 amino acids if  they assume a beta-sheet 
conformation.
Mutations in the signal-peptidase processing site appear to slow 
down or eliminate processing but generally do not affect export of the 
protein (Oliver, 1985). If the signal peptide is not cleaved properly, it
could act as an anchor in the membrane. Koshland and Botstein (1982),
have shown that the prepenicillinase of TEM-1 which is inactive, appears 
to have a d ifferent conformation to that of the mature protein. Since 
the two proteins d iffer in only the presence of the signal peptide, 
incorrect processing could yield inactive enzyme. How im portant the
signal peptide is to the activity of the protein is probably largely 
dependent on the enzyme studied. For example the signal peptide of 
yeast cytochrome oxidase subunit IV, when attached to mouse 
dihyrofolate reductase (ie DHFR, an enzyme located in the cytosol), 
yields fully active DHFR expressed in E. coli (Eilers and Schatz, 1986).
In many cases it seems the signal peptide is not sufficien t in 
itself to induce protein secretion and that the nature of the protein to 
which it is fused is of importance. Kadonaga et al (1984) have fused 
the signal peptide of TEM-1 beta-lactamase to triose phosphate isomerase.
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The hybrid protein is not secreted across the inner membrane of E. coll 
which has led the authors to suggest that features of the mature protein 
are required for translocation. Lingappa et al (1984) have in turn 
shown that at most the signal peptide and the first five amino acids of 
m ature TEM-1 beta-lactamase are sufficient for the translocation of a 
TEM-1/alpha-globin hybrid protein into dog microsomes. That the nature 
of the protein fused to the signal peptide is of importance is further 
exemplified by studies of the OmpA signal peptide fused to S. aureus 
nuclease A or TEM beta-lactamase. Deletion of two or more residues 
from the hydrophobic region of the signal peptide of the OmpA/nuclease 
progressively slowed processing of the preprotein. By contrast, the pre 
protein of OmpA/beta-lactamase was less sensitive to the length of the 
hydrophobic region than to the nature of the deleted residues (Lehnhardt 
et al (1987).
Beta-lactamases have proved extremely useful in the study of 
protein secretion. As yet the full mechanisms as to why there are 
differences in the mode of secretion of individual proteins are not 
understood. However the continuing use of the beta-lactamases should 
help to unravel the processes involved.
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Section 3: Mechanism of Action of Beta-Lactamases
3.1: General Properties of Beta-Lactamase Action
The main interest in beta-lactamases has undeniably come from
their role in mediating resistance to beta-lactam antibiotics. However 
apart from their clinical significance, these proteins have also proved
useful in many branches of biochemistry. This is because these proteins 
are readily purified and in many cases are available in large quantities, 
are easy to assay and provide a very simple marker by which to assess
their presence, namely antibiotic resistance. Consequently their genes 
have proved extremely useful as genetic markers in many plasmids such 
as pBR322 (Sutcliff, 1978). Beta-lactamases have also been useful in
studying protein secretion (Kadonaga et aU 1984; Lingappa et aU 1984) 
and the control of transcription (Olsson et al, 1983; Yamamoto et al, 
1982a). Despite all this information, the mode of action of 
beta-lactamases remained something of an enigma over the last decade.
Beta-lactamases catalyse the ring opening of the amide bond on 
the beta-lactam structure. This can lead to the form ation of stable 
products such as penicilloic acid shown in figure 1, or depending on the 
nature of the beta-lactam and the substituents present on the beta-lactam 
ring, the products following the ring opening may be unstable and 
undergo further decomposition (Faraci and Pratt, 1985). The beta-lactam 
ring of penicillins and cephalosporins is very susceptible to attack by 
nucleophiles which has been attributed to the non-planarity of the 
beta-lactam ring (Woodward, 1949). From the knowledge of other enzyme 
mechanisms, beta-lactam hydrolysis could be achieved by a general 
acid/base catalysis mechanism which could facilitate the direct attack of 
water on the beta-lactam carbonyl group. Alternatively the enzyme could 
hydrolyse beta-lactams by nucleophilic attack leading to the form ation of 
an acyl-enzyme intermediate as in in the serine proteases (Fersht, 1982). 
The latter mechanism was proposed as a possible mechanism by which 
beta-lactams inactivate their target enzymes, the penicillin-binding proteins 
(Tipper and Strominger, 1965), and since these enzymes were believed to 
be related it seemed reasonable to suppose that the beta-lactamases would 
employ a similar mechanism. However, the lack of any evidence upto 
1975 of acyl-enzyme intermediates in the reaction of these enzymes, lead 
Thatcher (1975), to propose that these enzymes may utilise a general 
acid/base catalysis mechanism. The break through came with the 
isolation of beta-lactamase inhibitors such as clavulanic acid figure 2, 
(Brown et al, 1976).
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Figure 2: Clavulanic Acid.
0 COOH
3.2.1: The Acvl-Enzvme Mechanism of Action of the Class A and Class C 
beta-lactamases
Clavulanic acid reacts with TEM beta-lactamase to give a 
hydrolysis product and also a transiently and irreversibly inhibited 
enzyme (section 4.2). Both types of inhibition showed an increase in 
absorbance at 281nm which was proportional to the decrease in enzyme 
activity. Hydroxlyamine treatment restored about 1/3 of the enzyme 
activity with a concomitant loss of the absorbance at 281nm (Charnas et 
al, 1978). This chromophore was proposed as being consistent with the 
formation of an alpha-beta unsaturated acyl-enzyme according to scheme 
1 (Fisher et al, 1980).
Scheme 1: Interaction of clavulanic acid with TEM beta-lactamase.
ECI ECII ECIII
E + C EC  — EC*    E + P
r
ECt
E, C, EC and EC* refer to the enzyme, clavulanic acid, Michaelis 
complex and acyl enzyme respectively. ECt is the transiently inhibited 
enzyme, whereas ECI are the different forms of irreversibly inhibited 
enzyme observed by Charnas et al (1978).
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At the same time several other inhibitors were found which were 
used to label the active site residue of the beta-lactamases. Cartwright 
and Coulson (1980), described a chloropenicillanic acid sulphone which 
inactivated the S. aureus PCI beta-lactamase by labelling serine 70 
(Ambler, 1980 classification scheme) in the peptide sequence 
ala-ser-thr-ser-lys. Fisher et al (1981) used quinacillin sulphone to label 
the homologous residue in TEM beta-lactamase on the peptide 
phe-pro-met-met-ser-thr-phe-lys. At about the same time, two other 
groups working independently on the mechanism of inhibition of B. 
cereus I enzyme by 6 /3-bromopenicillanic acid, showed that a serine 
residue homologous with that of the other class A beta-lactamases was 
labelled (Knott-Hunziker et al 1979; Cohen and Pratt, 1980). The 
chemistry of the reactions with these mechanism based inactivators are 
discussed in more detail in section 4.
So far evidence for an acyl-enzyme mechanism of action had been 
presented using inhibitors only. If an acyl-enzyme intermediate is the 
normal route used for beta-lactam turnover, it should be possible to 
observe this intermediate. None of the typical approaches such as 
trapping of the acyl-enzyme intermediate or product diversion have been 
successful in demonstrating the existence of an acyl-enzyme mechanism in 
the class A beta-lactamases. Typical substrates such as benzylpenicillin 
have values of kcat/K m around 1 0** M”1 s"1 (Fisher et al, 1980), which 
is close to the diffusion limit. It is possible that good substrates have 
kinetic characteristics that preclude the obsevation of reaction
intermediates, the lifetime of which may be too short and the steady 
state concentration too small to observe. On this basis Fisher et al
(1980) used a slow substrate cefoxitin with the TEM beta-lactamase (kca  ^
0.004 s"1, K m 650/im, kcat/K m 6 M-* s"*). Using Fourier transform
infra red measurements, they were able to show that the probable 
intermediate of the reaction was an acyl-enzyme involving an enzyme 
hydroxyl group. They were able to isolate ^ -C  cefoxitin bound to the
enzyme after rapid denaturation and gel filtration of the enzyme which 
suggests the presence of a covalent bond.
Cartwright and Fink (1982), were able to trap a covalent
intermediate in the reaction between B. cereus I beta-lactamase and 
dansylpenicillin at pH 2.0, 4 'C . This intermediate was found to be
attached to a serine residue. The results corresponded with those
obtained by Anderson and Pratt (1981, 1983), using a good substrate
dansylcephalosporin and S. aureus PCI beta-lactamase. Pre-steady-state 
kinetics were consistant with the formation of an acyl-enzyme of which
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the intermediate did not accumulate. Fisher (1984), has suggested that 
for good substrates and class A beta-lactamases, acylation is rate 
determining. This has been further demonstrated by Bicknell and Waley 
(1985a), using single-turnover and steady-state kinetics for the hydrolysis 
of slow cephalosporins by beta-lactamase I from B. cereus. No evidence
has been obtained for the accumulation of the acyl-enzyme intermediate.
The evidence for acyl-enzyme intermediates has accumulated using 
both substrates and inhibitors. An alternative method, site-directed
mutagenesis, has also been used to determine the importance of specific 
amino acids within the active site. Sigal et al (1982), have converted 
the active site serine of TEM beta-lactamase to cysteine which gives an 
enzyme that contains only a fraction of the wild-type activity and is 
sensitive to PCMB. K m for benzylpenicillin remained constant whereas 
kcat was reduced by 98% (Sigal et al, 1984). This result provides
further evidence for the essential involvement of serine in the 
mechanism of the enzyme. Mutants have also been prepared by 
Dalbadie-McFarland et al (1982), in which the active site serine
70/Threonine 71 of TEM beta-lactamase has been inverted to 
threonine-serine with concomitant loss of antibiotic resistance. Although 
these studies implicate the serine residue 70 in the mechanism of action
of TEM beta-lactamase, they have to be approached with some caution. 
Alteration of an amino acid can cause the loss of activity due to an 
alteration in the conformation of the enzyme rather than any inherent 
importance of the residue in catalysis. As an example, Craig et al
(1985), have shown that two point mutations in S. aureus PCI
beta-lactamase have caused the loss of beta-lactamase activity largely due 
to structural disruptions. Site-directed mutagenesis of threonine 71 to all 
other amino acids has shown that this residue in TEM beta-lactamase is 
not essential for catalysis but is involved in the stability of this enzyme 
(Schulz and Richards, 1986).
3.2.2: Class C beta-lactamases
Class C beta-lactamases have also been shown to be serine
enzymes, but unlike the class A beta-lactamases, deacylation appears to 
be rate limiting even for good substrates (Bicknell and Waley, 1985c).
Knott-Hunziker et al (1982a), were able to exploit nuclcophilic
partitioning to demonstrate the acyl-enzyme mechanism of action. In this 
instance methanol or ethanol can replace water as the nucleophile in the
hydrolysis of benzylpenicillin by both the P. aeruginosa chromosomal
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enzyme and the E. coli ampC beta-lactamase, to yield the corresponding 
alpha-methyl or ethyl benzylpenicilloate in addition to the normal 
hydrolysis product. For benzylpenicillin there is no effect on the overall
n oV
rate of reaction implying that the formation of an acyl-enzyme is rateA
determining and that the intermediate is partitioned amongst the 
available nucleophiles.
The active site serine of the class C beta-lactamases from P.
aeruginosa and E. coli has been labelled using the slowly hydrolysed 
substrate cloxacillin (Knott-Hunziker et al, 1982b). Enzyme preincubated 
with cloxacillin showed a pronounced lag when added to a 
benzylpenicillin solution, suggesting that the lag may be due to much of 
the protein being in the form of an acyl-enzyme. This lag did not 
appear to be due to cloxacillin inhibition of the enzyme (Knott-Hunziker
et al, 1982b) and the nature of the intermediate was confirmed by
trapping the acyl-enzyme under denaturing conditions on gel-filtration. 
Amino acid sequencing of the labelled peptides from either 
beta-lactamase showed that the site of attachment was serine 80. This 
implies that the serine residue is part of the active site. The active
site serine of E. cloacae P99 beta-lactamase has now been labelled both 
with cloxacillin and 6  /3-iodopenicillanic acid (Joris et al, 1984); the
serine residue labelled is analogous to the other class C beta-lactamases.
3.2.3: Comparison of the Mechanisms of Action of the Class A and C 
Beta-Lactamases
Despite the fact that both these groups are serine enzymes that 
interact with beta-lactam compounds, some significant differences exist 
between the two classes. This is underlined by the fact that it has not 
been possible to obtain nucleophilic partitioning for the class A 
beta-lactamases (Brenner and Knowles, 1981; Anderson and Pratt, 1981) 
except in the special case of transfer of an acyclic depsipeptide to a 
small amino acceptor (Pratt and Govardhan, 1984). This inability of 
class A beta-lactamases to use nucleophiles other than water may be a 
consequence of steric or electronic hindrence that prevents the entry to 
the active site.
Fisher (1984), has suggested that for good substrates of the class 
A beta-lactamases, acylation is rate limiting whereas for class C 
beta-lactamases deacylation appears to be rate determining 
(Knott-Hunziker et al, 1982a). This partly accounts for the problems 
found in identifying the acyl-enzyme intermediate mechanism of reaction
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in the class A proteins.
The behaviour of beta-lactamases towards mechanism based 
inactivators also differentiates the two classes of proteins. In the cases 
studied so far, clavulanic acid has a negligible activity against the class 
C beta-lactamases whereas the class A enzymes react via a 
branched-pathway mechanism (Cartwright and Waley, 1983; section 4.2). 
Penicillanic acid sulphone, is effective against the class A beta-lactamases 
but like clavulanic acid generally appears to have little effect against 
the class C beta-lactamases (English et aU 1978). However, Knight and 
Waley (1985), have investigated the mechanism of action of a 
hydroxylbenzyl penicillin sulphone, which is a potent inactivator of the 
class C beta-lactamases but in turn is ineffective against the class A
enzymes. 6  /3-bromopenicillanic acid and 6  /3-iodopenicillanic acid 
interact with both classes of proteins although the second order rate 
constant for the interaction with class C enzymes of E. cloacae P99 and
P. aeruginosa is much smaller than for the class A proteins (Joris et aU
1985; Knight and Waley, 1985). The differences between these two class
of proteins should eventually be revealed with high resolution X-ray 
crystallography which currently gives the resolution of one beta-lactamase 
at less than 0.25nm (Herzberg and Moult, 1987); more details of X-ray 
crystallography are given in section 3.5.
3.3: Mechanism of Action of the Class B and Related Beta-Lactamases
Beta-lactamase II from B. cereus requires Zn^+ for activity
although other ions such as Co^+ can replace zinc (Davies and Abraham, 
1974). There are two zinc binding sites but the catalytic activity is
dependent on the occupation of the tighter of the two sites (Bicknell 
and Waley, 1985a). This essential zinc ion is liganded to three histidine 
residues and one cysteine residue (Abraham and Waley, 1979) of which
the latter has been identified as being at position 198 of the 257 amino 
acid sequence since this is the only cysteine residue within the sequence 
(Ambler et al, 1985). No homology was seen between the amino acid
sequences of this beta-lactamase and the Zinc containing DD-peptidase of 
Streptomyces albus G (Joris et al, 1983).
A low temperature mechanistic study of this beta-lactamase by 
Bicknell and Waley (1985b), suggests that there are no covalent 
intermediates formed as in the class A or C beta-lactamases. In addition 
to the essential histidine and cysteine residues, Little et al (1986a) have 
recently demonstrated the presence of an essential glutamic acid residue
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at position 37. It appears that the inactivation of glutamate 37 makes 
the thiol group more reactive. Using this and previous observations as 
well as knowledge of other metallo enzyme mechanisms, these authors 
have proposed a mechanism of action for beta-lactamase II. In essence a 
water molecule bound to Zn^+ attacks the beta-lactam carbonyl group 
with glutamate 37 acting as a general base catalyst, deprotonating the 
water from which the proton can be donated to the nitrogen of the 
beta-lactam. Beta-lactamase II has been crystallised (Aschaffenberg et al,
1978) and high resolution X-ray crystallography should help to verify 
whether the above model is correct.
Beta-lactamase II of B. cereus was the only known metallo enzyme 
until the novel beta-lactamase LI, was isolated from P. maltophilia (Saino 
et al, 1982). This enzyme is unusual in that it is tetrameric but shares 
several properties with beta-lactamase II. Both enzymes are not 
inactivated by clavulanic acid, penicillin sulphones, 6  0 -iodopenicillanic 
acid or phenylboronic acids. However both enzymes can readily 
hydrolyse N-formimidoylthienamycin which is generally resistant to serine 
beta-lactamases. It is interesting to note that N-formimidoylthienamycin 
is hydrolysed by renal dipeptidase which is also a zinc metallo enzyme 
(Kim and Campbell, 1982). Peptides are not substrates for these
beta-lactamases (Bicknell et al, 1985b) although beta-lactamase II can 
catalyse the hydrolysis of depsipeptides as well as acyl transfer to small 
amino acceptors (Pratt and Govardhan, 1984). Bicknell et al (1985b)
have studied the properties of the Pseudomonas enzyme which suggest 
that it does not belong to the same structural class as beta-lactamase II. 
Cysteine does not appear to be necessary for the enzyme activity and 
the first 32 amino acids from the N-terminal end share no homology 
with beta-lactamase II. Consequently it is thought that the LI enzyme
may belong to a new structural class akin to the class A and C
division.
There are two new possible zinc beta-lactamases that have been 
identified from alkalophilic Bacillus spp. and Flavobacterium odoratum 
(Kato et al, 1985; Sato et al, 1982). The former has been identified as 
a class B enzyme from amino acid comparisons with the beta-lactamase 
II; 93% of the residues are identical in both proteins. The 
beta-lactamase from F. odoratum gives an Mr 26,000, is dependent on 
zinc for activity and is inhibited by EDTA, I2 , PCMB, HgCl2  and 
CUSO4 but not clavulanic acid or penicillanic acid sulphone. It has a 
broad substrate specificity and can hydrolyse N-formimidoylthienamycin. 
Therefore this enzyme is also a suitable candidate for a zinc protein
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although it is not yet possible to say whether it resembles LI or II
beta-lactamases.
3.4: Important Residues Within the Active Sites of Serine Beta-Lactamases
Apart from the active site serine that has been identified for 
the class A and C beta-lactamases by trapping of the acyl-enzyme 
intermediate, no other residues have been unambiguously shown to 
participate in catalysis. It might be possible that a "charge relay"
system similar to that of the serine proteases is present. Pain and 
Virden (1979) have reviewed active site-directed reagents that have been 
used to probe various beta-lactamases, some of which will be discussed 
here. Tryptophan had originally been thought to be catalytically 
important (Ogawara and Umezawa, 1975) in beta-lactamase I of B. cereus. 
This was discounted when the interaction of this enzyme with
6-/3-bromopenicillanic acid was studied (Cohen and Pratt, 1980).
Although the product of the reaction could be explained in terms of 
tryptophan destruction, it is unlikely since the same product is formed 
with the S. aureus PCI beta-lactamase which contains no tryptophan in 
its amino acid sequence (Ambler, 1975).
There have been several reports of arginine or lysine residues 
being involved in the active site of serine beta-lactamases.
Phenylpropynal has been shown to specifically inactivate beta-lactamase I 
from B. cereus which implicates a lysine residue within the active site
(Schenkien and Pratt, 1980). An arginine residue was also implicated
when phenylglyoxal was used to inactivate the same enzyme (Borders et
aU 1982). Further hints that amino groups may be implicated have come 
from less direct observations. pH profiles obtained for beta-lactamase I 
reacting with 6-/3-bromopenicillanic acid or benzylpenicillin give an 
indication that a functional lysine group may be present in the active 
site (Loosemore et al, 1980; Waley, 1975). Fisher et al (1980), have
suggested that an enzymatic base may be present to account for
inhibition by mechanism based inactivators. On the other hand, Cohen 
and Pratt (1980) have pointed out that although such a base would be
pleasing since one could propose the activation of the active site serine 
as in the serine proteases, there is no need for such a base to account 
for inhibition by 6  0 -brompenicillanic acid.
In addition to the possible presence of a lysine residue in the
class A beta-lactamase, Waley (1975) has suggested that an essential 
carboxyl group may be present in the active site of beta-lactamase I.
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Further investigation with carbodiimides by Little et al (1986b) for both 
the class A and C beta-lactamases confirmed this observation; 
beta-lactamase I and P99 enzyme appeared to have one essential group. 
More detailed examination of beta-lactamase I inactivation showed that 
glutamate 168 was the major site of labelling by the carbodiimide.
However the authors suggest that this residue may not be essential
because it is not conserved amongst the class A beta-actamases. The 
blockage at this residue in beta-lactamase I may inactivate the enzyme 
by sterically hindering the nearby glutamte 166 that is conserved.
Some indication of the catalytically important residues may be 
obtained by aligning amino acid sequences of the region around the 
active site serine beta-lactamases and penicillin-binding proteins. Table 2
shows the majority of known sequences for which the conserved residues
are highlighted.
Table 2: Alignment Sequences Around the Active Site Serine for Serine
Penicillin-Reactive Proteins. The boxed areas represent residues that are 
conserved. * Denotes the active site serine.
P r o t e i n
Ty p e
S o u r c e  a nd  
Fami  1 y
C l a s s  A TEM S F R P E E R F P M M S T F K V L L C G A V L ( b)
Be t a - P SE- 3 Q H R G D E R F P L N S T H K A F S C A A V L ( c )
L a c t a m a s e s  R . c a p s u l a t a S H R E D E L F L M N S T S K A I N S A I L L ( c )
K.  a e r o g e n e s F A M N S T S K (d)
B.  c e r e u s S Y R P N E R F A F A S T Y K A L A A G V L L ( b)
B.  1 i c h e n i f o r m i  s A Y R P D E R F A F A S T I K A L T V G V L L ( b)
S . a u r e u s K F N S D K R F A Y A S T S K A I N S A I L L ( b )
S .  a l b u s  G A Y R A D E L F P M C S V F K T L S S A A V L ( e )
E.  c o l i  ampC P V T Q Q T L F E L G S V S K T F T G V L G G ( f )
C l a s s  C C.  f r e u n d i i P V T Q Q T L F E L G S V S K T F N G V L G G ( g )
Be t a - E.  c l o a c a e P V T p Q T L F E L G S I S K T F T G ( h)
L a c t a m a s e s  P.  a e r u g i n o s a V T P E T L F E I G S V S K ( h)
E x o -  S t r e p t o m y c e s  R61 A I T T T D R F R V G S V T K S F S A V V L L ( c )
ce  1 l u l a r
D D - p e p t  i d a s e
B.  s t e a r o t  h e  rmoph i I  us E K N I D T V L G I A S M T K M ( i )
B a c i 1 1  us B . s u b t  i I i  s S K N A D K R L P I A S M T K M M T E Y L L L ( i )
PBPs
P B P l a N R A T Q A L R Q V G S N I K P F L Y T A A M ( j )
E.  c o l  i P B P l b N R A M Q A R R S I G S L A K P A T Y L T A [ t ( j )
PBPs PBP3 N R T I T D v HE P G S T V K P M V V M T A JL (k)
PBP5 E Q N A D V R R D P A S L T K M M T S Y V I G ( 1)
PBP6 E G N A D E K L D P A s L T K I M T S Y V V G ( 1 )
Reference Sources: (b) Ambler (1980), (c) Campbell and Ambler,
unpublished results, (d) Emanuel et al (1986), (e) Duez et al (1987), (f) 
Jaurin and Grundstrom (1981), (g) Lindberg and Nomark (1986), (h)
Knoot-Hunziker et al (1982b), (i) Waxman et al (1980), (j) Broome-Smith 
et al (1985), (k) Nakamura et al (1983), (1) Broome-Smith et al (1983).
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The residues that are common to all the serine beta-lactamases of 
the class A and class C group are Phe-(X3 )-Ser-(X2 )-Lys. Furthermore 
the Ser-(X2 )-Lys sequence is conserved amongst all the serine 
penicillin-binding proteins. The role of this serine • has been well 
characterised as described in the previous sections and will not be 
further discussed. However the lysine residue is also highly conserved 
which implies that it may have an important function and may well 
represent the amino group that has been identified with the active site 
directed reagents (Schenkien and Pratt, 1980; Waley, 1975). Within the
active site region of the class A beta-lactamases there is a conserved 
glutamate residue at position 64 and a leucine at position 81. The
importance of these residues can be assessed from high resolution X-ray 
crystallography, the information from which is summarised in the 
following section.
3.5: X-Rav Crystallography
Until recently beta-lactamases have proved remarkably resistant to 
X-ray crystallography at high resolution even though protein crystals 
have been available from the early 1970’s. At the low resolution for 
TEM and S. aureus PCI beta-lactamases (0.4nm and 0.5nm respectively),
little of biochemical interest is visible although the PCI beta-lactamase 
appears to be dimeric within the crystal (DeLucia et al, 1980; Moult et 
al, 1985). This latter observation has been tested by Braswell et al
(1986) for the PCI enzyme as well as other class A beta-lactamases. 
There is evidence for weak association of the protein monomers but it 
was concluded that if  the the crystalline dimers do exist under
physiological conditions, they will be so weakly associated that they are 
unlikely to have any physiological significance.
The structure of the B. cereus I and B. licheniformis at 0.25 and
0.35nm respectively, are of sufficient quality to show the backbone 
folding although regions of connectivity are missing (Samraoui et al, 
1986; Kelly et al, 1986). However of more importance was the finding
that the structures of these beta-lactamases could be superimposed on the 
structure of the serine DD-peptidase of Streptomyces R61. This latter 
protein has been resolved to 0.28nm (Kelly et al, 1985) and has no 
significant homology in the primary sequence with the class A 
beta-lactamases but appears to be more closely related to E. coli ampC 
class C enzyme (Duez et al, 1987). These findings suggest several
things:-
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(i) That the class A beta-lactamases and the DD-peptidases are related
and may have arisen from a common ancestral gene which verifies the 
original hypothes is proposed by Tipper and Strominger (1965).
(ii)Due to the similarities in the sequence between the class C enzymes and 
the DD-peptidase, suggests that these enzymes will also have a similar[ 
tertiary structure. The E. cloacae P99 class C
beta-lactamase has been crystallised (Charlier et al, 1983) and high
resolution data should confirm this hypothesis. Furthermore, these 
observations suggest structural homology between the class A and class C 
enzymes despite the lack of overall sequence homology.
(iii) The high resolution structure of the DD-peptidase can be used as
a model of the beta-lactamase active site owing to the similarity in their 
tertiary structure.
The last point needs to be approached with some caution since
there are some differences in both the kinetics (section 5.2) and the
structure of the proteins. The latter is not unexpected since there is a
size discrepancy of approximately 9000 daltons. In addition, the 
complete primary sequence of the R61 DD-peptidase had not been 
determined at the time of publication of the 0.28nm map so that the 
assignment of some of the residues is tenuous. However the predicted
active site serine for the DD-peptidase was confirmed by diffusing 
diisopropyl flurophosphate into the active site. Amine directed reagents 
appear to interact with a residue at position 47 which folds only 0.3nm 
from the active site serine at position 37. Surprisingly the highly
conserved lysine residue at position 40, was not labelled by the amine
directed reagent and appears to be 0.6nm from serine 37. More 
information in a recent publication (Herzberg and Moult, 1987), has 
given the structure of the class A beta-lactamase from S. aureus PCI at 
a resolution of 0.25nm. This structure is such that the active site of a 
beta-lactamase can be defined for the first time.
Using the Ambler numbering system (Ambler, 1980), the active site 
serine 70 lies in a cleft formed between the interface of two domains 
of or//3 and a. types. The conserved lysine residue 73 is adjacent to 
serine 70 and is in a position to form a salt bridge with glutamate 166, 
the residue proposed by Little et al (1986) as having a possible role in 
the active site of class A beta-lactamases. Model building performed by
Herzberg and Moult (1987) suggests that the carbonyl oxygen at position
C7 of ampicillin is in a position to interact with the hydroxyl oxygen 
of serine 70. Further proposed interactions have been given in figure 3 
below.
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Figure 3: Interaction of Ampicillin with the Active Site of S. aureus
PCI Beta-Lactamase.
Asn 132 
I\
H
lieu 239 %
\S~\
Val 103
Asn 170
/  / / r ~ H
MC Ser 70
Lys 73 NH3+ 
Glu 166 COO-
LVs 234
The information for the diagram above is taken from Herzberg and 
Moult (1987). For convenience, residues have not be drawn in the same
order as found in the actual structure. MC refers to main chain
interactions whereas all the other amino acids show side chain 
interactions.
The close relationship of a beta-lactam molecule to a peptide and
the probable evolutionary relationship of the class A beta-lactamases to 
the penicillin-binding proteins which catalyse both transpeptidation and 
carboxypeptidation reactions (section 5), suggest that parallels may exist 
between these enzymes and the serine proteases. The latter enzymes also 
take advantage of an acyl-enzyme mechanism of action so that the 
overlaying of the structure of a bacterial protease with that of the
beta-lactamase by Herzberg and Moult (1987) not surprisingly showed that 
the spatial arrangement of serine 70 - lysine 73 of the beta-lactamase is 
similar to the catalytic residue pair serine 195 and histidine 57 of the 
protease. As a contrast, there is no residue in an analogous position in 
the beta-lactamase to aspartate 102 of the protease which interacts with
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the active site histidine, although glutamate 166 is in position to interact 
with lysine 73 to shield it from the solvent. Hence it seems that the 
beta-lactamase has an analogous oxyanion hole to the serine protease.
The proposed catalytic mechanism involves the • binding of the 
substrate in the oxyanion hole in which the tetrahedral transition state 
is stabilised on the pathway to the formation of the acyl enzyme. Proton 
transfer is facilitated by the lysine 73 although the pKa of this residue 
is high and suggests that it does not act as a temporary "resting place" 
for the proton as in histidine 57 of the protease. Glutamate 166 may 
be involved in the deacylation step where it may enhance the 
nucleophilic attack by a water molecule on the acyl-enzyme. This step 
of the mechanism is unlike that of the serine proteases in which 
deacylation is a reversal of acylation. Such a reversal is possible since 
the hydrolysis of the peptide bond by the protease enables the leaving 
group to depart making way for a water molecule. In the 
beta-lactamase, the leaving group is still bound via the remainder of the 
beta-lactam structure so that a similar mechanism is not possible and the 
presence of what appears to be a binding site for water in the vicinity 
of glutamate 166, gives credence to the proposed role of this glutamate 
in deacylation.
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Section 4: Mechanism-Based Inactivators of Beta-Lactamases
4.1: General Features of Mechanism Based Inactivation
The incidence of beta-lactamase producing organisms in clinically 
important bacteria has spurred much activity in the pharmaceutical 
industry in searching for ways of overcoming this resistance. One 
approach has been to chemically alter beta-lactams to make them less 
susceptible to beta-lactamase hydrolysis. The second strategy has been to 
find molecules that can inactivate the beta-lactamase so that when used 
in synergy with antibiotics, these inhibitors can protect the antibiotic 
from destruction. The first such inhibitor to be discovered was 
clavulanic acid (Brown et al, 1976). Since then several other inhibitors 
have been discovered or synthesised which include penicillanic acid 
sulphones, halogenopenicillanates and the carbapenems. Mechanistic 
investigation of the interaction of these molecules has shown that they 
are all "mechanism-based" reagents. In essence these compounds exploit 
the catalytic specificity of the enzyme where the compounds initially 
interact with the enzyme as if they were normal substrates. During the 
catalytic turnover, a chemically reactive molecule is formed within the 
active site which can then inactivate the enzyme by covalent 
modification of some residue within the active site or by capturing some 
cofactor tightly bound within the enzyme (Rando, 1984). Several reviews 
have been published on mechanism-based inactivators and their kinetic 
properties and will not be discussed here (Rando, 1984; Walsh, 1984; 
Ringrose, 1985).
The beta-lactam mechanism-based inactivators that have been 
studied in some detail, fall into two categories. The first (type I) 
contains clavulanic acid, penicillanic acid sulphone and 
6-/3-bromopenicillanic acid and the second group (type II) contains the 
carbapemems such as the olivanic acids and N-formimidoylthienamycin. 
The mode of inhibition for the first type of inhibitor can be 
exemplified by looking at the reaction of penicillanic acid sulphone with 
TEM beta-lactamase of which the proposed mechanism of inactivation is 
given in figure 4.
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Figure 4: Interaction of Penicillanic Acid Sulphone with TEM
|5-Lactamase (adapted from Knowles, 1983).
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Discussion of the possible intermediates is given in the text below.
4.2: Mechanism of Action of the Type I Inactivators
The inactivator reacts with the enzyme in three ways the first of 
which involves hydrolysis caused by opening of the beta-lactam ring. 
Secondly the enzyme accumulates in a transiently inhibited state and 
finally the enzyme can be irreversibly inactivated. Evidence for the 
reaction scheme proposed in figure 4 is based on several observations. 
Firstly the product of hyrolysis is not the monocyclic penicilloic acid 
but semimalonaldehyde (F) and a sulphinate (E). This can be 
rationalised if the formation of the acyl-enzyme intermediate involves a
4 0
second bond cleavage at C5-S to give the imine (C). This second bond 
opening is possible since the substituent on the sulphur atom makes it a 
good leaving group. Deacylation of this imine acyl-enzyme then leads to 
product (D) which can fragment to (E) and (F) in solution (Knowles,
1983).
On formation of transiently inhibited enzyme, there is a large 
increase in absorbance at 280nm. This increase is consistent with an
enamine structure (G), which could be formed by tautomerisation of the
imine acyl-enzyme. This transiently inhibited enzyme has t \ j 2  of 13secs 
as observed when the rate of reactivation is measured using 
benzylpenicillin as the substrate (Kemal and Knowles, 1981). The 
formation of the irreversibly inhibited enzyme is much slower requiring
some 7000 turnovers before irreversible inactivation occurs of which 25% 
activity can be regenerated using hydroxylamine (Labia et al, 1980;
Fisher et al, 1981). It is possible that enzyme is irreversibly inhibited 
as a result of further covalent modification within the active site. The 
most convincing evidence for the branched scheme presented in the 
figure above comes from Brenner and Knowles (1981) using the 
dideuterated derivative of penicillinanic acid sulphone (figure 5 ).
Figure 5: Dideuterium Penicillanic Acid Sulphone.
coo-
If irreversible inactivation was a consequence of a pathway 
involving the formation of the enamine structure G in figure 4 i.e. 
where inactivation progressed via structure (G) to (H), it is expected that 
substitution of dideuterium at position C5  would be isotopically sensitive 
and hence would demonstrate a primary kinetic isotope effect. This is 
because formation of enamine structure (G), would involve one deuterium 
displacement. The experimental details showed an acceleration in the 
pathways leading to hydrolysis and irreversibile inactivation. This can 
be readily explained in terms of figure 4 where tautomerisation of the 
imine acyl-enzyme to the enamine form is the only step in the scheme
41
which is isotopically sensitive to deuterium at a-Cg and fi-Cfr The 
presence of the deuterium slows down the formation of enamine 
acyl-enyzyme so that more of the imine acyl-enzyme is available for the 
partitioning to hydrolysis or irreversible inactivation pathways.
The key to the success of penicillanic acid sulphone lies in the 
presence of a suitable substituent on the sulphur atom to enable ring 
opening to occur at C5 -S. The intermediate can then partition to a 
number of pathways. A similar mechanism has been identified for 
clavulanic acid by Fisher et al (1978) and Charnas et al (1978). As 
with penicillanic acid sulphone, TEM beta-lactamase can partition between 
hydrolysis, transient inhibition and irreversible inactivation. In the latter 
case there are at least three inactive enzyme species as identified by 
isoelectric focusing of which two forms contain the whole of the 
clavulanate skeleton and the third form only contains the beta-lactam 
ring (Charnas and Knowles, 1981). The transiently inactivated enzyme 
and irreversibly inactivated enzyme are both accompanied by an increase 
in absorbance at 280nm. Again this is consistent with the formation of 
an enamine structure which could be achieved by opening the clavulanic 
acid at C5 -O this time as a result of ketonisation at O4  (figure 6 ).
Figure 6 : Ring Opening of Clavulanic Acid at C5 -O to Yield an Imine 
Acyl-Enzyme.
In ac tiv a tio n
OH OH
COO- COO-
Clavulanic Acid
D eacylation
COO
Imine Acyl-Enzyme
T ra n sie n t Inhibibtion
The beta-lactamases from Actinomadura R39 and S. albus G also 
react via branched pathway mcchanisims with clavulanic acid. No 
transiently inhibited complex is observed with the S. albus G enzyme 
(Frere et al, 1982) which may be a result of efficient partioning of the 
acyl-enzyme to the irreversible inactvation and hydrolysis pathways. This 
beta-lactamase has also been shown to be a class A enzyme (Dehottay et 
al, 1986) and it seems that the clavulanic acid may have slightly
different modes of interaction with enzymes within this group. S.
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aureus PCI beta-lactamase reacts with clavualnic acid to give fully 
inactivated enzyme with only a small molar excess of inhibitor 
(Cartwright and Coulson, 1979).
The inactivation of 6 |3-bromopenicillanic acid with both class A 
and C beta-lactamases is unlike that of clavulanic acid and penicillanic 
acid sulphone since there is little or no turnover before the enzyme is 
totally inactivated. This inactivation is accompanied by the formation of 
a chromophore that has a characteristic peak at 326nm. Two groups 
working independently on B. cereus I beta-lactamase have studied this 
mechanism of inhibition (Pratt and Loosemore, 1978; Knott-Hunziker et 
al, 1979). The product of the reaction between the beta-lactamase and 
the inactivator was shown to be a dihydrothiazine group (Orlek et aU
1979) and was shown to be attached to the active site serine (Cohen and 
Pratt, 1980). Several mechanisms have been proposed to account for the 
formation of this product which may arise from fission of the C5-S.
The resultant thiolate could then attack the bromine on the Cg to
displace it to give the dihydrothiazine (figure 7).
There are no functional groups as such on the sulphur atom of
the thiazolidine ring and if ring opening at this atom was facile in 
penicillins, it might be expected that many more of these beta-lactams 
would be inhibitors. Knowles (1983) has suggested that the
fragmentation of C5 -S in 6 /3-bromopenicillanic acid may be as a result
of a greater instability of this bond due to the bulk of the bromo
substituent. In any case clavulanic acid, penicillin sulphone and
6 -0 -bromopenicillanic acid are inactivators as a consequence of an 
abnormal functionality that is built into the beta-lactam ring that then
allows ring opening at the Cg-heteroatom bond.
Figure 7: Interaction of 6-/3-Bromopenicillanic Acid with B. cereus I
|3-Lactamase (adapted from Cartwright and Waley, 1983).
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4.3: Mechanism of Action of the Type II Inactivators
The discovery of carbapenems such as thienamycin and the 
olivanic acids showed that they were both good antibacterials as well as 
potent beta-lactamase inhibitors. The olivanic acids MM13902 and 
MM4550 (Hood et n/, 1979), have been studied for their mode of
interaction with TEM beta-lactamase. Unlike the type I inhibitors, there
is no evidence for irreversible inhibition by these compounds. However 
the rate of recovery of inhibited enzyme when diluted into a solution 
of benzylpenicillin, is slower than the steady state turnover which
suggests that a branched pathway mechanism exists (Brenner and 
Knowles, 1984). The reaction pathway is divided between hydrolysis and 
formation of transiently inhibited enzyme of which the half-life is
approximately 8 seconds. By studying the changes during interaction of 
enzyme with inhibitor as well as product analysis, Easton and Knowles 
(1982) were able to propose a mechanism of action for olivanic acids. 
The normal acyl-enzyme yields the A2 pyrroline which is released on 
hydrolysis. Alternatively, the A2 pyrroline acyl-enzyme can tautomerise 
to the Al pyrroline which gives a transiently inhibited enzyme (figure 
8 ). The authors suggest there is no reason why the Al pyrroline should 
lead to a more stable acyl-enzyme. However Faraci and Pratt (1985)
have noted that cephalosporins with good C3 leaving groups can inhibit 
class A beta-lactamases by the formation of a more stable acyl-enzyme in 
the form of a methyldihydrothiazine derivative analogous to the Al 
pyrroline. The authors speculate that the occurence of an H bond
acceptor in the structures at the beta-lactam nitrogen, can cause a 
conformational change in the enzyme making deacyalation more difficult. 
Alternatively this acyl-enzyme could be more stable as a result of the 
loss of a H bond contact in going to the Al pyrroline form.
Hashizume et al (1984) have proposed a similar mode of action 
for imipenem (N-formimidoylthienamycin) with Proteus vulgaris 
beta-lactamase. Hence the carbapenems present a different mode of 
inhibition to the type I inactivators. However it should be pointed out 
that not all carbapenems are inactivators; MM22382 is an olivanic acid 
that lacks a sulphate group on Cg and does not act as an inactivator. 
Knowles (1983) has proposed that in lacking the sulphate ester, the 
acyl-enzyme is too short lived for partioning to occur to the Al
pyrroline. Hence mechanism based inactiviation is a complicated process 
between various chemical groups on the inactivator and the enzyme, 
making it difficult to predict the exact pattern of inhibition from the
4 4
inactivator structure alone.
Figure 8 : Inhibition of /3-Lactamase with a Type II Inhibitor, MM13902 
(adapted from Easton and Knowles, 1982).
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4.4: Design of Novel Mechanism-Based Inactivators
There is an obvious pharmaceutical interest in the development of 
beta-lactamase inhibitors. Clavulanic acid and many of the carbapenems 
were discovered as natural products after extensive screening procedures. 
Since this can be both costly and time consuming, rational design of 
novel structures is desirable. The knowledge of the. mechanism of 
reaction of the inhibitors discussed in the previous two sections has been 
used as a basis for the design of novel inactivators.
Fisher et al (1980) suggested that for inhibition of a 
beta-lactamase to occur, the reaction should proceed via an acyl-enzyme 
intermediate that hydrolyses slowly so that there is time for a chemical 
rearrangement to occur as a result of a specific inbuilt chemical feature. 
This was borne out by the observation that the sulphone of 
phenoxymethicillin (a good substrate) did not inhibit E. coli TEM 
beta-lactamase whereas the sulphone of a poor substrate, quinacillin, was
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an effective inactivator. Brenner and Knowles (1984) noted that for 
transient inhibition to occur in all the inactivators discussed above, 
tautomerisation of the first formed acyl-enzyme needs to occur. Since 
this tautomerisation often results in the formation of a conjugated 
unsaturated ester (eg the enamine structure (G) in figure 4), the authors 
have reasoned that if the first formed acyl-enzyme could be in the form 
of a conjugated unsaturated ester, an efficient inhibitor could result. 
On this basis they synthesised (6-methoxymethylene)penicillanic acid 
(figure 9a) which inhibits TEM beta-lactamase. This inactivator also 
displayed a branched pathway mechanism reminiscent of that of 
penicillanic acid sulphone. The transiently inhibited enzyme form was 
believed to be in the conjugated unsaturated ester form given in figure 
9b. This illustrates that the effect of certain features built into a 
substrate can to a certain extent be predicted. However the practicality 
of such an approach is not feasible in most instances due to the 
complexity of the interaction of these mechanism-based inactivators with 
beta-lactamases. This can be exemplified by the olivanic acid 
inactivation of the beta-lactamases where it was not possible to predict 
chemically that the . Al pyrroline would transiently inhibit the enzyme. 
The difficulty of predicting structure/function of compounds has been 
further exemplifed by Knight and Waley (1985). Penicillanic acid 
sulphones are generally regarded as being potent inactivators of the class 
A beta-lactamases but with little effect on the class C enzymes. These 
authors have shown that a hydroxybenzylpenicillanic acid sulphone is a 
potent inactivator of the class C beta-lactamase from P. aeruginosa but 
relatively ineffective against class A beta-lactamases.
The complexity of these interactions coupled to the permeability, 
pharmacokinetic and other properties of a good clinical compound, still 
makes the rational design of inhibitors remote.
Figure 9: (6-Methoxymethylene)penicillanic Acid (a) and Possible
Acyl-Enzyme (b)
OMe OMe
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4 6
Section 5. : Penicillin-Binding Proteins and the Mode of Beta-Lactam
Action
5.1: General Features of Penicillin-Binding Proteins
The penicillin-binding proteins (PBP’s) are enzymes involved in the 
synthesis of bacterial cell walls that are generally located in the inner
membrane (Tomasz, 1979; Shockman and Barrett, 1983; Spratt, 1983). The 
PBP’s exhibit different sensitivites to various beta-lactam antibiotics and 
can be segregated into the high and low molecular weight classes. The
E. coli system is the best characterised and consists of seven proteins 
(Spratt, 1983). Of the seven E. coli PBP’s, four are high molecular 
weight and are the killing targets of beta-lactam antibiotics (Spratt,
1983). Investigation of the activities suggested that they catalyse both 
the transglycosylation step in murein synthesis as well as a transpeptidase 
activity that cross links nascent murein. It is this latter activity that is 
sensitive to beta-lactams (Nakagawa et al, 1979; Susuki et al, 1980; Ishino 
and Matsuhashi, 1981) and has been demonstrated by Hedge and Spratt 
(1984). They constructed a fusion protein from the N-terminal region of 
beta-galactosidase and the C-terminal 349 amino acids of PBP3 of E. coli. 
The fusion protein could bind benzylpenicillin which established the 
C-terminal portion of the protein as the penicillin-binding transpeptidase
domain.
The low molecular weight PBP’s of E. coli also catalyse a 
penicillin sensitive reaction in which the terminal D-alanine residue is 
removed (Izaki et aU 1966), hence they have been referred to as
D-alanyl-D-alanine carboxypeptidases (DD-peptidases). The precise role of 
these proteins is not certain and PBP’s 4,5,6 may fulfill compensatory 
roles in which the function of one PBP may take over the role of
another (Waxman and Strominger, 1983). Deletion mutants of PBPS and 
PBP6 as well as the double mutant PBP5/PBP6 have been constructed
and are viable under laboratory conditions (Spratt, 1980; Broome-Smith 
and Spratt, 1982; Spratt, 1983). As yet no triple mutant 
PBP4/PBP5/PBP6 is available so that the contribution of PBP4 to the
PBP5/PBP6 double mutant cannot be assessed. Table 3 summarises some 
of the properties of the PBP’s from E. coli.
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Table3. Properties of PBP’s from E. coli. 
High Molecular Weight
PBP1A PBP1B 
Mr 92,000 90,000
Cell ElongationPhysiological
Role
Beta-lactams 
that inhibit 
particular 
PBP’s
Cephalexin
Cephaloridine
PBP2
66,000
Shape
Mecillinam
PBP3
60,000
Division
Cephalexin
Cefuroxime
Piperacillin
In vitro
enzyme
activities
Transglycosylase/
transpeptidase
Transglycosylase/
transpeptidase
Transglycosylase/
transpeptidase
No molecules 
per cell
230
(equivalent 
amounts of each)
20 50
Comments PBPlb appears 
to be the main 
enzyme in cell 
elongation. PBP1A 
may lead to 
diversity of wall 
structure and 
appears to act as 
a substitute in 
PBP1B" cells.
Low Molecular Weight
PBP4 PBP5 PBP6
Mr 49,000 42,000 40,000
Physiological
role
Non-essential 
under lab. 
conditions
Non-essential 
under lab. 
conditions
Non-essential 
under lab. 
conditions
Beta-lactam Benzylpenicillin
Ampicillin Cefoxitin
Cefoxitin
In vitro 
enzyme 
activity
DD-peptidase
Secondary
transpeptidase
DD-peptidase DD-peptidase
References:- Spratt (1980), De-Pedro and Schwartz (1981), Broome-Smith 
and Spratt (1982), Spratt (1983), Waxman and Strominger (1983), Frere 
and Joris (1985) Broome-Smith (1985), Reynolds (1986).
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5.2: Mechanism of PBP Interaction with Substrates and Beta-Lactams
That the PBP’s are very diverse was illustrated in the previous 
section; the high molecular weight PBP’s of E. coli appear to be strict 
transpeptidases whereas the low molecular weight PBP’s are 
DD-peptidases, although PBP4 also possesses a transpeptidase activity 
(Kozarich and Strominger, 1978). Furthermore Amanuma and Strominger 
(1980) have shown that under certain conditions the DD-peptidases can 
catalyse a transpeptidase reaction (scheme 2).
Scheme 2: Interaction of DD-peptidases with peptides
E and S are the enzyme and substrate, ES is the noncovalent Michaelis 
complex, ES* is the acyl-enzyme intermediate. P-OH is the product 
formed when the nucleophile is water as in a DD-peptidase reaction. 
Alternatively, if  the nucleophile is another peptide, product P-NH2  is 
formed in a transpeptidation reaction.
Using both natural substrates and substrate analogues such as 
diacetyl-L-lysyl-D-alanyl-D-alanine (diAc-L-lys-D-ala-D-ala), reactions of 
DD-peptidases have been studied. Partitioning of the reaction between 
transpeptidation and hydrolysis depends on pH and amino acceptor 
concentration. Since these parameters are not easily measured in vivo, it 
is not possible to determine which reaction occurs in the cell. The 
reactions of purified high molecular weight PBP’s from several species 
have proved more difficult to study, possibly due to a lack of 
appropriate substrates and also greater protein instability (Waxman and 
Strominger, 1983). It is believed that the transpeptidation reaction of
E + P-OH Peptidase
E + S ES — -ES*
E + P-NHR Transpeptidase
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this group of proteins follows the lower path of scheme 2, above.
Tipper and Strominger (1965), predicted that acyl-enzyme 
intermediates would be formed in reactions catalysed by PBP’s as shown 
in scheme 2. Using substrate analogues such as diAc-L-lys-D-ala-D-ala, it 
has been possible to trap the acyl-enzyme intermediate of S. aureus PBP4 
(Kozarich and Strominger, 1978) since k2 > k3\ Acyl-enzyme
intermediates have now been trapped for a number of other 
DD-peptidases including that of Bacillus stearothermophilus using ester 
analogues such as the depsipeptide diacetyl-L-lysyl-D-alanyl-D-lactate 
(Yocum et aU 1980). Trapping of the acyl-enzyme intermediate for high 
molecular weight PBP’s has proved more complicated, but Amanuma and 
Strominger (1984) have used a depsipeptide to trap the intermediate for 
E. coli PBP1A.
At first it was uncertain whether penicillin bound as an 
acyl-enzyme intermediate to the same residue in the active site as the 
substrate. However evidence has now been presented that for many 
PBP’s, substrate and beta-lactam antibiotics do indeed bind to the same 
residue. Yocum et al (1980), were able to trap the acyl-enzyme 
intermediate of the reaction between a substrate depsipeptide and 
l^C-benzylpenicillin with the DD-peptidase of B. strearothermophilus. 
Sequencing of the active site peptide revealed that serine 36 was labelled 
by both substrate and inhibitor. Similarly Duez et al (1981) were able 
to label the active site of the exocellular DD-carboxypeptidase/ 
transpeptidase of Actimomadura R39 with benzylpenicillin.
Proteolytic digests of depsipeptide labelled protein gave peptide maps the 
same as those of penicillin labelled protein indicating that the same 
residue is implicated in binding both substrate and beta-lactam. The 
information from the active site sequencing of various PBP’s and 
beta-lactamases has been collected and has already been shown in table 
2. Alignment of the sequences around the active site residue shows that 
there is a highly conserved ser-xxx-xxx-lys sequence that is used in both 
PBP’s and beta-lactamases. Apart from this region there are no other 
highly conserved residues for all the protein groups although extensive 
homology can be seen within related groups of proteins.
Detailed mechanistic studies on PBP’s have been complicated by 
the fact that these proteins are generally membrane bound. In addition, 
assays for the transpeptidase and DD-peptidases can be long and tedious. 
Fortunately two soluble transpeptidase/DD-peptidases are available from 
Streptomyces R61 and Actinomadura R39 which are readily purified. 
Although these proteins are not the killing targets for their respective
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species (Frere and Joris, 1985), they have proved extremely useful as 
models for PBP action.
The exocellular enzyme from Streptomyces R61 has been shown to 
interact with beta-lactams in a two step mechanism analogous to scheme
2; only slow hydrolysis is seen but no equivalent transpeptidation 
reaction. The efficiency of beta-lactams as antibiotics arises since they
can "tie up" the PBP’s as acylated enzymes i.e. the t j / 2  f ° r ®^1
DD-peptidase is 100 minutes with benzylpenicillin or 70 hours for the
R39 enzyme (Duez et al, 1981; Frere and Joris, 1985). PBP’s can regain 
catalytic activity by hydrolysis or fragmentation pathways. PBP4 of S. 
aureus and PBP’s 5 and 6 of E. coli have been found to act as weak 
beta-lactamases releasing penicilloic acid (Kozarich and Strominger, 1978;
Amanuma and Strominger, 1980) although it has been suggested that this 
activity maybe due to trace contamination by beta-lactamase (Frere and
Joris, 1985). Beta-lactam inactivated DD-peptidases from species such as 
Proteus spp. regain catalytic activity by fragmentation of the 
penicilloyl-moiety to yield phenyl acetyl glycine and dimethylthiazolidine 
or N-formyl-D-penicillamine (Schilf and Martin, 1980). This
fragmentation is slow and depends to some extent on the nature of the
side chain on the beta-lactam (Faraci and Pratt, 1986). Whether 
eventual hydrolysis or fragmentation occur is irrelevant for the 
effectiveness of beta-lactams. It is the length of time the enzyme is 
occupied as an acyl-enzyme intermediate that is important since it can 
no longer catalyse the normal reactions.
5.3: Mode of Inhibition of PBP’s bv Beta-Lactam Antibiotics
Tipper and Strominger (1965) proposed that the final crosslinking 
reaction of peptidoglycan synthesis was inhibited by penicillins because
they were acting as substrate analogues of D-alanyl-D-alanine. Closer 
examination of beta-lactams showed that the ground state conformation 
differed significantly from the shape of the alanyl dipeptide substrate 
(Rando, 1975; Rao and Vaudevan, 1983; Lamotte-Brasseur et al, 1984).
This is exemplified in the beta-lactam nitrogen which is pyramidal in 
the beta-lactam whereas the corresponding nitrogen in D-alanyl-D-alanine 
is planar. Since penicillin was not a substrate analogue Lee (1971) 
proposed that it may be a transition state analogue. If this were the 
case then one would expect the beta-lactam to have a high affin ity  for 
the enzyme since the active sites of enzymes are recognised to have 
evolved to ressemble the transition state (Fersht, 1982). However, the
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initial recognition between the beta-lactam and the R61 DD-peptidases is 
low for both substrate and beta-lactam as shown by the K m of 13mM 
for benzylpenicillin compared with the K m for the substrate 
diAc-L-lys-D-ala-D-ala of 14mM (Frere and Joris, 1985). Beta-lactams 
have now been described as active-site directed acylating agents 
(Ringrose, 1985) where the mode of interaction is initially similar to that 
of the beta-lactamases but unlike these enzymes, the final deacylation 
step is inefficient leading to the inhibition.
It was originally thought that a fused ring system was essential 
for the beta-lactams to be potent inactivators of the PBP’s where the 
fused ring acted as a steric hindrance to any incoming nucleophiles 
(Rando, 1975). However the isolation of monobactams lacking any fused 
ring system (Sykes et aU 1981), showed that the inhibition was not as 
simple as originally thought. It seems that the nature of the 
substituents on the beta-lactam ring play an important role. Frere et al 
(1982), tried to correlate the intrinsic reactivity of various beta-lactams 
as measured by their susceptibility to base hydrolysis, with their 
inactivating potency. No clear pattern emerged with the suggestion that 
how well the beta-lactam fitted into the active site was an important 
criterion for antibacterial potency. Using the model DD-peptidases of 
Streptomyces R61 and Actinomadura R39, as well as TEM beta-lactamase, 
Laurent et al (1984), showed that the orientation of a side chain on
7-/3-acyl cephems had very specific enzyme effects. All these pointed to 
the importance of side chain interactions and that the fate of a 
beta-lactam maybe decided on this basis. Therefore it is difficult to 
predict how efficient each beta-lactam will be as an inactivator for each 
PBP, the problems of which can only begin to be resolved with the
accurate details of several enzyme active sites.
5.4: Tertiary Structure of PBP’s and the Relationships Between PBP’s 
and Beta-Lactamases
Tipper and Strominger (1965), proposed that beta-lactamases had 
evolved from penicillin-binding proteins. This seems a reasonable 
assumption since both proteins bind beta-lactams via an acyl-enzyme
intermediate. By acquiring the ability to deacylate efficiently, PBP’s 
could have evolved to give the beta-lactamases. Spratt (1983) expressed
doubt about the relatedness of these proteins via a common ancestor, due 
to the lack of any primary sequence homology between these two groups 
of protein except for a small degree of weak homology around the
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active site serine residues. It seemed likely that these two groups of 
proteins were demonstrating convergent evolution as with the mammalian 
and bacterial serine proteases. Since then several more complete amino
acid sequences have become available for both groups of proteins. The
amino acid sequence as derived from the DNA sequence for Streptomyces
R61 DD-peptidase shows a weak but consistent homology with the whole
sequence of the class C beta-lactamase from E. coli (Duez et al, 1987). 
Mechanistically, some PBP’s have been shown to act as weak 
beta-lactamases as in the case of S. aureus PBP4 (Kozarich and 
Strominger, 1978). Interestingly Pratt and Govardhan (1984), have shown 
that beta-lactamases can catalyse the hydrolysis of acyclic depsipeptides 
and in addition the class C beta-lactamase from E. cloacae P99 also 
catalyses the acyl transfer of depsipeptides to an amino acceptor, 
D-phenylglycine. That these two groups of proteins can catalyse similar 
reactions serves to underline the similarity in these proteins.
The best proof of the evolutionary relatedness of the 
beta-lactamases and PBP’s comes from the homology in the tertiary 
stucture as seen for the R61 DD-peptidase and three class A 
beta-lactamases from S. aureus, B. cereus and B. IVcheniformis (Herzberg 
and Moult, 1987; Kelly et al, 1986; Samraoui et al, 1986). The tertiary 
structure of the DD-peptidase is very similar to the structure of the 
beta-lactamases. Furthermore since it has already been shown that the 
primary structure of the class C beta-lactamase from E. coli, is more 
closely related to the DD-peptidase, it is also expected that the class C 
beta-lactamases will possess a similar tertiary structure. Unfortunately 
the R61 DD-peptidase is not the best representative of the PBP’s since it 
is exocellular and can function as a transpeptidase or DD-peptidase. 
How this compares with the high molecular weight transpeptidases of E. 
coli and other organisms remains to be seen. In this instance 
determination of the tertiary structure is complicated due to the 
membrane location of these proteins. As an attempt to resolve this 
problem Hedge and Spratt (1984), have solubilised the transpeptidase 
activity of PBP3 from E. coli by splitting the DNA coding for this 
activity from the transglycosylase activity. It is not yet known whether 
such manipulations will alter the structure of the protein.
X-ray crystallography should also help to deduce whether there are 
any structural similarities between the zinc containing beta-lactamases of 
B. cereus and P. maltophilia when compared with the exocellular Zn 
DD-peptidase of S. albus G.
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Section 6: Dissemination of Bacterial Resistance
6.1: Plasmid Mediated Resistance
Prior to the antibiotic era, resistant bacteria were rare as 
determined from stocks of cultures that had been collected before the 
1940’s. The success of bacteria in adapting to changes in their
enviroment can be attributed to the fact that the majority of resistance 
determinants are carried on extrachomosomal pieces of DNA i.e. 
plasmids (Hardy, 1981). In 1974 the discovery that individual resistance 
genes on plasmids were transposable (Hedges and Jacob, 1974), added to 
the knowledge of how rapid spread of resistance occurs.
There are distinct advantages in carrying resistance genes on 
plasmids since these genes can evolve independently of the chromosome. 
Thus they are freed from the constraints imposed by the necessity to 
maintain the integrity of essential chromosomal genes. Furthermore,
synthesis of resistance gene products can be a disadvantage in the
absence of antibiotics so that plasmids offer a strategy by which these
genes can be maintained in a minority of the population. As soon as
antibiotics appear in the enviroment, the cells carrying the resistance 
genes are selected thereby conferring resistance. Plasmids often carry 
genes which code for their own transfer to other cells not just within 
their own species but also to other species. Plasmids that do not carry 
such genes can frequently be mobilised by other plasmids contained 
within the cell.
Many of the beta-lactamases from clinical isolates of Gram-negative 
organisims have been found to be plasmid specified. Matthew (1979), 
described 11 different types although some twenty or more different
beta-lactamases have now been found (Medeiros, 1984). These plasmid 
mediated enzymes include the TEM type and oxacillin hydrolysing 
beta-lactamases, the former being the most commonly occuring with an 
overall frequency of 77% (Matthew, 1979). The dissemination of these 
bacterial plasmids is a continuing problem which is exemplified by the 
following examples.
The plasmid mediated beta-lactamases of Pseudomonas, PSE 1-4 
(Matthew 1979), were originally thought to be Pseudomonas specific but 
have now been identified in E. coli, Shigella sonnei as well as Klebsiella
pneumoniae (Medeiros et al, 1982; Livermore et al, 1984). Eikenella 
corrodens is a Gram-negative bacterium that is implicated in respiratory 
infections. Rotyer et al (1986), have found a beta-lactamase producing 
strain of E. corrodens from which a plasmid has been isolated that
54
hybridises specifically with a plasmid from Neisseria gonorrhoea. This 
suggests that the plasmid may have been passed from one organism to 
another. There have been several instances in which two or more 
plasmid specified beta-lactamases have been found in one organism (Roy 
et al, 1983; Medeiros, 1984). Combinations of beta-lactamases can 
increase the spectrum of beta-lactams to which these organisms are 
resistant and hence cause problems for effective beta-lactam therapy 
particularly in the hospital environment.
Plasmids can also be found in Gram-positive organisms such as the 
Staphylococci and Streptococci. As in Gram-negative organisms, some of 
these plasmids carry genes which code for their own transfer within and 
amongst species although transfer between Gram-negative and 
Gram-positive organisms does not generally occur. The clinically 
important Gram-positive organisms are from Staphylococcus although there 
is one particular isolate of Streptococcus faecalis that is causing concern 
clinically since it can transfer resistance to penicillin, kanamycin 
gentamycin and tobramycin. The resistance to penicillin is specified by 
a beta-lactamase that has several features in common with the class A 
beta-lactamase produced by S. aureus (reported in Jacoby, 1985).
6.2: Chomosomallv Mediated Beta-lactamases
Matthew and Harris (1976), found that virtually all Gram-negative 
organisms produce chromosomally mediated beta-lactamases. The amount 
of beta-lactamase activity is frequently very low, but may increase 
because of induction of the gene or alteration in its number on the 
chromosome (Jaurin et al, 1981). Most of the chromosomally-determined 
beta-lactamases preferentially hydrolyse the cephalosporins including many 
of the newer compounds such as moxalactam and ceftazidime (Medeiros,
1984). These chromosomally mediated enzymes fall into two main 
categories; the broad spectrum enzymes such as that from Proteus vulgaris, 
that hydrolyse penicillins in addition to the cephalosporins, and the 
cephalosporinases that have little or no activity against the penicillins. 
Typical examples of the latter group include the constitutive enzyme 
produced by C. freundii and the inducible enzyme from P. aeruginosa. 
Strains producing both chromosomal and plasmid determined 
beta-lactamases pose a potential threat particularly if the two enzyme 
activities are complementary.
An example of how chromosomally mediated resistance can occur 
has been highlighted by a number of studies. The ampC beta-lactamase
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from E. coli has a low expression due to a weak promotor (Jaurin et ah 
1981). However this beta-lactamase has been found to be hyperproduced 
in a number of clinical isolates. Olsson et al (1983) have studied the 
hyperproduction of this beta-lactamase in six clinical isolates by DNA 
sequencing of the promotor region. It was found that the DNA
sequence was identical in all but one base out of 449 base pairs with
the S. sonnei beta-lactamase gene promotor. This single base pair change 
is a strong up-promotor mutation that can give rise to high levels of
expression. The authors have suggested that in addition to the mutation,
transfer of DNA between S. sonnei and E. coli has occurred. Such DNA 
transfer can therefore promote bacterial resistance and is causing concern 
since wide spread non-discriminatory use of antibiotics will select for 
such mutations.
6.3: Transoosons
An increasing number of resistance genes, including those coding 
for the beta-lactamases, have been localised to transposons. These are
genetic elements capable of transfering themselves from one DNA 
location to another independently of the host cell rec A recombination 
apparatus. The detailed structure of transposons and models for the 
transposition process have been reviewed by Kleckner (1981) and
Grindley and Reid (1985). A transposon consists of one or several genes 
and a section of DNA coding for transposition functions flanked on
either side by inverted repeats (IR’s). A different type of transposon is 
termed a composite transposon in which the resistance genes are flanked 
by two insertion sequences (IS elements). IS elements are themselves
capable of "illegitimate recombination" since they carry their own genes 
for transposition functions. The integration of transposons into target
DNA can lead to a number of different events which include cointegrate 
formation between two plasmids or deletions of adjacent sections of 
DNA, inversions or insertions. The transposition event is replicative in 
that a second copy of the transposon is synthesised regardless of the
intermolecular rearrangements that occur.
Beta-lactamases that have been localised to transposons are outlined 
in table 4. Yamamoto et al, (1981), isolated Tn2603 from E. coli plasmid 
RGN238. This transposon codes for the OXA-1 beta-lactamase along
with resistance to streptomycin/spectinomycin, sulphonamides and the 
mercuric ion. This linkage of resistance genes is also found for 
plasmids carrying OXA-2, PSE-1, PSE-2 and PSE-4 which are located on
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transposons (refer to table 4 for references). This common linkage of 
genetic determinants has been studied by Tanaka et al (1983), who 
suggest that these transposons stem from an ancestral mercury transposon. 
Kratz et al (1983), have suggested that the OXA-2 beta-lactamase isolated 
from Salmonella typhimurium located on Tn2410 of R1761, is also related 
to this mercury transposon.
Nies et al (1985), have looked at the processes that can lead to 
the evolution of transposons and plasmids. Detailed analysis of R1761 
carrying Tn2140 coding for the OXA-2 beta-lactamase, sulphonamide and
mercury resistance, showed that an IS element was responsible for a
series of deletions starting at a site bordering the tetracycline resistance 
gene. This IS element is present in several copies on this plasmid and 
has been designated as IS160. It is interesting to note that Yamamoto et 
al (1984), found a similar set of deletions on the related R46 plasmid, 
bordering the tetracycline resistance gene, which may carry the same IS 
element.
Transposition plays an important role in the dissemination of
bacterial resistance. A study of the OXA-1 beta-lactamase and its
frequent linkage to streptomycin, sulphonamide and mercury resistance 
has led to the speculation that a transposon such as Tn2603 has been 
involved in the spread of this beta-lactamase (Yamamoto et al 1983).
With the continued use of antibiotics the selection pressure is being 
maintained for the continued evolution of these plasmids.
6.4: Plasmid Types which Carry the OXA-2 Beta-Lactamase
R46 is a large conjugative plasmid (51.7Kb) that is found in many 
genera of the Enterobacteriaceae (Tardif and Grant, 1980). It codes for
the resistance to tetracycline, spectinomycin/streptomycin, sulphonamides, 
arsenate ions and ampicillin, the last being mediated by the OXA-2 
beta-lactamase. Brown and Willetts (1981), have constructed a detailed
restriction map of this plasmid which shows the clustering of the
resistance genes within a 15Kb segment. The bla gene coding for the
OXA-2 beta-lactamase has been localised between the replication origin 
and spectinomycin determinant. The data suggested that the bla gene
may span an EcoRl site and has been confirmed by Langcr et al (1981).
There is no evidence to suggest that the bla gene is transposon 
mediated in R46 despite the localisation of the OXA-2 beta-lactamase in 
R1767 on Tn2410 (Kratz et al, 1983). Brown et al (1984), have studied
the functions of R46 that promote fusions, deletions and cointegrate
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formation. These appear to be mediated by two insertion sequences 
designated IS46. R46 has been known to suffer deletions on storage and
general genetic manipulations. One of these derivatives, pKMlOl, no 
longer codes for resistance to spectinomycin, sulphonamides and 
tetracycline but still carries ampicillin resistance. Detailed
characterisation of pKMlOl has shown that it is the same as R46 but 
minus a 14kb section of DNA (Langer and Walker, 1981). IS46 mediated 
deletions appear to be responsible for the formation of pKMlOl and also 
the deletions that have been observed by Yamamoto et al, (1984).
Figure 10, shows the genetic maps of R46 and its relationship with 
pKMlOl.
Figure 10: Relationship of R46 to pKMlOl.
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6.5: Plasmids Specifying OXA-2 Beta-Lactamase used in this Project
The R46 plasmid is large and inconveniant to use for genetic 
manipulations. Consequently the bla gene was isolated and cloned into 
more convenient high copy number vectors that could be amplified 
thereby producing large quantities of DNA suitable for DNA sequencing 
and molecular characterisation. The plasmid pSU5 was constructed by 
taking the Bglll D fragment from R46 (Brown and Willetts, 1981) 
containing the genes for ampicillin and spectinomycin resistance and 
clonong it into the BamHI site of pED815, a derivative of pBR325 in
which the TEM beta-lactamase has been inactivated by a deletion around 
the Pstl site (Willetts, unpublished results). The insert in pSU5 was 
found to have suffered a deletion (figure 1 1) which did not affect
ampicillin resistance. The BamHI/Hindlll fragment of pSU5 was then
cloned into the BamHI/Hindlll restriction sites in pACYC184 (Chang and 
Cohen, 1978) to give pSU8 . These plasmids are shown in figure 11, in
a simplified format.
F i g u r e  11: P l a s m i d s  S p e c i f y i n g  the  O X A - 2  B - L a c t a m a s e  and their Re la t i onships
R46/pKM101
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Experimental
Section 7: Materials 
7.1: Strains
All the strains and their characteristics that have been utilised in 
this project are listed in table 5.
7.2: Antibiotics
Amoxicillin, benzylpenicillin, ampicillin and the lithium salt of 
clavulanic acid were obtained from Beecham Pharmaceuticals. Nitrocefin 
was obtained from Glaxo Research and oxacillin from Sigma.
7.3: Chemicals
Chemicals that have not been specified were routinely obtained 
from Sigma or BDH.
Aldrich
m-Aminophenylboronic acid 
BCL (Boehringer Mannheim)
Caesium chloride (analar), Deoxynucleoside triphosphates (dNTP’s), 
Dideoxynucleoside triphosphates (ddNTP’s).
BDH
Acrylamide Electran, Ammonium bicarbonate, Ammonium persulphate, 
Ammonium sulphate, Boric acid, Dimethyldichlorosilane,
Dimethylsulphoxide, Di-sodium hydrogen orthophosphate, Dithiothreitol 
(DTT), Ethylenediamine tetra acetic acid di-sodium salt (EDTA), 
Formamide, Hydrochloric acid aristar grade, Magnesium chloride 
hexahydrate, PAGE blue ’83, Phenol, Polyethelene glycol 6000, Propan-2-ol 
aristar grade, Sodium acetate, Sodium citrate, Sodium dihydrogen 
phosphate, Sucrose, Tetramethylenediamine (TEMED).
BRL (Bethesda Research Laboratories Inc.).
Agarose (Ultrapure), Phenol (Ultrapure), Urea (Ultrapure)
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May and Baker 
Sodium chloride
Oxoid
Bacteriological agar No 1, Tryptone, Yeast Extract.
Sigma
Coomassie brilliant blue G250, Ethidium bromide, Fluorescamine, Glycine, 
Herring testes DNA, Lysosyme (grade 1) Isopropyl- 
beta-D-thiogalactopyranoside (IPTG), Gamma-Methacryloxypropyl-
trimethoxy silane, Molecular weight markers (14,000-66,000) for SDS gel 
electrophoresis, NN’-methylene-bis-acrylamide, PPO (2,5. diphenyl oxazole), 
Ribonuclease type 1A, tRNA, Sodium dodecyl sulphate, Staphylococcal 
nuclease Y8 , Trypsin-TPCK treated, Trizma base (tris{hydroxymethyl)), 
X-gal (5-bromo-4-chloro-3-indolyl-beta-galactoside) Bovine Serum Albumin 
(pentax fraction Y)
Affigel 10 was obtained from BioRad Laboratories and Sephadex G25, 
G50, G75 and G100 fine grade were obtained from Pharmacia. Silica 
coated plastic sheets 2 0  x 2 0  cm for thin layer chromatography 0 .2 nm 
thickness were bought from BDH.
Restriction enzymes were purchased from BRL, BCL or New England 
Biolabs.
Calf Intestinal Alkaline Phosphatase, T4-ligase, Bacteriophage lambda DNA 
and 4>X174 DNA were purchased at BCL.
DNA polymerase I and Klenow fragment were obtained either from BRL 
or Amersham International PLC.
35S and 32p deoxyadenosine triphosphate triethyl-ammonium salt and 
Amplify for fluorography were purchased from Amersham International 
PLC.
M13mp9 and M13mpl8 (RF) DNA were obtained from New England 
Biolabs.
The Ampholine Polyacrylamide gel . (PAG) plates pH 3.5 - 9.5 were
obtained from LKB and the broad pi calibration kit (pH 3 - 10) was
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obtained from Pharmacia Fine Chemical AB.
Films
Kodak: X-Ray X-Omat film 
Fuji: X-Ray RX film
Polaroid: Positive/negative 4x5 land film type 665 
Agfa: 100 asa colour 35mm film
7.4: Media
The following media were each made up in a total volume of 1 1.
The pH was adjusted to 7.0 with sodium hydroxide. To make agar, 
15g/l was added. To make agar, 15g/l was added.
H-Top Agar 
lOg Tryptone 
8 g Sodium Chloride . 
8 g Agar
Glucose-minimal media 
6 g Na2 H P0 4  
3g KH2 P 0 4  
lg NH4 C1 
0.5g NaCl 
15g Agar
The volume was made up to 985ml and autoclaved. After the media 
had cooled, the following sterile reagents were added.
L-Broth
lOg Tryptone 
5g Yeast Extract 
5g Sodium Chloride
2xTY
16g Tryptone 
lOg Yeast Extract 
5g Sodium Chloride
lml MgSQ4
lml 0.1M CaCl2 
lml 1M Thiamine 
10ml 20% Glucose
6 4
7.5: Buffers
Standard buffers were prepared according to the directions given 
in "Data for Biochemical Research", 2nd edition (Dawson et al, 1969).
lOx Annealing buffer 
lOOmM Tris-HCl pH 8.5 
50mM MgCl2 
50 x Denhardt’s 
0.5g Ficoll (Mr  400,000)
0.5g Polyvinylpyrrolidine (MR 40,000)
0.5g Bovine Serum Albumin 
Water to 50ml
Hybridisation buffer 
6 x Sodium Citrate (SSC)
0.01M EDTA
5 x Denhardt’s 
0.5% SDS
100^g/ml Herring testes DNA 
32P labelled DNA
Prehybridisation buffer
6  x SSC 
0.5% SDS
5 x Denhardt’s
lOOfig/ml Herring testes DNA
20 x SSC buffer 
175.5g Sodium Chloride
88.2g Sodium Citrate made up in a total volume of 
800ml the pH brought to 7.0 and the volume adjusted to 11.
Ligation buffer 
0.66M Tris-HCl (pH 7.6)
0.05M MgCl2
0.05M Dithiotreitol (prepared as 1M and filter sterilised)
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Nick Translation buffer  
0.5M Tris-HCl (pH 7.2)
0.1M MgS04
ImM Dithiothreitol
500/^g/ml Bovine Serum Albumin
Tris-Borate-EDTA (TBE) buffer 
0.089M Tris 
0.089M Boric acid pH 
0.002M Na2EDTA
TBE Loading buffer for Agarose gel Electrophoresis 
TBE buffer as above containing 
50% Glycerol 
5% SDS
0.025% Bromophenol Blue
Tris-EDTA (TE) buffer 
lOmM Tris-HCl pH 8.0 
ImM Na2EDTA
7.6: Buffers for Restrition Enzvmes
Buffers were prepared at lOx the concentration and were diluted 
10 fold prior to use.
High Salt
lOOmM NaCl
lOmM Tris-HCl pH 7.5
lOmM MgCl2
ImM Dithiothreitol
Medium Salt 
50mM NaCl
lOmM Tris-HCl pH 7.5 
lOmM MgCl2  
ImM Dithiothreitol
Low Salt
lOmM Tris-HCl pH 7.5 
lOmM MgCl2  
ImM Dithiothreitol
Fsp I buffer 
50mM NaCl 20mM KC1
lOmM Tris-HCl pH 8.0 
lOmM MgCl2 
ImM Dithiothreitol
Sma I buffer
6 mM Tris-HCl pH 7.4 
6 mM MgC12 
6 mM 2-mercaptoethanol 
100/^g/ml Bovine serum albumin
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Section 8 : Methodology
8.1: Handling of DNA and Protein
Routine precautions were taken in the handling of- both DNA and 
protein samples. Care was always taken to wear disposable gloves to 
prevent nuclease digestion of samples. Similarly all buffers, tips and 
disposable tubes were autoclaved prior to use. Glassware for proteins 
was washed in Decon 90 followed by extensive washing in tap water 
then distilled water and finally in MiliQ water (18MC deionised distilled
water from Waters Filtration system). Glassware was then heated to 
120* C for 15mins prior to use. Protein samples for peptide mapping 
were prepared in sterile disposable tubes to prevent dust contamination;
peptides were spotted onto T.L.C. plates in dust free laminar flow hoods.
8.2: Charaterisation of Protein 
8.2.1: Protein Concentration
The protein concentration was measured by the Bradford method 
(Bradford, 1976) using bovine serum albumin as the standard. Standard 
curves were constructed each time the protein concentration was
determined using the same buffer as in the sample. The Bradford
r ■
reagent was filtered prior to use; 5ml was mixed with 0.1ml of protein
solution. The samples were well mixed and the absorbance read after
5mins at 595nm. Protein was diluted until the absorbance readings were 
in the linear part of the standard curve.
Bradford Reagent: lOOmg Coomassie Brilliant Blue G250 dissolved in 50ml
of 95% ethanol, 100ml 85% phosphoric acid (w/v). Diluted to 11.
8.2.2: Nitrocefin Microtitre Test
The chromogenic beta-lactamase substrate nitrocefin (O’Callaghan et 
al, 1972) was used to rapidly identify column fractions that possessed 
beta-lactamase activity. 50mg/ml nitrocefin was dissolved in
dimethylsulphoxide and stored at 4* C in the dark. This stock solution 
was diluted to 500/ig/ml of which one drop was mixed with one drop
of column effluent. A colour change from yellow to red showed the 
presence of beta-lactamase; the quicker the colour change, the more 
beta-lactamase present. This procedure gives a rapid estimate of column 
fractions that possess the most enzyme activity.
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8.2.3: Soectroohotometric Assay of Beta-Lactamase Activity
Enzyme activity was measured using a spectrophotometric assay 
described by Samuni (1975). Hydrolysis of substrate was measured at a 
wavelength that is characteristic of the substrate in question. This 
optimal wavelength is determined by comparing the relative absorption 
spectra from hydrolysed and unhydrolysed substrate and determining the 
difference spectrum. The actual wavelength chosen represents the 
differential peak.
The assays were carried out using a Beckman model 24 double 
beam uv spectrophotometer linked to a Beckman strip chart recorder and 
a Haake circulator. A typical assay consisted of 2ml of 0.025M sodium 
phosphate buffer at pH 7.4 prewarmed to 30* C. 0.5ml of substrate 
usually at 2.5mg/ml, was added to the cuvette and prewarmed to 30’ C. 
The reaction was started by adding 10-50/il of enzyme, mixing the 
cuvette by inversion against buffer as the blank. Table 6 gives the 
optimal wavelengths used for a range of substrates.
Table 6 : Optimal Wavelengths for monitoring the hydrolysis of substrates 
using' the Spectrophotometric assay.
Substrate 
Amoxicillin 
Ampicillin 
Benzylpenicillin 
Cephaloridine 
Oxacillin
8.2.4: Definition of Enzyme Units
One unit of enzyme activity is defined as 1/zmole of 
benzylpenicillin hydrolysed per minute at 30’ C in phosphate buffer pH 
7.4.
Wavelength (nm) 
250 
240 
240 
305 
263
6 8
8.2.5: Preparation of Beta-Lactamase from Crude Cell Extracts
The required strain was inoculated from a single colony grown on 
ampicillin L-plates into 10ml of L-broth and grown for 6  hours after 
which 6 ml was added to 100ml of prewarmed L-broth in a 500ml flask. 
Cells were grown at 37* C on an orbital shaker (MKV model set at 
amplitude 5) overnight with ampicillin selection. The cells were 
harvested at 4*C by centrifugation on an MSE high speed 18 at 9000 
r.p.m. in a 6 x 300ml rotor. The cell pellet was washed in 50ml of
0.05M sodium phosphate buffer pH 7.4 at 4 ’ C and resuspended in a
final volume of 5ml of the same buffer. Crude cell extract was made 
by sonicating the cell paste on ice in an MSE sonicator type 18, for 1-2 
minutes at amplitude 3. The disrupted cell suspension was centrifuged 
at 10,000 r.p.m. for 20mins (MSE 18, 16 x 15ml rotor at 4 'C )  and the 
suspension was stored at -2 0 ' C.
8.2.6: Sucrose Density Gradient Centrifugation of Proteins
Linear 5 - 20% sucrose density gradients in 0.1M sodium phosphate 
buffer at 20’ C, were constructed using a peristaltic pump. The linearity 
of the gradients was estimated by mixing bromophenol blue at O.Olmg/ml 
with the 20% sucrose solution. As the gradient was poured there was a 
gradual decrease in the concentration of the dye proportional to the 
sucrose concentration. Fractionation of the gradient was carried out by 
upward displacement on an MSE fractionator in which a 40% sucrose 
solution was pumped into the bottom of a tube. The denser solution 
forced the gradient upwards through a small hole out of which 0.5ml 
fractions were collected. These could then be read at 450nm and an
estimation of the linearity of the gradient made. 4.8ml or 12ml 
gradients constructed in this manner in polyallomer tubes (Beckman) and 
left for one hour at room temperature before assay, routinely gave linear 
gradients.
Protein samples in 0.15ml of the same phosphate buffer containing
no sucrose, were gently layered on top of the 1 2ml gradient with a
drawn out glass capillary. Alternatively 0.1ml was layered on to the 
4.8ml gradients. The tubes were centrifuged at 1 8 'C for 25 - 30 hours 
at 31,000 r.p.m. in a Beckman SW40Ti rotor for the 12ml gradients or 14 
- 16 hours at 38,000 r.p.m. for the 4.8ml gradients in an SW50.1Ti rotor. 
Centrifugation was always started with gentle acceleration and terminated 
with the brake off. The gradients were then fractionated into 0.5ml
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aliquots and assayed for enzyme activity and/or absorbance at 280nm.
8.2.7: Affinity Chromatography of OXA-2 Beta-lactamase on L-Boronic 
Acid Columns
This affinity  column was prepared as described by Cartwright and 
Waley, (1984). 20ml of affigel-10 was washed with propan-2-ol at 4* C 
and then transfered to 20ml of 1M KHCO3 containing 2g of sorbitol.
2 g of m-aminophenylboronic acid was dissolved in the gel by adding 
small aliquots. The reaction was mixed for one hour at room 
temperature maintaining the pH of the solution at 8.0 with solid 
KHCO3 . The gel prepared in this way was made into a column 1 x 
20cm and washed with 200ml 1M NaCl/0.5M sorbitol pH 7.0 followed by 
200ml 0.5M borate pH 7.0 and finally 20mM triethanolamine
hydrochloride/0.5M sodium acetate pH 7.0.
OXA-2 beta-lactamase was dialysed against 20mM
triethanolamine-HCl/0.5M sodium acetate at pH 7.0 before loading onto 
the column at 4* C in the same buffer. The column was washed in the 
same buffer at a flow rate of 20 - 30ml/hour until the OD at 280nm 
was zero. Beta-lactamase was eluted from the column with 0.5M
borate/0.5M sodium acetate pH 7.0. The position of the protein band 
was estimated at 280nm and also by activity measurement using the
nitrocefin microtitre test and the spectrophotometric assay.
8.2.8: Renaturation of Beta-Lactamase Activity from SDS Polyacrylamide 
Gels fTai et ah 19851
Beta-lactamase actvity can be renatured from SDS polyacrylamide 
gels by the method given below. The beta-lactamase activity is
visualised by the change in blue black colour of a starch-iodine complex 
to white, when penicilloic acid is formed as a result of beta-lactamase 
hyrolysis of penicillins.
(a) Preparation of Starch Iodine Paper. A stock solution of 0.25M 
iodine in 1.25M potassium iodide was prepared and stored in a dark 
bottle. This was diluted 100 fold by 2% starch that had been dissolved 
by boiling. Whatman 3MM paper was then dipped in this solution and 
allowed to dry before being stored in a cool, dry and dark place. This 
paper was kept stored for a maximum of one month.
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(b) SDS Polyacrylamide Gel Electrophoresis. This was carried out as
described by Laemmli and Favre (1973), with 6 % and 15% (w/v)
acrylamide being used for the stacking gel and resolving gels 
respectively.
(c) Renaturation of Beta-Lactamase Activity. After electrophoresis the 
gel was washed in 0.005M potassium phosphate buffer for 1 hour with 
one change of buffer after 1 /2  hour, at room temperature with gentle 
agitation. The gel was then left in fresh buffer at 37’ C for 90mins 
with a change of buffer after 45mins. To test for beta-lactamase 
activity, the gel was placed on a clean glass plate and covered in 
Whatman 3MM paper that had been soaked in lOmg/ml of 
benzylpenicillin dissolved in 0.01M phosphate buffer/0.5M sodium acetate 
buffer pH 7.0. The gel was covered with a second glass plate and the 
gel sandwich left for 15mins. The filter was then replaced with
starch-iodine paper soaked in the same bezylpenicillin solution and left 
for 1 - 1 2  hours in the dark after wrapping in clingfilm to prevent the 
gel from drying out. The appearance of bands was monitored regularly 
and the results photographed on a Polaroid Land camera.
8.2.9: Isoelectric Focusing (I.E.F.) of Beta-Lactamases
Isoelectric focusing was carried out on an LKB Multiphor system 
as described in the LKB insruction sheet 1804 supplied with the
preprepared LKB Ampholine PAG plates, pH range 3.5 - 9.5. Protein
samples were applied in 15/tl aliquots to the application filters provided 
with the plates. The position of these filters on the gel was estimated 
from the expected pi of the sample; filters were positioned so as to 
avoid sample focusing directly beneath the filter and also to avoid 
extremes of pH. Beta-lactamase samples were run in duplicate and were 
routinely stained by two methods after cutting the gel in half following
I.E.F. The first of these was by activity staining with the chromogenic 
substrate nitrocefin. Nitrocefin was dissolved in dimethylsulphoxide at 
50mg/ml before diluting in sodium phosphate buffer 0.025M pH 7.5 to
0.5mg/ml. Whatman 3MM filter paper was then dipped in this substrate 
solution and was used to overlay the I.E.F. gel. Beta-lactamase activity 
could be observed by the appearance of red bands within 5 - 3 0  
minutes. The position of the bands was then recorded by photography 
on a Polaroid Land camera. The second method used to record the 
position of the beta-lactamase was by Coomassie blue staining using the
procedures outlined in the LKB instruction sheet 1804. This method was
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used to determine the position of pi markers that were run on each gel.
8.2.10: Trvosin Hydrolysis
Samples of OXA-2 beta-lactamase (200 - 800/xg) were dialysed 
against 0.1M ammonium bicarbonate buffer pH 8.2. lmg/ml trypsin
(TPCK treated) in 0.1 mM HC1 was added to the beta-lactamase at a 
concentration of 1% (w/w of protein). The sample tube was purged
with nitrogen and stoppered so as to limit the oxidation of amino acid 
side chains before leaving at 37* C for 5 - 5.5 hours. At this point the 
reaction could be freeze dried after which the partial tryptic digests 
could be analysed. Alternatively, a second addition of trypsin at 1% 
(w/w) could be made and the protein left a further 18 - 19 hours for
complete hydrolysis of the beta-lactamase. The tryptic digests were 
freeze dried and stored at -20* C.
8.2.11: Peptide Mapping
Silica G T.L.C. plates were trimmed to a dimension of 14 x 
20cm to fit  the LKB flat bed multiphor system. 5 - 1 0  nmoles of 
OXA-2 beta-lactamase that had been hydrolysed by trypsin, were 
resuspended in 0.1M ammonium bicarbonate buffer pH 8.0 and were
applied to the T.L.C. plate using a drawn out glass capillary tube. The 
peptides were applied to one spot in several aliquots, drying the spot in
a jet of cold air after each application. In this way the spot could be
kept to a maximum diameter of 2mm. The position to which the 
peptides were applied was estimated from the pi of the protein. Since
OXA-2 beta-lactamase is basic, the majority of the peptides were 
expected to move towards the cathode. Consequently the application spot 
was 3cm away from the centre and was nearer to the anode.
Electrophoresis was carried out in the first dimension on an LKB 
muliphor system containing a water cooled plate which was maintained 
at 10' C. The T.L.C. plate was dampened with the electrophoresis buffer 
(pyridine/ acetic acid/ water 25/1/225 v /v /v  pH 6.5) by placing
moistened Whatman 3MM paper over the surface of the plate, leaving the 
application spot exposed and letting buffer diffuse in from four
directions. This results in the sharpening of the spot to which the 
peptides have been applied. The T.L.C. plate was placed on the cooled 
plate which had been smeared with light paraffin  to ensure that no air
bubbles were trapped under the T.L.C. plate; contact was made with the
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buffer and plate by folded Whatman 3MM paper. Electrophoresis was
carried out for 1 hour at 500V, 95mA after which the T.L.C. plate was
removed and dried in a jet of cool air.
Chromatography was carried out in the second dimension by 
placing the T.L.C. plate perpendicular to the direction of electrophoresis
in a vertical chromatography tank that had been prequilibrated in
butan-l-ol/acetic acid/water/pyridine (15/3/12/10 by volume). The solvent 
front was allowed to reach within 1cm of the top, before the plate was 
removed and thoroughly dried. Peptides were visualised by dipping in 
acetone followed by 1% triethylamine and 0 .0 1 % fluorescamine in acetone. 
The process was repeated and the peptides visualised under long 
wavelengh uv at 366nm. Alternatively when ^ C  labelled peptides were 
mapped, the T.L.C. plate was dipped in 7% 2,5-diphenyloxazole in
acetone. The T.L.C. plates were exposed to preflashed X-ray film for a
suitable period of time.
8.3: DNA Manipulation
Quantitation of DNA using spectrophotometric methods, 
phenol/chloroform extraction of DNA, ethanol precipitations and 
horizontal agarose gel electrophoresis in TBE buffer, were carried out as 
described in Maniatis et al, (1982).
8.3.1: Small Scale Preparation of Plasmid DNA (Birnboim and Dolv. 1979)
The following protocol was adapted for isolation of large plasmids
from 10ml L-broths. Strains were grown overnight at 37* C in L-broth
containing 5 - 20jig/ml ampicillin to select for plasmid carrying cells. 
Cells were spun for 10 minutes in an MSE Chilspin centrifuge at 4500
r.p.m. at 4* C. The supernatant was discarded and the cells resuspended
in lml of lysis buffer (25mM Tris-HCl pH 8.0, lOmM EDTA, 50mM
glucose) which contained freshly prepared lysosyme at 2mg/ml. The cells 
were kept on ice for 30mins before addition of 2ml of alkaline SDS
(0.2M NaOH, 1% SDS). After 5 minutes on ice, 1.5ml of 3M sodium
acetate pH 4.8 was added and the cells kept on ice for a further 
60mins. This procedure precipitates the chromosomal DNA and protein
which can be removed by centrifugation at 4500 r.p.m. at 4 ’ C. The
supernatant was removed and 2  volumes of cold ethanol were added to 
precipitate the DNA at -70* C for 30 minutes. The DNA was collected 
by centrifugation and the precipitate was resuspended in lml of 0.1M
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ammonium acetate. It was found that contaminating proteins could be 
removed at this stage by a phenol/chloroform extraction and the DNA 
was ethanol precipitated as previously described. After centrifugation
the DNA pellet was dried in a dessicator under vacuum and resuspended 
in TE buffer to give the desired concentration. At this stage any 
contaminating RNA could be removed by adding 50/ig/ml heat-treated
ribonuclease (boiled for 15 minutes to destroy any DNase activity).
8.3.2: Large Scale Isolation of Plasmid DNA from E. coli
Many methods are available for the large scale purification of 
DNA but the following method proved to be very good in our
laboratory. Reagents: Brij/Doc (1% Brij 58, 0.4% sodium deoxycholate,
lOmM Tris-HCl pH 8.0, ImM Na2 EDTA); Sucrose solution (25% sucrose, 
50mM Tris-HCl pH 8.0); Lysosyme solution (20mg/ml lysosyme, 250mM 
Na2 ETDA).
Procedure: A single colony of the required strain was inoculated into 
10ml of L-broth containing the appropriate concentration of ampicillin. 
The culture was grown overnight at 37* C before inoculating 500ml flasks 
containing 100ml L-broth with the required concentration of ampicillin. 
Cells were grown at 37* C with shaking until the OD at 600nm had
reached 0.9. The plasmid DNA was amplified by adding 150^g/ml of
chloramphenicol or if  the plasmid specified chloramphenicol resistance, 
170^g/ml spectinomycin was used to amplify plasmid DNA. The cells 
were then grown for another 18 hours before harvesting for 10 minutes 
at 6000 r.p.m. in an MSE High speed 18 centrifuge in a 6  x 300ml 
rotor at 4* C. Cells were resuspended in 2.6ml of the sucrose solution 
and transfered to a 50ml centrifuge pot. 0.4ml of freshly prepared 
lysosyme solution was then mixed with the cell suspension by swirling 
the tubes gently on ice for 5 mins. 2.6ml of 250mM Na2EDTA was
then added to the tubes and left for a further 5 minutes on ice.
Brij/Doc (4ml), was rapidly added to the cells and mixed before leaving 
on ice for 30 minutes. The cell debris was removed at 15,000 r.p.m. at 
4* C. Supernatant was carefully removed and made 0.95g/ml with CsCl 
and 0.5mg/ml with ethidium bromide.
The cleared lysate prepared in this way was added to a Beckman 
Quickseal polyallomer tube which was sealed and spun in a Beckman 
L8 -M ultracentrifuge with the Ti70.1 fixed angle rotor at 40,000 r.p.m. 
Spins were routinely carried out for. 48 hours at 20’ C before collecting 
plasmid DNA. This was collected by viewing the DNA under uv at
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254nm as follows: one hypodermic needle was inserted in the top of the 
polyallomer tube, and a second needle attached to a sterile syringe was
inserted through the side of the tube just below the plasmid band, 
which could then be withdrawn.
Ethidium bromide was extracted from the plasmid DNA with an 
equal volume of CsCl saturated propan-2-ol equilibrated with CsCl
saturared water, a total of three times. The DNA was then dialysed 
against 4 x 500ml of TE buffer before precipitating with ethanol and 
redissolving in an appropriate amount of TE buffer. The quality and
amount of the DNA was checked spectrophotometrically.
8.3.3: Restriction Endonuclease Digestion of DNA
Restriction digests of DNA were carried out according to the 
manufacturers instructions. 1 - 5/ig of DNA in TE buffer were
routinely mixed with I pi of the appropriate lOx buffer and I pi of 
restriction enzyme in a total volume of lOpl. Digests were carried out
for 1.5 - 2 hours at 37* C (30* C for Smal) and analysed on agarose
gels. Double digests were carried out in the same way except that one
enzyme at a time was used, the first enzyme used being the one that 
required the lower salt concentration. Before addition of the second
enzyme and the appropriate concentration of NaCl if needed, the first 
enzyme was heat inactivated for lOmins at 70* C. Enzymes that could 
not be heat inactivated were phenol extracted. Table 7 shows the
appropriate buffers and special conditions if  any, for the restriction 
enzymes that were used.
Table 7: Buffers Used for Restriction Endonuclease Digests of DNA.
Buffer Type
Medium 
Low 
High
Medium or alternatively Fspl buffer 
Medium
Medium or High 
Low
Smal buffer
Restriction Enzyme
BamHl
Clal
EcoRl
Fspl
Hincll
Hindlll
Kpnl
Smal
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8.3.4: Recovery of DNA from Low-Temoerature Melting Agarose
Low-temperature melting agarose was dissolved in TBE buffer at a 
concentration of 1% and melted by heating at 70* C. The gel was
cooled to 37’ C and made 0.5/xg/ml with ethidium bromide before 
pouring into a BRL mini gel precooled to 4 ’ C. DNA samples were 
loaded and the electrophoresis was carried out at 4 ’ C to prevent the gel 
from overheating and melting. The desired fragment of DNA was cut 
out from the gel under uv and transferred to a microfuge tube 
containing approximately 2 - 3  volumes of TE buffer. The tube was 
heated to 65* C for five minutes to melt the gel which was then 
extracted with phenol prequilibrated with TE buffer. The two phases 
were separated by centrifugation and the aqueous phase was recovered 
and extracted twice more with phenol/chloroform followed by chloroform 
and finally water saturated ether before precipitation with ethanol.
8.3.5: Isolation of DNA from Agarose Gels using NA45 Membrane
The method is described by Young et al (1985) in which DNA
stained with ethidium bromide was electroeluted onto Schleicher and
Schull NA45 DEAE membranes. This was done by making a cut just
above and below the band of interest and inserting TE soaked
membranes into the cuts. The DNA was collected into the lower 
membrane by electroelution whereas the upper membrane prevented any 
unwanted DNA from contaminating the lower membrane. Electroelution 
was continued until it was seen that all the DNA had collected on the 
membrane under uv. The membrane was quickly rinsed with TE buffer 
and placed into a microfuge tube. The DNA was extracted into 0.4ml 
of 1M NaCl/0.05M arginine by incubating at 70* C for 2 hours. The 
DNA could then be precipitated from this solution with ethanol.
8.3.6: Dephosphorvlation of DNA
The terminal 5’ phosphates can be removed from DNA by calf
intestinal phosphatase. This enzyme was used to dephosphorylate the
digested vector DNA to prevent intra-vector ligation. The method used
was as described in Maniatis et al (1982).
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8.3.7: Ligation of DNA fragments
Ligations were carried out using a ratio of insert to vector DNA
of 3:1 where it was possible to quantitate the amount of insert DNA.
Typical ligations were set up in which 5/d of insert DNA were mixed
with 2/d of vector DNA, 1/d of lOx ligase buffer, 1/d of lOmM ATP 
and 1/d of T4 ligase. Ligations were kept at 1 4 'C overnight before 
transformation. Vector DNA was routinely dephosphorylated to prevent
self ligation particularly since most of the ligations carried out, were 
blunt ended. Rigorous controls were set up to test the efficiency of 
ligation and transformation; these included unligated vector DNA, 
dephosphorylated DNA and uncut vector DNA.
8.3.8: Formation of Competent Cells
All transformations carried out in this project were on E. coli 
strain JM101 and were performed as published in the Amersham 
Technical booklet (1982) provided with the M13 sequencing kit. 40/d of 
an overnight culture was inoculated into 4 x 10ml of 2 x TY broths 
and left at 37’ C with shaking until the OD at 600nm had reached 0.5 - 
0.6. The cells were spun down at 4500 r.p.m. in an MSE Chilspin, at 
4* C, for 10 minutes after which they were suspended in ice cold 0.05M 
CaCl2  and left on ice for 20 minutes. The cells were respun and the 
supernatant poured off before resuspending in l / 2 0 th of the original 
volume of cold CaCl2 . 0.3ml aliquots of these competent cells were 
dispensed into bijou bottles containing 5/d of the DNA from the ligation 
mix. Samples were then left on ice for a further 40 minutes before 
heat shocking at 42’ C for 3 minutes and returning to ice.
IPTG (isopropyl-0-thio-galactopyranoside) induction was used to 
detect recombinant clones since the vector DNA contained the insert 
within the beta-galactosidase gene. Any transformants that did not 
contain insert DNA would show normal expression of the /3-galactosidase. 
This can be easily recognised by incorporating X-gal
(5-bromo-4-chloro-3-indolyl-B-galactoside), a chromogenic substrate, into the 
media which turns blue around plaques that code for a functional 
enzyme; transformants that possess the insert DNA are white. The 0.3ml 
of transformed cells were added to 3ml of H-top agar containing 10/d 
of lOOmM IPTG, 40/d of X-gal and 50/d of an overnight broth of E. 
coli JM101. The H-top agar was. poured over 2 x TY plates and 
allowed to set before incubating at 37’ C overnight.
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8.4: DNA Manipulation using Radio-labelled Nucleotides
8.4.1: Nick Translation
Nick translation can be used to label both strands of DNA. The 
duplex is nicked at various positions by DNAse I and is filled in with 
labelled nucleotides by DNA polymerase I. DNA labelled in this way 
can be used to probe for similar sequences in either DNA or RNA that 
has been immobilised. In this particular instance, plasmid DNA was 
isolated from beta-lactamase specifying strains. To immobilise this DNA 
in a form suitable for probing, digests of plasmid DNA were carried out 
with BarriRl and separated on agarose gel electrophoresis. The DNA was 
denatured in the gel to make it single stranded by soaking in 0.5M 
NaOH/1.5M NaCl for one hour before neutralising in four changes of 
1M Tris-HCl pH 8.0/1.5M NaCl. Transfer of DNA to nitrocellulose
membranes was carried out as specified by Southern (1975). These
membranes were stored for a maximum of five days in a dark and dry
place before use. The nick translation reaction was started by adding
the following materials:-
5/d 10 x Nick Translation Buffer
2ml each of 0.5mM dCTP, dGTP, and dTTP in water
0.5-1 jig of DNA
Water to give a total volume of 50/d
2/d of 32P-dATP (lOuCi//d)
0.5/d of DNAse I at 0.01/ig/ml in prehybridisation buffer and 0.5/d of
DNA polymerase I (5 units) were added to the mix and kept at 16* C 
for 3 hours. During this incubation time, 1ml sephadex G50 columns 
in 1ml plastic disposable syringes were prepared as decribed in Maniatis 
et al (1982), to separate the incorporated label from unincorporated
material. Once these columns were equilibrated in TE buffer, the nick
translation reaction was terminated by adding 2/d of 0.5M EDTA and 
making the volume up to 100/d with TE buffer; the whole sample was 
then loaded onto the sephadex G50 column and spun. The labelled
DNA was eluted in the void volume of the column whereas small
unincorporated material remained within the column. DNA labelled in 
this way was used for hybridisation reactions.
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8.4.2: Hybridisation of ^^P-Labellcd DNA
Before commencing nick translation, the nitrocellulose filter 
containing the DNA to be probed, was soaked in 6 x SSC and placed in 
a plastic bag with 0 .2 ml of prehybridisation buffer per cm^ of filter. 
The bag was sealed and kept at 6 8 * C unless otherwise specified, for 3 - 
4 hours.
The labelled DNA prepared from the sephadex G50 column was
boiled for 4mins after which it was put immediately on ice. Meanwhile 
hybridisation buffer at 0.05ml/cm^ of filter was introduced into the bag 
with the membrane, after removal of the prehybridisation buffer. The 
labelled DNA was added and the bag sealed before leaving at 6 8 * C for 
18 hours with occasional agitation.
After completion of hybridisation, unbound label was washed from 
the membrane by pouring off the hybridisation buffer containing the 
label and removing the membrane from the plastic bag. The filter was 
then washed successively in 2 x SSC + 0.5% SDS for 5mins at room 
temp, 2 x SSC + 0.1% SDS for 15mins at room temperature and finally 
in 0.1 x SSC + 0.5% SDS for 2 hours at 6 8 ’ C with a change of buffer 
after 1 hour. This washing procedure was sufficient to remove any
background label. The filter was air dried before exposing to X-ray 
film at -70’ C with intensifying screens or directly at room temperature.
8.4.3: DNA Sequencing Using Dideoxvnucleotides
This method of sequencing utilises the Ml 3 vector system 
developed by Messing and Vieira (1982). In essence the vector is a
single stranded DNA virus that replicates as a double stranded molecule 
(RF) within E. coli. During replication, new virus is synthesised as 
single stranded DNA and is packaged into virus coat protein. The virus 
particles are then extruded through the membrane (unlike lytic phages 
that cause cell lysis) into the surrounding medium. Consequently single 
standed DNA can be isolated from the the broth. The M13 vector
system has since been adapted to contain a polylinker site (Messing and 
Vieira, 1982); DNA cloned into the RF form of Ml 3 within the 
polylinker site inactivates the beta-galactosidase gene. The clones 
carrying the insert can then be readily identified using IPTG induction 
of the beta-galactosidase gene and adding X-gal to the media as in 
section 8.3.8.
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(a) Preparation of single stranded DNA. Single colourless plaques were 
picked off from the transformation experiments with sterile toothpicks 
and inoculated into 1.5ml aliquots of 2 x TY broth containing 20/d of
an overnight culture of E. coli JM101. These 1.5ml cultures were grown 
with vigorous shaking at 37* C for 6.5 - 7.5 hours. Single stranded 
DNA was purified from these broths by transferring the cultures to 
1.5ml microfuge tubes and spinning for 3 minutes. The supernatant was 
then poured into fresh tubes and respun. 1ml of this broth was taken
and added to 250/d of 20% polyethylene glycol in 2.5M NaCl and mixed
by inversion. After 15 minutes at room temperature, the phage were 
harvested by centrifugation for 10 minutes. The supernatant was poured 
off and the tubes respun for 3 secs before removing traces of 
polyethylene glycol (PEG) with a drawn out pasteur pipette. (It is
important to remove all traces of the PEG since it can interfere with
the sequencing reaction.) The virus coat protein was removed by
resuspending the pellet in 100/d of TE and extracting with 
phenol/chloroform. The aqueous phase was separated by centrifugation
and precipitated with 2.5 volumes of cold ethanol and 10/d of 3M
sodium acetate. Single stranded DNA precipitations were routinely left 
at -70’ C for 2 hours or at -20* C overnight. DNA precipitated in this
way was resuspended in 100/d of TE buffer and was treated with 1/d
of proteinase K at 5mg/ml for 20 minutes to remove any contaminating 
nucleases. The DNA was again phenol/chloroform extracted and ethanol 
precipitated before finally redissolving in 20 - 40/d of TE. DNA 
prepared in this way was ready for use in the sequencing reaction.
Phage stocks of various clones were kept at 4 ’ C in broth; to
prepare more DNA, these stocks were used directly to infect JM101.
However if the phage stocks were older than 2 weeks, plaque
purification was carried out. Phage was diluted in water at various 
dilutions and plated out as described above. Single plaques were
purified and single stranded DNA isolated.
(b) Annealing reaction. The purified single stranded DNA was run out 
on a 1% agarose gel to determine the concentration of DNA. From the 
intensity of the ethidium bromide stained bands it was possible to 
determine the amount of DNA to be added to the sequencing reaction.
The first stage involved annealing a universal 17-mer primer (CellTech)
just upstream of the polylinker site containing the cloned insert of DNA.
This primer was then extended with the Klenow fragment of DNA 
polymerase I, using each of the dideoxynucleotides.
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Annealing Mix: 5-7/d of single stranded DNA
1/d of lOx annealing buffer 
2fil of universal primer 
H2 O to bring the volume to lO/il 
The reactions were left at 60’ C in an oven for 1-1.5 hours in tightly 
capped tubes. After this time, the tubes were spun briefly to bring any 
fluid from the top of the tube to the bottom. Samples were now ready 
for use in the sequencing reaction.
fc) Sequencing reactions. The stock solutions used are outlined below. 
Stock Deoxynucleotides (dNTP’s): lOmM in water kept at -20’ C.
Stock Dideoxynucleotides (ddNTP’s): lOmM in water
dNTP mixes in /d: T* C* G* A*
0.5mM dTTP 1 20 2 0 2 0
0.5mM dCTP 2 0 1 2 0 2 0
0.5mM dGTP 2 0 2 0 1 2 0
TE Buffer 2 0 2 0 2 0 20
Chase Mix: 0.5mM of each of the four dNTP’s.
ddNTP Working Mix: These concentrations can be altered to
requirements, but examples are given below. Each sequencing
may require fine adjustments.
Short Gel Long Gel
ddATP 0.1 mM 0.05mM
ddCTP 0.1 mM 0.05mM
ddGTP 0.4mM 0.2mM
ddTTP 1.0 mM 0.5mM
dNTP/ddNTP Mix: Equal amounts of dNTP* and ddNTP working
mix were mixed together and 2 /d of this were dispensed into the 
respective T, C, G, A tubes.
Formamide Dye Mix: 100ml of formamide were deionised with
5g of Amberlite MB1 ion exchange resin (BDH) by mixing gently 
for 30 mins. The resin was removed by filtration and 30mg 
of xylene cyanol FF, 30mg of bromophenol blue and 0.75g of 
EDTA was added.
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Procedure: A convenient number of clones to sequence on one gel was
five. Since there are four types of nucleotides, tubes were colour coded
for each type of nucleotide ie a total of 2 0  tubes for fivr clones. 2^1
of the dTTP/ddTTP mix were added to the first tube for each of the
five clones. 2^1 of the dCTP/ddCTP mix were then added to the
second tube of each clone. This was repeated for dGTP/ddGTP and
dATP/ddATP so that each of the 20 tubes contained 2\i\ of the
appropriate nucleotide mix. At this point the annealing reactions of
which there was one for each clone, were taken out of the oven and
allowed to cool before qdding 1_ unit of klenow (undiluted) and lOjtCi 
The annealing reactions were then added to the dNTP/ddNTP mixes, 
of ^S-dA TP (Amersham SJ264) per clone, yy The reactions were started
simultaneously by spinning the contents of each tube to the bottom and
then leaving at room temperature for 20 minutes. After exactly 20
minutes, 2^1 of the chase mix were added and the tubes left for a
further 20 minutes. After this time, the tube contents were split in
half; 2 /il of the dye mix were added to the half that was to be
sequenced directly the other half being kept at - 2 0 'C. The maximum
storage time of these sequencing reactions was kept to 14 days.
(d) Preparation of the sequencing gel and running of the samples. Stock
solutions of 38% acrylamide, 2% bis acrylamide in water were prepared
by mixing 100ml with 5g of Amberlite MB1 ion exchange resin for 1/2
hour. The acrylamide was filtered and stored in the dark at 4* C until
needed. Before preparing the sequencing gel, the 20 x 40 cm glass
plates were thoroughly washed in detergent to remove any traces of
grease. The detergent was washed off with distilled water and the
plates allowed to dry before siliconising the notched plate with
dimethyldichlorosilane. Siliconising prevents the gel from sticking to the
notched plate and allows easy separation of the plates. The back plate
was wiped with a mixture of 10ml ethanol, 150^1 of 10% acetic acid
and 30fil of 7 -methacryloxy-propyl-trimethoxysilane and allowed to dry.
This treatment causes the acrylamide gel to stick to the back plate.
Both plates were then washed with ethanol and allowed to dry before
being assembled using the plasticard spacers and vinyl tape to prevent
leakage of acrylamide.
7.5ml of stock acrylamide were added to 5ml of lOx TBE buffer
and 21g of urea. The total volume was brought upto 50ml with water 
and warmed to 37* C to dissolve the urea. 50 t^l of TEMED 
(NNN’N-tetramethylenediamine) were then added to the acrylamide 
solution followed by 280/tl of . freshly prepared 1 0% ammonium
persulphate. This mixture was gently sucked into a 50ml syringe which
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was used to introduce the acrylamide into the glass plates to prevent the 
introduction of air bubbles. The comb was then introduced into the gel 
which was left for a minimum of one hour to set before use. Before 
running the gel, the vinyl tape was removed from the bottom of the 
plates which were then put into the gel tank (Raven Scientific) 
containing 1 x TBE buffer. The plates were clipped into place, the 
comb removed and the wells flushed with buffer. The gel was prerun 
for 10 minutes at 40W constant power (1.4Kv, 28mA) before reflushing 
the wells. At this point the sequencing samples were boiled for 3 
minutes and loaded directly onto the sequencing gel using drawn out 
plastic tips. 3.2/d of sample were loaded onto the gel and and current 
applied at 40W constant power for 1.5 - 6 hours depending on which 
part of the sequence was to be read. Following electrophoresis, the 
plates were separated and the DNA fixed in 10% acetic acid/10% 
methanol for 20 minutes changing the solution after 10 minutes. Traces 
of urea were removed by washing the gel and plate under a running 
tap for 5 minutes before finally drying the gel in an oven at 80’ C for 
45 minutes. X-ray film was placed over the gel from between 12 - 96 
hours depending on the activity as estimated by a Geiger counter.
8.4.4: Preparation of Single Stranded DNA Probes
Single stranded DNA probes were synthesised using the Ml 3 vector 
system (Messing and Vieira, 1982). Hybridisation of the universal primer 
to the Ml 3 clones allows synthesis of the DNA with Klenow fragment
of DNA polymerase I to take place across the insert and beyond.
Cutting at EcoRl, which is the last restriction enzyme site just beyond
the insert DNA, releases the newly synthesised strand which can be
separated on an agarose gel. If this DNA is denatured first, then the 
single stranded DNA can be isolated directly from the agarose gel. The
following method gives the procedure adapted from Burke (1984), to
generate high specific activity DNA probes.
The appropriate clone in M13mp8 was taken and used in an
annealing reaction as described in section 8.4.3 part (b). After the
annealing reaction was completed the contents of the tube were spun to 
the bottom and 1/d each of ImM dTTP, dCTP and dGTP were added to
the tube. 1/d of 10/iCi//d of ^ p .^ A T P  (250Ci/mMole) was added and
the synthesis reaction was started by adding 0.3/d of Klenow (1 unit). 
Reactions were left at room temperature for 15 minutes before the
addition of a further 1/d of each of the four cold dNTP’s at ImM.
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Again reactions were left for 15 minutes before heating to 65* C for 10 
minutes to stop the reaction. The newly synthesised DNA was cut with 
EcoRl by adding 2/il of the lOx high salt buffer and l/il of 50 units//*l 
of restriction enzyme. The digestion was left for 1.5 hours at 37* C
during which time the prehybridisation of a nitrocellulose filter 
containing fragments of DNA transferred by Southern blotting (Southern,
1975), was commenced as described in section 8.4.2. The EcoRI digest
was stopped by adding 4/d of 1M NaOH for 5 minutes followed by
10/d of 1M Tris-HCl pH 4.6. This treatment also caused denaturation of 
the double stranded DNA which can be separated if placed directly on
a 1.2% agarose gel. Newly synthesised DNA is much smaller than the
rest of the DNA and runs well ahead of the Ml 3 DNA. Since small
s.s.DNA is not visible in agarose gels by ethidium bromide staining, it
was possible to mark the exact position by 5 minute autoradiography;
once the marker dye has run far enough in the gel, the buffer was 
poured off and clingfilm was placed over the gel. A piece of X-ray 
film cut to the exact dimensions of the gel was placed on the surface 
and left in the dark for 5 minutes. After developing the film, the
position of the insert DNA was clearly visible. This DNA was eluted
into NA45 membranes as described in section 8.3.5 although the elution
time into arginine/NaCl was reduced to 75 minutes.
The prehybridisation buffer in which the nitrocellulose membrane 
was soaked, was substituted with hybridisation buffer as described in
section 8.4.2. The s.s.DNA probe in the arginine/NaCl solution was
added directly to the hybridisation buffer and was then left for 18 
hours. Subsequent steps are described in section 8.4.2.
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Section 9: Determination of the Molecular Weight and the Hvdrodvnamic
Properties of the OXA-2 Beta-Lactamase 
9.1: Background Information
The molecular weights of purified beta-lactamases have been used 
as one of the physical properties to differentiate and classify these 
proteins (Sawai et al, 1982; Medeiros, 1984). Unfortunately the use of 
molecular weight as a criterion for measuring the relatedness of proteins 
is open to error since molecular weights of beta-lactamases have been 
determined by a variety of methods in many different laboratories. 
These methods include gel-filtration (Andrews, 1964), SDS-polyacrylamide 
gel electrophoresis (Weber and Osborn, 1969; Laemmli and Favre, 1973) 
and equilibrium ultracentrifugation (Yphantis, 1964). Anomalies in Mr 
determinations have been found in some of the beta-lactamases such as
the TEM enzyme from E. coli. The first Mr reported for this protein 
was 16,700 as determined from ultracentrifugation (Datta and Richmond, 
1966). Remeasurement of this value by gel filtration and centrifugation 
indicated that the Mr was 21,000 (Dale and Smith, 1971b) where the 
error in the previous value was probably due to impure enzyme. The 
subsequent amino acid sequence and that derived from the DNA 
sequence, gave the Mr as 28,000 (Ambler and Scott, 1978; Sutcliffe, 1978).
A further example of the problems encountered in Mr 
determinations is with the exocellular beta-lactamase of Actinomadura R39 
(Duez et al, 1982). Gel filtration gave an apparent molecular weight of
29,000 whereas SDS-polyacrylamide gel electrophoresis gave a main band 
at 15,000. Analysis of the diffusion coefficient showed the enzyme to 
have a frictional ratio of 1.47, indicating this beta-lactamase to be 
asymmetrical which could account for the discrepancies in the Mr
determinations.
The original molecular weight investigations of the OXA-2 
beta-lactamase by the method of gel filtration (Andrews, 1964) showed 
that the native Mr was 44,600 (Dale, 1971). SDS-polyacrylamide gel
electrophoresis by the method of Weber and Osborn (1969), gave a single 
band of Mr 28,000 which lead Dale and Smith (1976), to propose a
dimeric nature for the OXA-2 beta-lactamase. Subsequent studies by 
Holland and Dale (1984), gave a subunit molecular weight of 32,170 by 
SDS-polyacrylamide gel electrophoresis using the method of Laemmli and 
Favre (1973). These Mr determinations do not reflect an exact 
relationship between monomer and dimer. This observation coupled with 
the failure to crosslink this beta-lactamase with dimethylsuberimidate
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(Holland and Dale, 1984), has caused confusion leading some authors 
either to quote this beta-lactamase as being dimeric (Coulson, 1985) or 
monomeric (Braswell et al, 1986). Due to the discrepancies, it was
considered important to establish the precise nature of the subunit 
number within the OXA-2 enzyme. SDS-polyacrylamide gel
electrophoresis shows quite clearly that OXA-2 beta-lactamase if  dimeric, 
contains subunits of identical size. To determine the true molecular 
weight of the native enzyme, non-denaturing systems other than gel 
filtration need to be used. It is possible that the OXA-2 beta-lactamase 
may be highly asymmetrical giving an anomalously high Mr on gel 
filtration (c./. the beta-lactamase from Actinomadura R39). The following 
chapter describes molecular weight determinations from sucrose density 
gradients, sedimentation velocity and sedimentation equilibrium.
9.2: Measurement of the Molecular Weight in Sucrose Density Gradients 
in the Preparative Ultracentrifuge
An isokinetic gradient is a gradient in which at constant rotor 
speed a given macromolecule moves at a constant velocity independently 
of the distance sedimented. These conditions are met if  as the particle 
sediments, the increasing centrifugal force is balanced by the increasing 
density and viscosity of the gradient medium. The advantage of using 
these gradients is that after centrifugation, the distance through which a
particle has sedimented is directly proprtional to its sedimentation 
coefficient. If two proteins are sedimented under the same conditions, 
then any variations in centrifugal conditions will affect the 
macromolecules equally. The sedimentation coefficient S2  of a 
macromolecule can be estimated by comparison of its migration (I2 ) in
the gradient with that of a macromolecule of known sedimentation 
coefficient Sj that has moved a distance of 1] from the following 
equation (Young, 1984):- r
S2  = S] . I2 /  li Equation 1
The distance travelled by a protein in an isokinetic gradient can 
be easily determined by fractionating the gradient into aliquots of equal 
volume. The distance the macromolecule has travelled is proportional to
the fraction number. Martin and Ames (1961), have exploited the 
isokinetic properties of 5-20% sucrose gradients to study the molecular 
weights of known and unknown proteins. They have shown that an
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approximate molecular weight can be calculated for a protein by 
comparing its migration in a gradient with that of a protein of known 
Mr.
r  _ Distance travelled from meniscus by unknown (I2 ) Equation 2
Distance travelled from meniscus by standard (lj)
For macromolecules of the same partial specific volume
R = S20.W of unknown Equation 3
S2 0 ,W known 
Mr can be determined from the approximation
51 = Equation 4
^2 I Mr 2 J
Where R £ S1/S2  (Schachman, 1959; Martin and Ames, 1961)
Sucrose gradients were constructed as descibed in section 8.2.6 and 
left for one hour before being used in a Beckman L5-65 preparative 
ultracentrifuge on an SW40Ti swing out rotor. Two protein standards 
chosen as molecular weight markers were bovine serum albumin (Mr 
68,000) and ovalbumin (Mr 45,000). The choice of this molecular weight 
range was based on the fact that if native OXA-2 beta-lactamase is 
dimeric and is composed of two identical subunits of Mr 32,000, then
the expected Mr will be 64,000 although gel filtration results showed
that the native Mr of this beta-lactamase was 44,600 (Dale, 1971). The
conditions of centrifugation found to be most suitable for separating 
these standards have been given in section 8.2.6. Ideally all proteins
should be centrifuged in the same tube so as to minimise errors due to
variations in the gradient. However since contaminating protein may 
interfere with the assay for beta-lactamase activity when using nitrocefin 
(C. Reading personal communication) it was judged best to centrifuge 
samples simultaneously but on separate gradients. After the gradient was 
fractionated, the position of protein peaks was determined by measuring 
the OD at 280nm. A rapid estimation of the location of beta-lactamase 
activity was made from the nitrocefin microtitre assay. The fractions 
showing beta-lactamase activity were then assayed using the
spectrophotometric assay with benzylpenicillin as the substratate. Figure 
12 shows a typical profile for the position of OXA-2 beta-lactamase
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activity with respect to the other proteins.
Since two protein standards were used, it was possible to assess
the accuracy of the system by using one protein standard to determine 
the molecular weight of the second protein standard. If the determined 
molecular weight was outside a 5% margin of error, then the values for 
that sucrose density run were not used to calculate the Mr of the 
OXA-2 beta-lactamase. Table 8 shows the the Mr determined for OXA-2 
beta-lactamase as well as the calculated Mr for each of the standard
proteins. At the same time it is possible to calculate the sedimentation 
coefficient for the OXA-2 beta-lactamase from equation 1 using the 
bovine serum albumin as the standard which has an S2 0  of 4.55
(Peters Jnr, 1985). The value thus obtained was 4.3 S.E. ± 0.2S (a mean
of five separate determinations).
Table 8 : Determination of Mr for the OXA-2 Beta-Lactamase Using 
Standard Proteins in Sucrose Densisty Gradients.
DETERMINED
Mr
STANDARD PROTEINS
Ovalbumin Bovine Serum albumin
Ovalbumin 45,500 SE ± 2100 (5 )
Bovine serum 
albumin 66,700 SE ± 1600 (4 )
OXA-2 65,100 SE ± 2200 (5) 64,600 SE ± 1900 (4 )
Figures in brackets indicate the number of individual experiments.
This result shows that the native Mr of OXA-2 beta-lactamase is 
close to the predicted value of 64,000 as would be expected if  this 
beta-lactamase was composed of two identical subunits of Mr 32,000. 
However this method is only an approximation since the relationship 
between S and Mr is affected by the shape of the molecule (Martin and 
Ames, 1961). It has been reported that Actinomadura R39 beta-lactamase 
is asymmetrical (Duez et al, 1982). If the beta-lactamase was very 
asymmetrical than the above approximation would be subject to a large
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degree of error. Therefore the molecular weight of native beta-lactamase 
was remeasured using both sedimentation velocity and sedimentation 
equilibrium.
9.3: Determination of the Sedimentation Coefficient bv Moving Boundary 
Analysis
In conjunction with Dr. M. A. Rosemeyer of the Biochemistry 
Department, University College London, moving boundary experiments 
were performed to determine the sedimentation coefficient. This 
coefficient characterises the rate at which a macromolecule sediments and 
is defined in equation 5 as the sedimentation velocity in unit field 
strength (Svedberg and Penderson, 1940):
S = 1 . dr Equation 5
oP-r dt
where r is the distance from the axis of rotation at time t and co is 
the angular rotor speed in radians/sec.
>■ .
Sedimentation coefficients are expressed in Svedberg units where 
one unit is 10“^  seconds. When a centrifugal force is applied to a 
uniform protein solution, the protein molecules will move at a rate 
depending on their size and shape towards the bottom of the chamber. 
As a consequence a boundary forms between the sedimenting protein and 
the solvent (figure 13). Measurement of the boundary position at 
various time intervals allows the calculation of the sedimentation 
coefficient according to equation 5. The position of the boundary was 
viewed by schlieren optics which show the changes in the refractive 
index of the solution as illustrated in figure 13. By using a 
counterpoise with reference holes, it was possible to determine the exact 
distance of the boundary from the axis of rotation.
Electrophoretically homogeneous OXA-2 beta-lactamase was dialysed 
against 0.1M sodium phosphate buffer pH 7.5. The protein concentration 
was determined as 9 .0 mg/ml of which 0 .6 ml were placed in a single 
sectored chamber within a D2 rotor. The experiments were performed 
on a Beckman Model E analytical ultracentrifuge which was accelerated 
to 59,780 r.p.m. and maintained at 10* C by an RTIC unit (rotor 
temperature indication and control unit) fitted to the centrifuge. The 
position of the boundary was photographed on Ilford rapid orthometallic 
plates after lOmins and then every 16mins for a total of 90mins (plate
9 0
1). A travelling microscope was used to measure the exact distance of 
the peaks for each time point directly from the photographic plates. 
Calculations of the boundary distance from the centre of axis were 
adjusted for rotor stretch at 57,780 r.p.m. from the manufacturers 
specifications.
Plate 1: Photograph Taken During the Sedimentation Velocity Run
The protein was 9mg/ml in 0.1M sodium phosphate buffer pH 7.5. 
Migration is from left to right. The photograph was taken after 76 mins 
after reaching a speed of 59,780 r.p.m. The temperature was 10°C and the 
schlieren plate angle was 60° C.
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Figure 13: Effect of a Centrifugal Field on a Protein Solution.
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Figure 14: Plot of Logjo (r) versus Time in Moving Boundary Analysis 
to Determine the Sedimentation Coefficient for the OXA-2 
Beta-Lactamase.
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The sedimentation coefficient can be determined from equation 5 
after rearranging to give equation 6 :
d r / r  = S.o^.dt Equation 6
Intergration gives:
Ln(r) = (S oP- t) + A Equation 7
A plot of ln(r) or as was used in this instance logio(r) versus
time t, gives a line with slope S.co^  and intercept A (figure 14). Since 
the angular velocity is known for the particular rotor used, 
determination of the slope gives S0 bs of 3.02 S.E.± 0.02. This value is 
dependent on the solution conditions used in the experiment. However, 
it is customary to express the sedimentation coefficient under standard
conditions where the value of the coefficient is adjusted to that if  pure
water was the solvent at 20* C. The S0 bs has been corrected as 
described by Schachman (1959) using data for density and viscosity from 
the International critical tables. The value so calculated gives S2 0  \y:
S20,W = 4.2 S.E. ± 0.02
This value is very similar to the S20,W of 4-3S obtained from the 
sucrose density gradient.
9.4: Diffusion Coefficient of the OXA-2 Beta-Lactamase
The diffusion coefficient D, is defined as the quantity of material 
diffusing per second across a surface area of lcm^ when the
concentration gradient is unity. The diffusion coefficient can be 
measured in the analytical ultracentrifuge by forming an initial sharp 
boundary between the buffer and the protein solution and watching the
spread of the boundary with time. This can be conveniently carried out 
by using a double sectored cell where the two chambers are joined by a 
fine capillary synthetic boundary centrepiece. Buffer is introduced into 
the left hand sector and a smaller volume of protein solution is
introduced into the right hand sector. As the centrifuge is accelerated, 
the buffer from the left hand side chamber is forced through the
capillary joining the two sectors, onto the protein solution in the other 
chamber. This results in the formation of a sharp boundary whose
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spread with time can be observed by schlieren optics. The use of a
double sectored cell means that the buffer that remains in the left hand 
side of the chamber gives a buffer baseline that is used in subsequent 
analysis of schlieren patterns to measure the peak height (figure 15).
Figure 15: The Diffusion of a Protein Solution in a Centrifugal Field.
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Analysis of the schlieren patterns obtained from experiments 
described above can be used directly to calculate the diffusion 
coefficient using the height/area method (Schachman, 1959). As the 
diffusion progresses, the maximum height of the schlieren peak falls 
with time but the area remains constant (figure 15c). The area of the 
peak is a measure of the total concentration of the protein across the 
boundary which should remain constant throughout the run. The 
height/area method can be analysed from equation 8 . Hence a plot of 
(A/H)2 against t gives a slope equal to 4.x.D from which the diffusion 
coefficient is determined.
H^max = A^ Equation 8
4 t D t
where A is the area and H is the maximum height.
Using a Beckman model E analytical ultrcentrifuge fitted with an 
RTIC unit, a double sectored boundary centrepiece was used. 0.18ml of 
pure OXA-2 beta-lactamase (9mg/ml) in 0.1M sodium phosphate buffer 
pH 7.5 was placed in the right hand sector and 0.4ml of buffer in the 
other chamber. The centrifuge was accelerated to 12,590 r.p.m. at 10* C 
for 98mins. The spreading of the peak was viewed by schlieren optics
and photographs taken every 8 minutes with the first photograph
recorded after lOmins from the start of the run. The maximum peak
heights and areas of peaks for various time points were analysed from
the photographs with a travelling microscope. A plot of (A/H)^ versus t
(min) was used to calculate the observed diffusion coefficient (figure 16). 
The value calculated gave D0 bs as 4.22 x 10“7 s.E. ± 0.32 x 10"? cm^s"*. 
Correction of D0 bs to standard conditions gives:
D20,w = 5.9 x 10-7 S.E. ± 0.4 x 10”7 cm^s-l or 59 ± 4 ixrn^s'^
The accuracy of the determination is greatly influenced by vibrations
and the precision with which the temperature can be maintained during 
the run. Minor fluctuations were observcred in the temperature which 
may have contributed to the poor correlation coefficient of 0.93 of 
figure 16. The value of the diffusion and sedimentation coefficients
can be used to calculate the molecular weight of OXA-2 beta-lactamase 
as discussed in the next section.
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9.5: Determination of the Molecular Weight of* OXA-2 Beta-Lactamase
from the Svedberg Equation
The molecular weight M, of a protein can be determined from the 
Svedberg equation (Svedberg and Pederson, 1940):
M = R T S Equation 9
D(l-up)
where R is the universal gas constant in ergs m or^K - ,^ T is the 
absolute temperature, p is the density of the solvent (p water = 
0.9982g/cm3 at 20* C) and v is the partial specific volume of the 
protein.
The partial specific volume is defined as the increment in volume when 
lg of dry solute is added to a large volume of solution. This 
parameter is most widely calculated from the amino acid composition of 
a protein on the assumption that the partial specific volume is the
additive property of the partial specific volumes of the constitutive 
amino acids. This method is only applicable if  there is no non-protein 
component.
The partial specific volume of the OXA-2 beta-lactamase has been 
determined from the amino acid composition (derived from the DNA 
sequence, Dale et aU 1985) using the method of Cohn and Edsall (1941). 
The value determined for v is 0.731ml/g. This value and the values for 
the sedimentation and diffusion coefficients determined in sections 9.3 
and 9.4 respectively, can be substituted into equation 9 to give the Mr 
for the OXA-2 beta-lactamase.
Mr OXA-2 beta-lactamase is 64,600 to 3s.f.
This value is closely related to the Mr of 64,600 or 65,100
obtained from sucrose density gradient centrifugation with ovalbumin and 
bovine serum albumin as the standard molecular weight markers. As a 
final check on the Mr of the OXA-2 beta-lactamase, determinations were
made from sedimentation equilibrium runs. The advantage of this last 
system is that the heterogeneity of the protein can be assessed (Creeth
and Pain, 1967).
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9.6: Frictional Ratio: Analysis of the OXA-2 Beta-Lactamase Shape
The frictional ratio f / f 0, is valuable in giving a qualitative 
indication of the departure of the protein from a spherical shape. It 
refers to the ratio between the actual frictional coefficient as calculated 
from the diffusion coefficient and the coefficient if the protein was 
assumed to be a perfect sphere. Hence proteins that approach a true 
spherical shape such as ribonuclease give a frictional ratio close to 1 
whereas the rod shaped protein of the tobacco mosaic virus coat portien 
gives f / f 0 > 3 (Dawson, 1974). Calculation of this ratio gave 1.47 for 
the Actinomadura R39 beta-lactamase, which was concluded as being 
asymmetrical and hence giving rise to the anomalous Mr determined from 
gel filtration (Duez et al, 1982). Calculation of the frictional ratio for 
the OXA-2 beta-lactamase was made to determine whether the anomalous 
Mr given by gel filtration for this protein was for similar reasons as 
the Actinomadura enzyme.
The frictional ratio f, for the OXA-2 beta-lactamase was 
calculated directly from the diffusion coefficient determined in section 
9.4. Expressing Fick’s first law of diffusion as in equation 10:-
D = R T /N f Equation 10
where R is the universal gas constant, T is the absolute temperature and 
N is Avogadro’s number, gives the frictional coefficient f  as 
6.81 x 10"8 g cm '^ s 'l .
f 0 is the frictional coefficient of the enzyme assuming that it is a 
perfect sphere and can be calculated from the Stokes radius which is 
related to f  (equation 11) where
f 0  =  6 r  v Rs Equation 11
v is the viscosity of the medium and R s is the Stokes radius. Since a 
sphere is being considered, the radius Rs can be expessed as:
f 0  = 6  x v (3Vs/4x / 3 Equation 12
Vs refers to the volume of a sphere for a single molecule and can be 
written in terms of Mr as Mu/N. Calculation of f 0  using M as 64,600, 
0.01002 cm3 g"* for the vicosity of water at 20* C and v as 0.731 ml/g
9 9
gives 5.0 x 10' 8 g cm"2 s“*.
Hence the frictional ratio f / f 0  is 1.36
The ratio suggests that OXA-2 beta-lactamase is not as asymmetric 
as the Actinomadura R39. Since this value is qualitative, it is difficult 
to predict by how much the Actinomadura enzyme is more asymmetric 
and by how much these differences will affect the elution profile from
gel filtration. Discussion of these results is given in section 9.8.
9.7: Sedimentation Equilibrium
At equilibrium the situation is such that the process of 
sedimentation is balanced by the process of diffusion. The analysis of 
this distribution offers an extremely powerful method by which to 
determine the molecular weights and study molecular interaction. Often, 
the molecules in a biological sample do not have a homogeneous 
molecular weight. Therefore if the system is polydisperse, the molecular 
weight calculated is an average value. The two main types of average, 
Mn and Mw, are yielded by different techniques (eg end group analysis 
and sedimentation respectively) where Mn is an average over the number 
fraction of molecules and Mw is an average over the mass fraction of 
molecules. Since heavier molecules contribute more mass than lighter
molecules, Mw is more sensitive to heavier molecules whereas Mn is more 
sensitive to lighter molecules. Other averages are more abstract to 
visualise but can be readily defined algebraically.
Mn =X(njxMi) Mw =E(nixMi2) Mz =E(nixMi 3)
E(n|) E(hj[xM|) rfojxMi2)
where nj is the number of molecules having a molecular mass of Mj.
The importance of these averages is that for a homogeneous
protein sample where all the molecules have the same molecular weight, 
Mn = Mw = Mz. Mz and Mw can be evaluated from the sedimentation 
equilibrium method employed (Pearse and Rosemcyer, 1974) and hence a 
useful check on the homogeneity of the system can be made. 
Sedimentation equilibrium runs were performed with M. A. Rosemeyer,
using the method of Van Holde and Baldwin (1958), on a Beckman
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Model E analytical ultracentrifuge fitted with an RTIC unit. The 
equation used to evaluate the results is given below.
M = RT . 1 ,dc Equation 13
(1-v p)oP- r c dr
where r is the radial distance and c is the concentration at a given
point in g/unit volume. If A = a>2(l-up)/2RT then the equation given 
above can be simplified as given below.
M = * . 1 . dc Equation 14
2 A r e  dr
Since r, c, and dc/dr can be obtained experimentally, the molecular 
weight can be determined from equation 14 or from its intergrated form.
Freshly purified OXA-2 beta-lactamase at lOmg/ml giving a single 
band on SDS-polyacrylamide gel electrophoresis, was dialysed against 0.1M 
sodium phosphate buffer pH 7.5. A moving boundary experiment was 
performed as previously described to check on the homogeneity of the 
preparation. For the sedimentation equilibrium run, 0.11ml of protein 
solution was placed in the left hand side of a chamber in a double
sectored cell and 0.13ml of buffer solution in the right side to give a
base line. The equilibrium run was carried out by spinning at 8766
r.p.m. for 28 hours at 10" C after which the distribution of the protein 
in the cell as viewed by schlieren optics, was photographed. A second
experiment was performed to determine the initial concentration of the 
protein by a synthetic boundary run. In essence the method was the
same as for the diffusion run in which buffer was layered onto a
solution of protein during acceleration to the same speed as used for the 
equilibrium run. The area of the peak was measured from schlieren
photographs at the same mirror angle as was used for the sedimentation 
equilibrium; this was then used to calibrate the system.
The data from the sedimentation equilibrium runs and the 
synthetic boundary experiments were used to evaluate equation 14 (using 
v as 0.73), from computer programs written by M. A. Rosemeyer. 
Heterogeneity in the system was detected by determining Mw and Mz as 
described in Pearse and Rosemeyer (1974). Mw was obtained from the 
integrated form of equation 14 by plotting ln(cr ) versus r^:
ln(cr) = ln(ca) + AM(r^ -a^) Equation 15
1 0 3
where cr and ca are the weight concentrations at radial position r and
the meniscus a, respectively. Alternatively the Mz was obtained directly 
from equation 14 by plotting 1/r.dc/dr against cr-ca the latter being 
concentration difference. These plots are shown in figures 17 and 18
and are quite clearly non linear. The non linearity of the system 
suggests that the protein may be aggregating as was found for other
beta-lactamases (Braswell et al, 1986). Observation of figure 17 for the
Mz plot, shows that the first set of points are linear. Using the data 
for the first 6  points only, Mz was recalculated as 63,500 where the
correlation coefficient was 0.998 (figure not shown). This value 
corresponds to the lowest molecular weight species present at the 
meniscus side of the cell. Calculation of Mw using only the first 6  
points of the data from the Mw plot, gave a ratio of Mz/M w »  1 
suggesting that the system may be heterogeneous. It was considered 
possible that if  high molecular weight species were present in the
sample, then during the run loss of the protein may have occured due 
to sedimentation. Determination of Mw is dependent on the knowledge 
of the protein concentration at the meniscus which will be affected by 
the loss of material due to sedimentation. Mz data is not affected by 
this since it is the concentration change with radial distance that
determines Mz. Preliminary data suggests that the OXA-2 beca-lactamase 
may be forming aggregates to give octamers (Rosemeyer et al, in 
preparation). This phenomenon of aggregation has been seen with other 
proteins such as erythrocyte 6 -phosphogluconate dehyrogenase (Pearse and 
Rosemeyer, 1974). More' recently aggregation of beta-lactamases has been 
observed by Braswell et al (1986).
9.8: Discussion of Results
Using several related but different techniques has provided 
information not only about the molecular weight of native OXA-2
beta-lactamase but also information about its symmetry and possible 
protein-protein interactions. Preparative ultracentrifugation has shown the 
molecular weight to be the same as the predicted molecular weight of
64,000 daltons for a dimeric enzyme assuming the monomeric weight to 
be 32,000 daltons (Holland and Dale, 1984). This finding confirms the 
proposed dimeric nature of the OXA-2 beta-lactamase (Dale and Smith,
1976) despite the failure to crosslink monomers with dimethylsuberimidate 
(Holland, 1983). The failure to crosslink the subunits is probably due to
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a lack of suitably positioned sites on the protein surface.
The molecular weight determined from sedimentation velocity
experiments is in excellent agreement with that determined from the 
sucrose density gradient experiments. Similarly the sedimentation 
coefficient determined from moving boundary analysis agrees closely with 
that estimated from density gradient centrifugation. This confirms the 
reliability of the density gradient data and gives confidence to the 
molecular weight calculated from the Svedberg equation in section 9.4. 
The uniform peak that was observed in plate 1 for the sedimentation
velocity run, indicates a homogeneous protein sample although the
presence of small quantities of either low and/or high molecular weight 
species cannot be dismissed. Sedimentation equilibrium experiments were 
carried out for this reason since heterogeneity in a protein sample can 
be readily detected from discrepancies in M\y and values. In
addition, it is generally accepted that sedimentation equilibrium is more
accurate for the determination of the Mr since it does not rely on the 
independant determination of the diffusion coefficient. This coefficient 
is particularly prone to error due to fluctuations in rotor temperature as 
well as rotor wobble.
The results of sedimentation equilibrium showed that OXA-2 
beta-lactamase appears to aggregate at high protein concentrations into 
much higher molecular weight species, possibly octamers. However the 
lowest molecular weight species seen in the run corresponds to an Mr of 
63,500 which is consistent with the enzyme being a dimer. The 
physiological effect of such an aggregation in vivo is not understood, if 
it occurs at all. Interestingly aggregation of this type is not confined 
to the OXA-2 beta-lactamase since Brasswell et al (1986) have 
demonstrated that a low degree of association occurs with the 
beta-lactamases from B. licheniformis 149/c, E. cloacae P99 and also 
TEM-2 at high protein concentrations. of these enzymes was
approximately 9% greater than that of the monomer. A greater degree 
of aggregation was observed in the presence of ammonium sulphate but 
not as much as for the OXA-2 beta-lactamase in the absence of 
ammonium sulphate. The study of Braswell et al (1986), was originally 
carried out to test whether beta-lactamases which are potentially dimeric 
in their crystalline structures, are dimeric in solution. No evidence was 
presented for this and the authors suggest that association seen within 
the crystal structure may be weak and probably has no physiological 
significance. On the contrary there is no evidence available from the 
present studies to suggest that OXA-2 beta-lactamase is monomeric. The
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smallest molecular weight species corresponds to a dimer. It is possible
that OXA-2 beta-lactamase has developed further to maximise
inter-subunit contacts to form a true dimer. Further experiments to 
study protein-protein interactions at different concentrations of the 
beta-lactamase would be of interest.
The discrepancy in the Mr between that obtained in gel filtration 
experiments (Dale, 1971) and the data obtained in the present study, is
difficult to explain. Asymmetric proteins such as Actinomadura R39 
beta-lactamase give apparent molecular weights by gel filtration larger 
than the true molecular weight (Duez et al, 1982). If OXA-2
beta-lactamase was an asymmetric monomer, it could explain the apparent 
Mr of 44,600 obtained by gel filtration. However from centrifugation 
studies there is no evidence to suggest that OXA-2 beta-lactamase is 
monomeric. The frictional ratio was determined to be 1.36 compared to 
1.47 determined for the R39 beta-lactamase. That OXA-2 enzyme has a
frictional ratio greater than 1 would suggest that it is asymmetric. 
However to what degree the asymmetry varies from that of the R39 
enzyme, is not possible to judge on these values alone. To try and
establish the significance of the frictional ratio, the hydrodynamic 
parameters for bovine serum albumin which has a similar Mr to OXA-2
beta-lactamase, were taken from Peters Jnr. (1985). Calculation of the 
frictional ratio gave 1.33 which is similar to the value for the
beta-lactamase. Bovine serum albumin is not known to be highly
asymmetric and is used as a standard molecular weight marker for gel 
filtration experiments to determine the native molecular weight of
proteins (Andrews, 1964).
Another explanation of the discrepancy in the original estimations 
of the molecular weight of native OXA-2 beta-lactamase could be 
explained if a monomer dimer equilbrium was present. If at low
protein concentrations as were used in gel filtration (Dale, personnal
communication) a monomer dimer equilibrium was promoted, an Mr 
intermediate between 32,000 and 64,000 might be expected. This seems
unlikely in view of experiments carried out by Dale and Smith (1976). 
OXA-3 beta-lactamase is related to the OXA-2 beta-lactamase in that it
appears to be dimeric but differs in its pi and banding patterns on
starch gel electrophoresis. This enzyme shows a similar discrepancy in
Mr obtained by gel fitration and SDS polyacrylamide gel electrophoresis. 
If these proteins exist in a monomer dimer equilibrium, then one would
expect to see the formation of a hybrid protein for which no evidence 
was found. However, when the plasmids specifying both beta-lactamases
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were introduced into one cell, hybrid beta-lactamase appears to have 
been formed presumably as a result of in vivo formation directly after 
protein translation. This suggests tight association of dimers and 
therefore a monomer dimer equilibrium does not seem to be a suitable 
explanation for the gel filtration Mr results. Another possibility is that 
the OXA-2 beta-lactamase may bind anomalously to the dextrans used in 
gel filtration which would give rise to retardation of the protein and 
consequently an anomalous Mr. This last possibility seems to be the 
most likely at present and may also account for the low Mr obtained on 
gel filtration for other beta-lactamases. Future experiments to study the 
subunit interactions would prove valuable in unravelling the mechanisms 
of action in the OXA-2 beta-lactamase.
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10: Interaction oF the OXA-2 Beta-lactamase with Mechanism Based
Inactivators
10.1.1: Attempts to Isolate the Active Site Peptide Following Trypsin 
Hydrolysis
The binding of inhibitors or substrates has been used to 
demonstrate the acyl-enzyme intermediate in the mechanism of action of 
serine beta-lactamases (Fisher et al, 1980; Knott-Hunziker et al, 1982a). 
The OXA-2 beta-lactamase behaves like a serine enzyme in its mode of 
action with the mechanism based inactivator clavulanic acid (Holland, 
1983) although Medeiros et al (1985), have stated that clavulanic acid 
does not inhibit OXA type enzymes. The pattern of inhibition is very 
similar to that of TEM-2 beta-lactamase in that the reaction follows a 
branched pathway giving rise to hydrolysis, a transiently inhibited 
enzyme and an irreversibly inactivated enzyme. Approximately 30 
turnovers occur before the enzyme is inactivated and hydroxylamine 
regenerates 50% of the enzyme activity. Holland (1983), has proposed 
scheme 3 for the interaction of clavulanic acid with the OXA-2 
beta-lactamase.
Scheme 3: Possible Interaction of the OXA-2 Beta-Lactamase with
Clavulanic Acid.
EX EY 
\ /
E + C ^  EC -----► EC* — * E + P
\ t
ET
E and C are enzyme and clavulanic acid respectively, EC is the 
Michaelis complex and EC* is the acyl-enzyme intermediate. ET is the 
transiently inhibited enzyme and EX and EY are different forms of the 
irreversibly inhibited enzyme.
It was hoped that clavulanic acid may be used to identify the 
active site of the OXA-2 beta-lactamase. Since it was possible that 
clavulanic acid reacts with this enzyme to form more than one inactive 
enzyme species, it was first necessary to identify the number of inactive 
enzyme species. One approach that has been used previously for TEM-2 
beta-lactamase is analytical isoelectric focusing (I.E.F.) of the clavulanic
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acid inactivated enzyme (Charnas et al, 1978). Unfortunately this 
method is far from ideal for the OXA-2 enzyme, owing to the large 
number of satellite bands obtained by I.E.F. for this enzyme.
Consequently peptide mapping was chosen as an alternative to study the 
interaction of the OXA-2 beta-lactamase with clavulanic acid. Even if 
more than one labelled peptide was isolated, it was hoped that other 
residues at which clavulanic acid interacts could be identified.
The amino acid composition of the OXA-2 beta-lactamase gives 15
lysine and 20 arginine residues (Holland and Dale, 1984) although the 
completion of the DNA sequence (section 12) indicates that there are 13 
lysine and 25 arginine residues in the mature protein. Since trypsin 
cleaves at the C-terminal end of these residues, upto 39; peptides are 
expected after trypsin hydrolysis. Initial experiments were conducted to 
deduce the optimal conditions for trypsin hydrolysis of the OXA-2 
beta-lactamase.
10.1.2: Trypsin Hydrolysis of the OXA-2 Beta-Lactamase
OXA-2 beta-lactamase was purified as described by Holland and 
Dale (1984), to give a single band on SDS-polyacrylamide gel 
electrophoresis. The specific enzyme activity was determined as 147 
units/mg. Purified protein was used to assess the most suitable methods 
for hydrolysis by TPCK (tosyl-L-phenylalanine-chloromethyl ketone)
treated trypsin.
Both native and heat denatured (2mins at 100* C) OXA-2 
beta-lactamase were subjected to trypsin hydrolysis in 0.1M ammonium 
bicarbonate buffer pH 8.2 under the same conditions as described in 
methods section 8.2.10 (Allen, 1981). Trypsin was added to 0.2mg/ml of 
the OXA-2 beta-lactamase and incubated at 37* C. Aliquots of protein
were removed every 2  hours over a 6  hour period before freeze drying.
The progress of digestion was observed on 15% SDS-polyacrylamide gel
electrophoresis. After 6 hours the native enzyme remained largely in an 
undigested form although the heat denatured protein showed that 
digestion had progressed further (results not shown). The experiment 
was repeated but longer times of digestion were employed. Native 
OXA-2 beta-lactamase was incubated for 5.5 hours at 37’ C after which
a second addition of trypsin was made. Samples were then left 
overnight so that the incubation was for 22 hours. Heat denatured 
beta-lactamase was also left for 14 hours at 37’ C. SDS-polyacrylamide 
gel electrophoresis showed no trace of any fragments in either native or 
heat denatured protein which suggests that digestion had progressed to
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the point where the size of the peptides was too small to be resolved or 
visualised. One dimensional chromatography on T.L.C. plates (section 
8 .2 .11) showed a line of peptides moving upwards with the solvent 
(results not shown). Subsequent digests were carried out on native 
enzyme for 2 2  hours since this procedure was less drastic than boiling 
the enzyme and hence less likely to alter any labile covalent 
intermediates. Peptides were routinely freeze dried before storage at 
-20* C and subsequent peptide mapping.
10.1.3: Two Dimensional Peptide Mapping of Trvosin Digested OXA-2 
Beta-Lactamase
The full details of the method have been given in section 8.2.11. 
3-8 nMoles of freeze dried peptides were resuspended in 10-15 /laI of 0.1M 
ammonium bicarbonate buffer pH 8.2. This was applied directly to 20 x 
15cm plastic backed thin layer chromatography (T.L.C.) plates so that the 
application spot was no greater than 2mm in diameter. Peptide mapping 
was originally carried out by chromatography in the first dimension 
followed by electrophoresis in the second dimension. This method gave 
peptides that were smeared and poorly resolved probably as a result of 
the wetting procedure prior to electrophoresis (section 8 .2 .11 ); wetting of 
the T.L.C. plate after chromatography can only be carried out from two 
directions because of the chromatographlcally resolved line of peptides. 
However if electrophoresis is carried out in the first, then wetting of 
the T.L.C. plate can occur from all four directions resulting in the 
sharpening of the application spot. The electrophoresis was originally 
carried out in pyridine/acetic acid/water at a ratio of 1/10/189 v /v /v  
pH 3.5. However improved resolution was obtained when the 
electrophoresis buffer was changed to pyridine/acetic acid/water at a 
ratio of 25/1/225 v /v /v  pH 6.5 (Perham, 1967). Visualisation of the 
peptides after two dimensional peptide mapping was by reaction with 
fluorescamine as given in equation 16 below. An example of a peptide 
map obtained for the OXA-2 beta-lactamase is given in figure 19.
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Equation 16: Interaction of Fluorescamine with Peptides
R-N
The peptide map still showed some smearing but the peptides were 
sufficiently resolved to identify approximately 27 peptides. The
resolution was judged to be of a good enough quality to detect any 
peptides that may be labelled with clavulanic acid.
Figure 19: Typical Peptide Map of OXA-2 Beta-Lactamase.
Cl
CCLDO
C Q
(-)ELECTROPHORESIS
Conditions for peptide mapping are given in section 8.2.11. X is the 
application spot and the dotted lines indicate weakly visible spots.
10.1.4: Inhibition of the OXA-2 Beta-Lactamase with Clavulanic Acid
potassium clavulanate was obtained from Beecham
Pharmaceuticals. This compound contained a generally labelled carbon 
skeleton as indicated in figure 20.
Figure 20: Potassium Clavulanate.
* UUU-K+
* Indicates the labelled carbon atoms.
Holland (1983), has shown that approximately 30 molecules of 
clavulanic acid are consumed before the protein is fully inactivated. 
Therefore a 30 fold minimum excess of clavulanic acid is necessary to 
fully inactivate the OXA-2 beta-lactamase. All solutions were prepared 
fresh each day and used immediately to inactivate the beta-lactamase 
since the potassium salt of clavulanic acid is not completely stable in
aqueous solutions (C. Reading, personal communication).
potassium clavulanate (specific activity 6.18 /iCi/mg) was used 
in 299 fold excess to inactivate 75^M OXA-2 beta-lactamase in 0.1M 
ammonium bicarbonate buffer pH 8.1 for 30 mins at 37* C. A sample 
of this fraction was assayed for beta-lactamase activity against
benzylpenicillin but showed no activity (section 8.2.3). To separate any
small molecules that were not bound to the inactivated enzyme, dialysis 
was carried out against the same buffer for 16 hours at 4*C. Assay of 
the dialysed protein showed no activity against benzylpenicillin. The 
labelled OXA-2 beta-lactamase was then separated in a 15%
SDS-polyacrylamide gel (Laemmli and Favre, 1973) half of which was 
stained with PAGE Blue ’83 and the other half containing duplicate 
samples, was soaked in "Amplify" (Amersham) for fluorography. The gel 
was dried down and exposed to preflashed Kodak X-Omat X-ray film 
(Laskey and Mills, 1975). The film was developed after 14 days and 
showed one band corresponding to the OXA-2 beta-lactamase of molecular 
weight 32,000 (results not shown). This indicates that the clavulanic 
acid inactivates the enzyme under these conditions and that the nature 
of the association was covalent since the clavulanic acid is not
* 0 OH
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dissociated from the enzyme during dialysis or SDS-electrophoresis.
10.1.5: Peptide Mapping of Clavulanic acid Labelled OXA-2 
Beta-Lactamase
Two slightly different methods were used to inactivate the OXA-2 
beta-lactamase prior to peptide mapping. In the first instance the
inhibition conditions were essentially the same as those in section 10.1.4 
The second method used only a slight molar excess of clavulanic acid 
over the minimum necessary to achieve total inactivation. This was to 
limit any non specific interactions from taking place as a result of 
clavulanic acid instability.
(i) potassium clavulanate (6.18/iCi/mg) was incubated in 236 fold
excess of 75/*M OXA-2 beta-lactamase in 0.1M ammonium bicarbonate 
buffer pH 8.1 for 30 minutes at 37 * C. The inactivated sample was
separated from unreacted material on a sephadex G15 column (25 x 
0.5cm) prequilibrated in the same buffer at 4* C. Trypsin digestion of 
the inhibited enzyme was carried out as described in section 8.2.11 after 
which the peptides were freeze dried prior to peptide mapping.
(ii) 14c potassium clavulanate (12.94/iCi/mg) at 40 fold excess, was used 
to inactivate 60/iM OXA-2 beta-lactamase in 0.05M sodium phosphate 
buffer pH 7.4 for lOmins at 37* C in a total volume of 200/d. This
was applied directly to a sephadex G15 column (25 x 0.2cm) equilibrated 
in 0.1M ammonium bicarbonate buffer pH 8.0 at 4* C. The enzyme
fraction was collected in a total volume of 1ml which was tested for 
enzyme activity against benzylpenicillin. No activity was detected so the 
enzyme was subjected to trypsin hydrolysis as described in section 8.2.11
for 24 hours at 3 7 'C before freeze drying. Unfortunately some material 
was lost on freeze drying so that an estimate of the total amount of
activity remaining bound to the enzyme, could not be made accurately.
Peptide mapping was carried out as described in section 8.2.11 
where the peptides from experiment (i) were dissolved in a total volume 
of 30/d and those from (ii) in 20/d. Thin layer fluorography was used 
to visualise peptides by dipping the T.L.C. plates in 7% (w/v) PPO (2,5 
diphenyloxazole) in acetone w/v (Laskey and Mills, 1975). The T.L.C. 
plates were then exposed to preflashcd X-ray film at -70* C for between 
25 and 143 days. Plate 2 shows a photograph of the fluorograph
obtained from the peptide map of experiment (i). The result was very 
similar for experiment (ii) except that much more smearing was present 
making the results less clear. It is quite clear from plate 2 that several
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r i a t e  2: P e p t i d e  M a p  o f  14C P o t a s s i u m  C l a v u l a n a t e  I n a c t i v a t e d  O X A - 2  
B e t a - L a c t a m a s e .
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P h o t o g r a p h  o f  f l u o r o g r a m  f r o m  e x p e r i m e n t  (i) s e c t i o n  10.1.5. T h e  T.L.C.
p l a t e  w a s  d e v e l o p e d  i n  7% 2 , 5 - d i p h e n y l o x a z o l e  ( P P O )  in  a c e t o n e  ( w / v )
a n d  d r i e d .  K o d a k  X - O m a t  X - r a y  f i l m  w a s  p r e s e n s i t i s e d  b y  f l a s h i n g
w i t h  d e e p  o r a n g e  l i g h t  p r i o r  to e x p o s u r e  f o r  25 d a y s  a t  - I d '  C. T h e
a r r o w  i n d i c a t e s  t h e  e x t r a  p e p t i d e  n o t  f o u n d  in  n a t i v e  e n z y m e .
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have been labelled although some of the resolution has been lost as a 
result of overexposure. More discrete bands may have been obtained if 
direct autoradiography had been used since Laskey and Mills (1975) 
suggest that fluorography does not necessarily improve the efficiency of 
detection of *4C labelled compounds.
The results from both experiments show that there are at least 8 
peptides labelled by clavulanic acid. This very large number of peptides 
indicates that this system is unsuitable for easy identification of the 
active site peptide. Even if  three labelled peptides had been visualised, 
it would still have been possible to isolate the individual peptides and 
to sequence them thereby identifying other residues at which clavulanic 
acid interacts within the active site. Further discussion of this is given 
at the end of this chapter in section 10.3.
Since problems were experienced with clavulanic acid, a novel 
mechanism based inactivator BRL36148, was characterised with the 
OXA-2 beta-lactamase with a view to use as an alternative label. This 
work was carried out at Beecham Pharmaceuticals, Brockham Park, a 
report of which is given the appendix. BRL36148 forms a chromophore 
on interaction with OXA-2 beta-lactamase but I.E.F. suggested that more 
than one form of inactive enzyme species existed. As such, 
identification of a single active site residue again could prove very 
difficult. In view of the difficulties experienced in isolating a single 
inactive enzyme species and the progress of the DNA sequencing, it was 
considered that a putative active site serine might be determined more 
quickly from the amino acid sequence derived from the DNA sequence 
than from peptide isolation and sequencing. The obvious advantage in 
obtaining a complete primary sequence is that this unusual beta-lactamase 
can be compared with other well characterised beta-lactamases.
10.2.1: Partial Trvosin Hydrolysis Indicates a Domain Structure for the 
OXA-2 Beta-Lactamase
In the process of determining the most suitable conditions for the 
complete digestion of native protein, it was found that native enzyme 
was still largely undigested after 6 hours (10.1.2). Observation of the 
results on SDS-polyacrylamide gel electrophoresis (plate 3) revealed that 
trypsin cleaves the protein into two fragments of Mr  18,840 SE ± 880 
and Mr 12,950 SE ± 580 (mean of seven separate determinations). The 
sum of these two fragments corresponds to the Mr of the undigested 
OXA-2 beta-lactamase on SDS gel electrophoresis which may be indicative
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of a domain structure. This pattern of cleavage is readily observed 
even after the first half hour in the presence of trypsin. Interestingly, 
purified OXA-2 beta-lactamase that has been stored at -20* C and 
defrosted several times, also shows traces of bands at these molecular 
weights.
10.2.2: Attempts at Separation of the Tryptic Cleaved Fragments from the 
OXA-2 Beta-Lactamase
From secondary structure prediction programs Bunster and Cid
(1984), predicted that the class A beta-lactamases consist of two domains 
one of which may contain the catalytic site with an Mr 10,000 - 12,000. 
Since at the time of this study no X-ray crystallography data was 
available as to the fine structure of any beta-lactamase, it was 
considered possible that the 13,000 dalton fragment from partial tryptic 
hydrolysis of the OXA-2 enzyme may correspond to the catalytic domain. 
To test this hypothesis attempts were made to isolate this fragment and 
test for catalytic activity. Initial experiments were performed using
non-denaturing systems such as Sephadex G50 superfine grade which has
a fractionation range of 1,500 - 30,000 daltons for proteins (Pharmacia, 
Gel filtration Theory and Practice, 1984).
Sephadex G50 was equilibrated in 0.025M sodium phosphate buffer
pH 7.5 in column of (1 x 70cm). The OXA-2 beta-lactamase partial 
digest was prepared as described in section 8.2.11 at a protein
concentration of 3.2mg/ml. 1ml was run on the column which had been
calibrated with bovine serum albumin and bovine pancreatic ribonuclease 
A. The protein peaks were recorded by absorbance at 280nm and 0.62ml 
fractions were collected at a flow rate of 0.31ml/min. The elution 
profile showed a single peak for the partial tryptic digest eluting at the 
same position as bovine serum albumin (Mr 68,000) at the void volume
of the column (results not shown). No peaks were observed in the 
region of the bovine pancreatic ribonuclease peak (Mr 13,700). To
determine the nature of the protein peak from the beta-lactamase partial 
tryptic digest column, fractions covering this peak were freeze dried.
The contents of each tube were taken up in 14/d of water before
testing on SDS-polyacrylamide gel electrophoresis (15% gel). The Mr of 
these bands represented the native enzyme and the two smaller
fragments. Therefore Sephadex G50 did not resolve the partial tryptic 
digest, either because the domains were very tightly associated or the
domains formed dimers which were eluted at the void volume of the
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column. To discount the latter possibility, the experiment was repeated 
using Sephadex G75 which has a fractionation range of 3,000 - 70,000 
for proteins (Pharmacia, 1984). Using the same size column and buffer 
as for the Sephadex G50 fractionation, only a single protein peak was 
observed for partially hydrolysed OXA-2 beta-lactamase. Analysis of this 
peak revealed that it contained undigested enzyme as well as the partial 
tryptic fragments (results not shown). Therefore under these conditions, 
OXA-2 beta-lactamase cleaved by trypsin remains associated as a tight 
complex.
Some attempts were made to separate the domains using HPLC and 
a Beckman spherogel TSK 3000SW column (7.5 x 300)mm. Initial
experiments showed a difference in the elution profile of native and 
digested enyzme. The results looked very promising but the position of 
the peaks was not consistent from day to day. This was later shown to 
be due to a defective column. However since the principle of this
separation is size fractionation, it is similar to the sephadex separations
and therefore is unlikely to improve the results. Coupled to the
complications arising from the dimeric nature of the enzyme and the
various associations that are possible for the fragments, denaturing 
systems were used to separate the two domains.
10.2.3: Separation of Tryptic Cleaved Fragments in Denaturing Systems
Since the fragments from partially digested OXA-2 beta-lactamase 
appear to be resolved best in denaturing systems, a novel method
developed by Tai et al (1985), was used to simultaneously separate the
fragments and test for activity. The class A beta-lactamases of B. cereus 
569H, B. licheniformis 149/C and E. coli TEM-1 have been renatured
directly from SDS-polyacrylamide gel electrophoresis gels (Tai et al, 1985). 
48/ig of native and partially hydrolysed OXA-2 beta-lactamase were
separated on duplicate 15% SDS polyacrylamide gels according to the
method of Laemmli and Favre (1973). In addition crude cell 
preparations from beta-lactamase carrying strains S. aureus ’Russell’, E. 
coli (TEM beta-lactamase) and P. aeruginosa 10662 were run out on the 
gels to test the renaturation system for beta-lactamases carried by these 
organisms. One of the gels was renatured in potassium phosphate buffer 
as described in section 8.2.8 whilst the other gel was stained with
Coomassie blue. Visualisation of beta-lactamase activity in the renatured 
gel was carried out by placing starch-iodine filter paper soaked in
lOOmg/ml benzylpenicillin over the gel. Presence of beta-lactamase
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P l a t e  4: R e n a t u r a t i o n  o f  B e t a - L a c t a m a s e s  f r o m  C r u d e  Ce l l  E x t r a c t s  as 
w e l l  as P u r e  O X A - 2  B e t a - L a c t a m a s e  in  S D S - P o l y a c r y l a m i d e  Gels .
20/*l o f  c r u d e  cel l  e x t r a c t s  w e r e  l o a d e d  i n t o  e a c h  t r a c k .  A: S . a u reu s  
R u s s e l l ,  B: 48 / ig  o f  p u r e  u n h y d r o l y s e d  O X A - 2  b e t a - l a c t a m a s e ,  C: 48 / ig  o f  
p u r e  O X A - 2  b e t a - l a c t a m a s e  t h a t  h a d  b e e n  h y d r o l y s e d  f o r  5 h o u r s  b y  
t r y p s i n  a t  3 7 ’ C, D: E. co li c a r r y i n g  T E M ,  E: P. a eru g in o sa  10662
p r e p a r e d  b y  T.  F a r m e r ,  F  a n d  G  a r e  r e p e a t s  o f  B a n d  C r e s p e c t i v e l y  
b u t  o n l y  20 / ig  o f  p r o t e i n  w e r e  lo a d e d .
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activity is revealed by the formation of penicilloic acid which
decolourises the blue/black starch-iodine complex, to white. The
appearance of white bands corresponding to bands in the Coomassie blue 
stained gel, were taken to indicate the presence of beta-lactamase 
activity. In this way beta-lactamase from S. aureus Russell was
successfully renatured as was the TEM beta-lactamase (plate 4). 
Unfortunately very soon after the appearance of a white band in the 
TEM enzyme track of the gel, a large white area developed obscuring 
the band. This area covered part of the track containing the P. 
aeruginosa crude cell extract which appears to have a band of Mr 
slightly greater than the S. aureus band. No activity was seen in the 
tracks carrying either the native or the partially hydrolysed OXA-2 
beta-lactamase which implies that the conditions for the renaturation of 
this beta-lactamase were unsuitable. Further experiments need to be 
carried out to determine the optimum conditions for the OXA-2 enzyme 
renaturation before attempts can be made to renature the partial tryptic 
digests. Even if  such conditions were found but no activity was
observed in the partial tryptic fragments, this need not be attributed to 
the fragments lacking catalytic activity; the fragments may require
significantly different conditions for renaturation than undigested enzyme. 
Generally a negative result is very difficult to interpret since any one 
of a number of possibities may account for this.
10.3: Discussion of Results
Proteolytic enzymes have been used to probe the domain structure 
of a number of proteins, recent examples of which include the aromatic 
acid biosynthesis protein complex and histones (Coggins et al, 1985;
Crane-Robinson and Bohm, 1985). Trypsin and pronase have also been 
used to examine the conformational changes in TEM beta-lactamase after
interaction with certain substrates such as cefoxitin (Citri and Zyk, 
1982).
Partial typsin hydrolysis of the OXA-2 beta-lactamase gives rise to 
two fragments of approximate Mr 19,000 and 13,000. Mild non 
denaturing conditions do not separate these two fragments which suggests
that they may be tightly associated in the native enzyme. However the 
two fragments can be separated readily in denaturing systems using SDS. 
To test the hypothesis that one of the fragments may be the catalytic
domain, attempts were made to renature the fragments directly from
SDS-polyacrylamide gels. Unfortunately the results were inconclusive
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since undigested beta-lactamase could not be renatured under the 
conditions used. The failure to renature undigested beta-lactamase 
warrants further investigation. Tai et al (1985), have shown that carrier 
proteins enhance the activity of the beta-lactamase in the gel after 
renaturation. The authors found that lower levels of beta-lactamase 
could be detected in crude enzyme preparations loaded onto the gel; 
approximately 30 times as much pure enzyme was needed to give an 
equivalent amount of activity. Since purified OXA-2 beta-lactamase was 
used in the experiments presented here, detection of enzyme activity may 
be improved by adding carrier proteins that do not show any activity 
with the starch/iodine complex. Possible candidates that have similar
molecular weights to each of the tryptic fragments and native enzyme 
are cytoctochrome C (Mr 12,500), /3-lactoglobulin (Mr 18,500) and DNase I 
or adenosine deaminase (Mr 31,000 and 32,000 respectively).
Renaturation of OXA-2 enzyme activity from urea, guanidinium 
hydrochloride as well as SDS has previously been unsuccessful (Dale and 
Smith, 1976). The inability to regain enzyme activity after denaturation 
may well be a feature of this protein. It is possible that the
polypeptide folds in a specific way during translation to give a structure 
that is different from one that is formed when the whole polypeptide is 
available. Koshland and Botstein (1982), have shown that the 
prepenicillinase of TEM-1 beta-lactamase which is inactive, appears to 
have a different conformation to that of the mature protein. Therefore 
it is not unreasonable to suppose that there may be more than one 
folded form where only one conformation will give active enzyme.
Despite the fact that it may not be possible to renature the enzyme 
fragments, the denaturing systems are still useful for separating the 
fragments which can then be used to study the N-terminal sequence to 
establish where exactly in the beta-lactamase sequence the trypsin cleaves.
The experiments using non denaturing systems have used only very 
mild conditions for the separation of the partial tryptic digests. Since 
there is no evidence for the presence of a disulphide bridge in the
protein either from the amino acid composition (Holland and Dale, 1984) 
or the DNA sequence (Dale et ah 1985), the two fragments must be held 
together by ionic, hydrogen bond and hydrophobic interactions.
Consequently it may be possible to separate the fragments by disrupting 
these interactions using high ionic strength buffers or reducing the
polarity of the solvent. A similar problem of tightly associated protein 
regions has been observed in the aromatic acid biosynthesis enzyme
complex (Coggins et ah 1985) from Neurospora sp. The quaternary
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structure could only be separated in denaturing conditions after partial 
tryptic hydrolysis.
Study of the fatty acid synthetase complex from vertebrates by 
Hardie and McCarthy (1985), showed that out of the many potential 
elastase cleavage sites, four were predominantly attacked in a well 
defined order. The separated enzyme activities were much more resistant 
to further enzyme hydrolysis. A similar situation exists with the OXA-2 
beta-lactamase in that only a particular site appears to be very labile to 
trypsin cleavage. Even after 14 hours with trypsin, some of the native 
enyme as well as the 19,000 and 13,000 dalton fragments remained 
unhydrolysed. These results are indicative of a domain structure within 
this beta-lactamase.
Bunster and Cid (1984), have predicted that the class A 
beta-lactamases are composed of two domains from the primary sequences. 
Although secondary structure predictions need to be treated with some 
caution, other evidence is available that suggests that there is a domain 
structure within these enzymes. The crystal structure of the S. aureus 
beta-lactamase is now available at a resolution of 0.25nm (Herzberg and 
Moult, 1987) and quite clearly shows that this enzyme is composed of 
two domains. The resolution of the B. cereus I structure has been 
sufficient to give the polypeptide backbone which is similar to the S. 
aureus enzyme (Kelly et al 1986). Since all these structures are similar
it is expected that all the class A beta-lactamases will possess this 
domain structure.
Peptide mapping of the OXA-2 beta-lactamase has shown that 
approximately 27 peptides are present. This is less than the predicted 
| 39 peptides but may be accounted for if  there are tandem lysine or 
arginine residues present within the amino acid sequence. In this 
instance trypsin may be cleaving at only one or the other residue which 
will lead to peptide heterogeneity (Allen, 1981). After the completion of 
the DNA sequence, it was possible to see with hind sight why some of 
the problems occurred with peptide mapping. The amino acid sequence 
deduced from the DNA sequence (section 12) has been used to assess the 
possible tryptic peptides. The majority of peptides are 4-12 amino acids 
in length. There are two large peptides of 26 and 33 amino acids
which may have problems in migrating during chromatography (Allen,
1981); this may account for some fluorescence observed at the application 
spot of the T.L.C. plates. Six peptides were present that had 2 - 3
arginine and or lysine residues in tandem at one end of the peptide.
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These peptides include the putative active site peptide (section 13.2) 
which is given in figure 21.
Figure 21: The putative active site peptide identified from the DNA 
sequence of the OXA-2 beta-lactamase gene.
*
K K R Y S  P A S  T F  K I P H T L  
t t T t
* *
* Represents the putatve active site peptide, t represents the possible 
cleavage sites for trypsin and * for chymotrypsin.
Figure 21 clearly indicates that the N-terminal end of the putative 
active site peptide contains tandem arginine and lysine residues which 
will lead to heterogeneity. Consequently clavulanic acid labelled
beta-lactamase that has been hydrolysed by trypsin will not give a single 
labelled spot which will also be the case if other active site labels are
used. Knott-Hunziker et al (1982b), described a similar problem 
encountered with the active site peptide of ampC beta-lactamase. The 
problem was resolved by using chymotrypsin which cleaves at the 
C-terminal end of aromatic side chains. Figure 21 shows that
chymotrypsin is a more suitable protease to use in the isolation of the 
active site peptide from the OXA-2 beta-lactamase where only a single 
peptide containing label is expected.
Charnas et al (1978), have shown that clavulanic acid reacts with 
TEM-2 beta-lactamase to form three inactive enzyme species. This may
be a result of alkylation or acylation of amino acids other than the
active site serine which in turn may result in the crosslinking of amino
acids that are distant in the primary sequence. Holland (1983), has
suggested that a similar case may exist for the OXA-2 beta-lactamase 
where two inactive enzyme species are present in clavulanic acid
inactivated enzyme, only one of which can be reactivated by
hydroxylamine. When this information is coupled with the heterogeneity
of the tryptic fragments, it is not surprising that several labelled 
peptides are obtained. In addition, if crosslinking of amino acids occurs
within the active site of the OXA-2 beta-lactamase, the resultant linked 
peptides after trypsin hydrolysis, will show altered mobilities. This may 
explain why the peptide maps of native and clavulanic acid inactivated
R S 
t
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OXA-2 beta-lactamase differ cf. figure 19 and plate 2, the most obvious 
difference which has been marked with an arrow in plate 2.
Both BRL36148 and clavulanic acid have proved difficult to use
as active site labels for the OXA-2 beta-lactamase. However, the active 
site serine has been identified from the DNA sequence and will be
discussed in the following chapters. To check that the assignation of 
the active site serine is correct, further proof is needed such as 
substrate and or inhibitor labelling of the active site. 6 
/3-bromopenicillanic acid which inactivates both class A and class C
beta-lactamases (Cartwright and Waley, 1983), labels a unique residue and 
may prove to be a good label for the OXA-2 beta-lactamase.
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11: Crystallisation of the OXA-2 Beta-Lactamase
11.1: Background
The resolution of the OXA-2 beta-lactamase tertiary structure is of 
great interest primarily for study of possible evolutionary relationships 
with other related enzymes. Secondly it appears to have several
properties that distinguish it from other beta-lactamases which include its 
dimeric nature and binding to cibacron blue. X-ray crystallography is 
the most reliable and accurate method by which to study protein
structure although more recently N.M.R. has been used for the same
purpose (Kline and Wuthrich, 1986). This latter technique has the 
advantage over X-ray crystallography in that proteins do not need to be 
crystallised prior to structural studies. Unfortunately a high resolution is 
not yet attainable by N.M.R. and the maximum protein size amenable for 
resolution is < 100 amino acids (R. Leatherbarrow, personal
communication. Hence as a prologue to structure analysis of the OXA-2 
beta-lactamase by X-ray crystallography, it is necessary to determine
conditions that are suitable of crystallisation.
The principles involved in protein crystallisation are the same as
those used for small molecules. The only difference is the inherent
lability of proteins which therefore need to be maintained at or near
physiological conditions. Consequently much gentler crystallisation 
procedures need to be adopted which can vary significantly even
between molecules possessing similar amino acid sequences. To illustrate 
this, table 9, shows the various conditions that have been used to
crystallise penicillin reactive proteins some of which share > 30%
primary sequence homology (Ambler, 1980). The general principle 
adopted is to guide the system slowly toward a state of minimum
solubility by modifying the properties of the solvent to bring about a 
degree of super saturation. This can be achieved for example by using 
precipitating agents or altering the pH. The presence of an isomorphous 
precipitate is an indication that saturation has proceeded too rapidly. 
As proteins crystallise they lose translational and rotational energy which 
lowers the entropy of the system, but this is compensated for by the 
formation of new bonds between the protein units. Small molecules such 
as ammonium sulphate can be used to stabilise this aggregation and 
promote further addition of units to the ordered structure.
In general, the conditions used to bring about crystallisation are 
difficult to predict since the behaviour of macromolecules in solution is 
complex depending on shape, polyvalent surface character and dynamic
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Table 9: Conditions that have been Successful in Crystallising Some 
Penicillin-Reactive Porteins.
D - L a c t m a s e B u f f e r P rote in  
cone mg/ml
C r y s t a l l i s i n g
C o m p o u n d
M eth o d A u t h o r s
TEM 0 - 0 7 5 M
I m ad azo le  
Chloride  
pH 6 - 9
5 0 ( N H ^ S O ,  
2 7 %  
A c e t o n e  1 0 %
V apour
D i f f u s i o n
10 d a y s
K n o x  e t  al  
( 1 9 7 3 )
B. c e r e u s  I 0-1 M 
T r i s - H C l  
pH 8-6
5 ( N W
6 3  %
Vapour
D i f f u s i o n
2 - 3  w e e k s
A s c h a f f e n b u r g  
e t  a l  
( 1 9 7 8 )
5 6 9
P 9 9 0 - 0 5  M 
S o d iu m  
Cacodylate  
pH 7
15 PEG 2 8 %  
M * 6 0 0 0 - 8 0 0 0
V apour  
D i f f u s i o n  
1 - w e e k
C h a l i e r  et al  
( 1 9 8 3 )
B. l i c h e n  iformis 0 - 0 5  M 
S o d i u m  
C a c o d y la f t  
0 - 0 1  M 
S o d i u m  
A zide  
pH 5-5
10
i
PEG 2 7 %  
MR6 0 0 0
H a n g i n g  
D r o p  
2 d a y s
D i d e b e r g  
e t  al  
( 1 9 8 5 )
7 4 9 /  C
S . a u r e u s 0 - 0 5 M  
Ammonium  
/ ' A c e t a t e /  
Acetic ac id  
pH 5-0
1 0 -  2 0 (NHASO,  
6 0 -  7 5  %
Vapour  
D iff usi on
4  -  weeks
Moult e t  al 
( 1 9 8 5 )PCL
S t r e p t o m y c e s 0 -0 5 M
P h o s p h a t e
B u f f e r
p H 6-8
20 PEG 1 5 %  
8 0 0 0
H a n g i n g
D r o p
Kelly et  al  
( 1 9 8 5 )R61 
Carboxypepti -  
d a s e  /  Trans-  
p e p t i d a s e
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properties. To add to the problem, the factors that influence 
crystallisation are poorly understood (McPherson, 1976) so that 
crystallisation is often a product of trial and error. In an attempt to 
crystallise the OXA-2 beta-lactamase, the following conditions have been 
used since they have proved successful for other beta-lactamases.
11.2: Attempts at Crystallisation of the OXA-2 Beta-Lactamase
Despite the potential of X-ray crystallography to generate valuable 
information, the common and recurring problem is obtaining single large 
crystals. Attempts were made to grow OXA-2 enzyme crystals by the 
batch method, microdialysis, vapour diffusion on plates and by hanging 
drops using ammonium sulphate or polyethylene glycol 6000 as the 
precipitant. OXA-2 beta-lactamase was purified as described by Holland 
and Dale (1984), to give a single main band and two minor 
contaminants on SDS-polyacrylamide gel electorphoresis. The protein was 
repurified according to the method of Cartwright and Waley (1984), and 
was shown to be homogeneous on SDS-polyacrylamide gel electrophoresis. 
The specific enzyme activity for benzylpenicillin was 124 units/mg.
(a) Batch Method
The protein concentration was determined as 9.0mg/ml after 
dialysis against 0.025M sodium phosphate buffer pH 7.4. Solid 
ammonium sulphate was added to 0.8ml aliquots of protein solution at 
4 ’ C to give the final concentrations as % of saturation as given below.
Tube
1 56%
2 60%
3 64%
4 68%
The concentrations were centred around 60% since this concentration is
known to to precipitate OXA-2 beta-lactamase (Holland and Dale, 1984). 
The samples were sealed in small glass tubes at 4 ‘ C which were then
left for a period of three months. Tubes 2, 3, and 4 showed an
amorphous precipitate within a day whereas the same precipitate was
seen in tube 1 after 2 weeks. After a total of three months there was 
no evidence of any protein crystals being formed and no change was 
observed in the precipitate.
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(b) Vapour Diffusion by the Hanging Drop Method
Several systems were set up using both polyethylene glycol 6000 or 
ammonium sulphate as the precipitating agents. OXA-2 beta-lactamase 
was dissolved as a pure protein in various buffers after freeze drying 
of the purified protein.
(i) At 4 ' C, 7.5/d of 9mg/ml OXA-2 beta-lactamase was mixed with 
an equal volume of ammonium sulphate at 50%, 60%, 70%, 80% and 90% 
saturation in 0.025M sodium phosphate pH 7.4. These drops were 
suspended on the under side of siliconised glass cover slides which were 
placed over individual wells in Limbro 6 x 4  well tissue culture plates.
To ensure that the wells were airtight, a small amount of vacuum grease
was placed around the edge of the well before placing the cover slip on
top of the well. The wells contained 1ml of buffer containing 
ammonium sulphate at twice the % saturation in the drop. The plates 
were left at 4 'C  for 6 months. After two weeks an amorphous 
precipitate was seen in all the drops but after a further month the 
precipitate disappeared in those drops exposed to the 60%, 70% and 80% 
concentrations. There appeared to be microcrystals in the drops at the
50% saturation although they rapidly redissolved on handling of the tray. 
No further changes were observed.
(ii) A repetition of (i) was carried out with a narrower range of 
concentrations of ammonium sulphate i.e. 52%, 56%, 59%, 60%, 62%, 65% 
saturation. The plates were left at 4 'C  for 2 months during which the 
formation of an amorphous precipitate was observed, but which did not 
disappear. No further changes were observed.
(iii) At 20' C, polyethylyene glycol (PEG) 6000 was dissolved in 
0.05M sodium cacodylate pH 7.0 at a stock concentration of 30% (w/v). 
6/*l aliquots of lOmg/ml OXA-2 beta-lactamase were mixed with an equal 
volume of PEG to give a range of concentrations at 2% intervals 
between 6% and 28% concentration. Drops were suspended over 1ml of 
PEG concentration at twice the drop concentration before sealing and 
leaving for 4 months at 20* C. OXA-2 beta-lactamase rapidly formed an 
amorphous precipitate with concentrations above 8% PEG. Below this 
concentration an amorphous precipitate was formed after 1-2 weeks. No 
other change was seen until the samples dried out.
(iv) Since beta-lactamases have been proposed as being "floppy 
enzymes" (Frere, 1981) lOmg/ml OXA-2 beta-lactamasse in 0.05M sodium 
cacodylate buffer pH 7.0 was incubated with a 50 fold excess of 
clavulanic acid for 30mins at 30' C. It was hoped that the clavulanic 
acid may stabilise the enzyme conformation. Using inhibited enzyme,
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hanging drops were made as in (iii). As in the previous instances the 
rapid formation of a precipitate without any crystals was observed after 
3 months.
(v) OXA-2 beta-lactamase was dissolved in the same buffer as in
(iii) but at a concentration of 20mg/ml. Hanging drops were made at 
20' C with 6.5/il of protein solution mixed in an equal volume of PEG 
6000 at 0, 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, 17% (w/v) in the buffer. 
PEG solutions were then suspended above 1ml wells containing 28% 
polyethylene glycol. Precipitate was seen to form much more slowly 
over a space of 1-3 weeks but no crystals were seen to develop.
(c) Vapour Diffusion by the Plate Method
10/d of 15mg/ml solution of OXA-2 beta-lactamase in 0.05M 
sodium phosphate buffer pH 7.5 was mixed with 10/d of (1, 2, 3, 4, 5)% 
PEG 6000 in the same buffer. The drops were placed on a sterile 
multiple depression spot plate (Sterilin) over an inverted petridish in a 
plastic container. 200ml of 10% PEG 6000 in the same buffer was 
added to the container which was then sealed. Samples were left at 
room temperature but the only changes seen during 3 months were the 
gradual formation of a precipitate.
(d) Microdialysis
Using 50/d dialysis cells (Cambridge Repetition engineers Ltd, 
dialysis cells) 25/d of OXA-2 beta-lactamase at 20mg/ml were dissolved 
in 0.05M sodium phosphate buffer pH 7.5 containing various amounts of 
ammonium sulphate as indicated in figure 22. The chambers were 
carefully sealed with dialysis tubing so as not to form air bubbles. The 
cells were then introduced into Limbro cell tissue assay plates containing 
2ml of differing ammonium sulphate concentrations. The wells were 
sealed with cover slips using vacuum grease and the samples left at 
20* C. The ammonium sulphate concentration in the dialysis cell and in 
the medium was designed to bring the protein gradually to equilibrium. 
Unfortunately the conditions gave a rapid formation of an amorphous 
precipitate which had not disappeared after 3 months.
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Figure 22: Conditions used for Setting up Crystallisation 
Experiments by Microdialysis.
100%
The figure above shows a Limbro 6x4  assay plate. Using 50ul dialysis 
cells (Cambridge Repetition Instruments), 2$ul of beta-lactamase at 
lOmg/ml was mixed with 2Sp\ of ammonium sulphate solution to give the 
final concentration as indicated in the top of each circle. These dialysis 
cells were introduced into 2ml of ammonium sulphate solution whose 
concentration is indicated as the bottom number in each circle. The wells 
were then sealed with cover slips.
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11.3: Discussion
The results were disappointing in that no crystals were grown.
The most encouraging result was from experiment (b,i) in which micro 
crystals were observed at 50% ammonium sulphate saturation. These 
microcrystals were very unstable since they rapidly redissolved on 
handling of the tray. Nevertheless, the conditions under which these 
microcrystals were observed should be used as a starting point for future 
crystallisation attempts.
The literature available on the crystallisation of beta-lactamases 
shows that these enzymes are known to be difficult to crystallise. As 
an example of this, Moult et al (1985), have had difficulty in
reproducing crystallisation despite the the homogeneity of the S. aureus 
PCL beta-lactamase as judged by SDS gel electrophoresis and N-terminal 
sequencing. This was attributed to variations in the method used to 
purify this protein. The effects of such changes and other factors on 
the crystallisation of the OXA-2 beta-lactamase are discussed below.
It is possible that the method used to purify the OXA-2
beta-lactamase may affect its ability to crystallise. Several steps in the
purification process for the OXA-2 beta-lactamase involve Cl" ions which
are known to inhibit this enzyme (Dale and Smith, 1971). In addition
the OXA-2 beta-lactamase is acid labile (Dale and Smith, 1976) giving
altered patterns on I.E.F. when loaded at the acidic end of the gel.
Use of ammonium sulphate in purification steps at 60%, is likely to 
lower the pH which could result in enzyme degradation. Similarly the 
use of ammonium sulphate at high concentrations as a crystallising
reagent will overcome the buffering capacity of the low ionic strength 
buffers used. Consequently this may result in enzyme degradation which 
will inhibit crystal dvelopment (R. Todd, personnal communication). 
Since microheterogeneity can affect crystallisation, the protein should be 
homogeneous to maximise the probability of success (McPherson, 1985). 
Partial denaturation due to acid lability has already been mentioned as a 
possible cause for heterogeneity although several other factors can lead 
to protein heterogeneity. One such example is the presence of many 
satellite bands on I.E.F., the number of which depend on the purity and
age of the protein sample (Holland, 1983). In general the purer the
protein, the more bands are seen which may be caused by the loss of
amido groups from asparagine and glutamine residues. This will cause 
charge-heterogeneity which in turn may affect the crystallisation of this 
beta-lactamase. A solution to this problem may be to use preparative
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isoelectric focusing which will be both milder and allow purification of 
homogegenous material as opposed to the current methods.
OXA-2 beta-lactamase also shows size heterogeneity as discussed in 
section 9 but how this heterogeneity will affect OXA-2 beta-lactamase 
crystallisation is uncertain. Other class A beta-lactamases that have been 
crystallised appear to exhibit a very low degree of size heterogeneity in 
solution (Braswell et aU (1986). This heterogeneity is not as marked as 
in the OXA-2 enzyme and therefore may have much less of an effect. 
On the other hand, the aggregation seen for the OXA-2 protein may 
well promote the formation of crystals.
A further feature worth considering is that beta-lactamases have 
been described as "floppy enzymes" that may exist in multiple 
conformational states (Frere, 1982). Work on S. aureus PCL 
beta-lactamase has shown that it can exist in at least two conformations 
one of which is active and the other inactive (Carrey and Pain, 1978). 
McPherson (1985), suggests that the conformational instability due to the 
dynamic nature of the molecule causes heterogeneity that can minimise 
the chances of crystallisation. To counteract this problem it may be 
possible to use effectors to aid crystallisation by "locking" the protein 
into one conformation. Clavulanic acid, a site directed inhibitor was 
used in an attempt to aid crystallisation of the OXA-2 beta-lactamase. 
However this may not be the most suitable effector since it cross reacts 
within the enzyme active site (section 10) to give several enzyme species. 
These inactivated proteins may well exhibit slight differences in 
structure. The use of effectors such as NADH, has proved successful in 
the crystallisation of lactate dehydrogenase where the apo enzyme on its 
own, could not be crystallised (Hacker et al, 1973). Therefore it is 
worth testing other substrates and inhibitors to see if  they aid 
crystallisation of the OXA-2 enzyme. The problem of variable 
conformation appears to be general problem with the beta-lactamases 
since the difficulties in both obtaining and interpreting high resolution 
maps for several beta-lactamases have been put down to variable 
conformation (B. cereus I, Samraoui et al> 1986; S. aureus PCL, Moult et 
al, 1985; B. licheniformis, Dideberg et al, 1985).
Polyethylene glycol (PEG) is a polymer made of alternating ether 
oxygens and ethene groups which perturb the structure of water and 
hence can promote phase separation. PEG in the molecular weight range 
of 2000-6000 has been used most commonly for protein crystallisation. 
However some proteins only crystallise in the presence of a specific 
molecular size (McPherson, 1985). This gives a precedent for trying
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different Mr sizes for the crystallisation of the OXA-2 beta-lactamase.
In summary, although preliminary experiments were unsuccessful 
there are numerous conditions that need to be tested for the
crystallisation of the OXA-2 enzyme. To aid crystallisation,
microheterogeneity will need to be minimised by choosing novel and 
possibly more gentle purification steps. These include affinity
chromatography (Cartwright and Waley, 1984; section 15), or preparative 
isoelectric focusing. The latter seems especially promising since charge 
heterogeneity can be eliminated. The age of the stored enzyme extract 
from which the OXA-2 beta-lactamase was purified, may play a major 
part in the probability with which crystallisation may occur. (OXA-2 
beta-lactamase was prepared from a frozen sample of cell extract that 
had been prepared as a 400 1 batch fermentation in 1982. The
concentrated stock has been maintained at -20* C and used as a source 
for this protein). Consequently it would be prudent to repeat 
crystallisation experiments using enzyme from freshly grown cells. 
Further organic solvents can be tried to aid crystallisation as for the 
TEM beta-lactamase (Knox et aU 1973). Inclusion of substrates has also 
been known to stabilise proteins in one conformational state and hence 
crystallisation methods may be based on this fact (McPherson, 1976).
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12: DNA Sequencing of the OXA-2 Beta-Lactamase Gene
12.1: Background
Physical characterisation of the OXA-2 beta-lactamase both in the 
current and in previous work, indicates that this enzyme has several 
properties that make it very distinctive from other beta-lactamases 
(section 1.4) and which suggest that it may be a member of a new class 
(Coulson, 1985). On the other hand, the mode of interaction of this 
enzyme with clavulanic acid is similar to the class A enzyme, TEM 
beta-lactamase which led Holland (1983), to tentatively assign the OXA-2 
beta-lactamase to class A in the absence of the amino acid sequence. 
This assignment was further corroborated when the amino acid 
composition was used as a parameter to measure the relatedness of 
proteins by the method of Cornish-Bowden (1983). The OXA-2 
beta-lactamase was found to be related to the class A beta-lactamases of 
K. aerogenes, B. cereus I but not B. licheniformis (Emanuel et al, 1986). 
However since it is well documented that the B. cereus and B. 
licheniformis enzymes are closely related (Ambler, 1980) it is surprising 
that the OXA-2 enzyme should only appear to be related to one of 
these proteins. The quickest and most definitive method by which to 
classify this enzyme, is by comparisons of the amino acid sequence with 
those of the other beta-lactamases. Since some clones were already 
available for the DNA segment containing the OXA-2 beta-lactamase gene 
and preliminary sequencing had already been commenced, it was decided 
that the amino acid sequence could most readily be obtained from the 
DNA sequence. The added advantage of having a complete amino acid 
sequence, was that the active site could be tentatively assigned by 
searching for homologies with the active sites of other beta-lactamases. 
The following section describes the DNA sequencing and features o f  the 
sequence coding for the OXA-2 beta-lactamase gene.
12.2: Preparation of Sequencing Clones
The sequencing method used was that of the dideoxy chain 
terminating method of Sanger et al (1982). This method has been 
described in detail in the above paper and also in section 8.4.3 and will 
not be discussed here. The source of the DNA specifying the OXA-2 
beta-lactamase was from both R46 and pKMlOl of which detailed 
restriction maps have been published (Brown and Willets, 1981; Langer 
and Walker, 1981). R46 was used to construct plasmids pSU5 and pSU8
1 3 4
as described in section 6.5.
The sequencing stratedgy adopted was to use several restriction 
endonucleases to generate smaller fragments from plasmids R46, pKMlOl, 
pSU5 and pSU8 within the specific region of the OXA-2 beta-lactamase 
gene. These fragments were then cloned into the Ml 3 phage vectors 
mp8, mp9 or mpl8 described by Messing and Vieira (1982). In addition 
to the clones that were already available for DNA sequencing, more 
clones were prepared as discussed in section 14.4.2. They were made 
originally to generate specific DNA probes but the information obtained 
from these clones was extremely useful in extending the available 
sequence. Furthermore these new clones provided overlaps for stretches 
of DNA that had remained unconnected and verified sequence that was 
already established. The extra sequence data is presented in this 
chapter.
12.3: Sequence of the OXA-2 Beta-Lactamase Gene
The Ml 3 clones were sequenced as described in section 8.4.3 from 
which the data was collected and analysed by the computer programs of 
Staden (1982). Further data analysis was carried out on the University 
of Winsconsin genetics computer group (UWGCG) package of programs 
(Devereux et al, 1984) which are held at the Edinburgh Regional
Computing Centre. The system was accessed via JANET using the PAD 
facility at the University of Surrey. The final sequencing strategy is 
given in figure 23 and is updated from that published in Dale et al
(1985). The sequence for the coding region of the OXA-2 beta-lactamase 
has been determined from both orientations although some of the 
sequence outside the coding region is available in only one direction and 
is indicated in figure 24.
A single open reading frame was found within this segment of 
DNA which corresponded to 275 amino acids and contained the 
N-terminal sequence of the OXA-2 beta-lactamase as determined from 
N-terminal amino acid sequencing (Holland and Dale, 1984). The open 
reading frame contained a single EcoRl restriction site at position 1045 
(figure 24) the presence of which was predicted from the restriction map 
of Langer et al, (1981). Within this open reading frame there are two 
residues that are ambiguous; one at position 1040 and the other at 
position 1473. In both instances there was a definite G residue in the 
coding strand which was not seen in the opposite strand. In the first 
case, if  the G residue was excluded from the sequence, then the open
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Figure 24: Sequence of the OXA-2 Beta-Lactamase Gene.
Lower case letters in the nucleotide sequence represent residues that are 
uncertain. The amino acid sequence is numbered from the ATG 
initiation codon with the start of the mature protein is underlined. The
dots under the sequence represent residues have been missed out of the
sequence following rexamination of the gels. The postion of the residue 
that has been missed is immediately to the right of the base below
which the dot is present. The numbering system has not taken these
residues into account.
10 20  30 40 50 60
CTCGGGAACA TCAAGGCCCG ATCCTTGGAG CCCTTGCCCT CCGCAGATGA TCGTGCCGTG
.T  .C
70 80 90 100 110 120
ATCGAAATCC AGATCCTTGA CCGCAGTTGC AAACCCTATG ATCGCATGCC CGTTCATAAG
.C .CC .C .C  .C
130 140 150 160 170 180
AAGCTGGGCG AACAAACGAT GTGCCTTCCA GAAAACCGAG GATGCGAACC ACTTCATCCG
190 200  210 220 230 240
GGGTCAGCAC CACCGGCAAG CGCCGCGACG GCCGAGGTCT TCCGATCTCC TGAAGCCAGG
250 260  270 280 290 300
GCAGATCCGT GCACAGCACc TTGCCGTAGA AGAACAGCAA GGCCGCCAAT CCTGACGATG
310 320  330 340 350 360
CGTGGAGACC GAAACCTTGC GCTCGTTCGC CAGCCAGGAC AGAAATGCCT CGACTTCGCT
370 380 390 «. 400 410 420
GCTGCCCAAG GTTGCCGGTG ACGCACACGT GAAACGGATG AAGGCACGAA CCCATGGACA
•G .G .G
430 440  450 460 470 480
TAAGCCTGTT CGGTTCGTAA ACTGTAATGC AAGTAGCGTA TGCGCTCACG CAACTGGTCC
490 500 510 520 530 540
AGAACCTTGA CCGAACGCAG CGGTGGTAAC GGCGCAgcGG CGGTTTTCAT GGCTTGTTAT
550 560  570 580 590 600
GACTGTTTTT TTGTACAGTC TATGCCTCGG GCATCCAAGC AGCAAGCGCG TTACGCCGTG
610 620  630 640 650 660
GGTCGATGTT TGATGTTATG GAGCAGCAAC GATGTTACGC AGCAGGGCAG TCGCCCTAAA
670 680  690 700 710 720
ACAAAGTTGG GCATTAAGGA AAAGTTAATG GCAATCCGAA TCTTCGCGAT ACTTTTCTCC
M A I R  I F A I L F S 1 1
730 740 750 760 770 780
ATTTTTTCTC TTGCCACTTT CGCGCATGCG CAAGAAGGCA CGCTAGAACG TTCTGACTGG
I F S L A T F  A H A  Q E G  T L E R  S D W 3 1
790 800 810 820 830 840
AGGAAGTTTT TCAGCGAATT TCAAGCCAAA GGCACGATAG TTGTGGCAGA CGAACGCCAA
R K F  F S E F  Q A K G T I  V V A D  E R Q 5 1
850 860 870 880 890 900
GCGGATCGTG CCATGTTGGT TTTTGATCCT GTGCGATCGA AGAAACGCTA CTCGCCTGCA
A D R  A M L V  F D P  V R S  K K R Y  S P A  71
_  910 920 930 940 950 960
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TCGACATTCA AGATACCTCA TACACTTTTT GCACTTGATG CAGGCGCTGT TCGTGATGAG
S T F  K I  P H  T L F  A L D  A G A V R D E 9 1
970 980 990 1000 1010 1020
TTCCAGATTT TTCGATGGGA CGGCGTTAAC AGGGGCTTTG CAGGCCACAA TCAAGACCAA
F Q I F R W D G V N R G F A G H N Q D Q 1 1 1
1030 1040 1050 1060 1070 1080
GATTTGCCAT CAGCAATGCg GAATTCTACT GTTTGGGTGT ATGAGCTATT TGCAAAGGAA
D L R S A M R N S T V W V Y E L F A K E 131
1090 1100 1 1 10 1 120 1130 1 140
ATTGGTGATG ACAAAGCTCG GCGCTATTTG AAGAAAATCG ACTATGGCAA CGCCGATCCT
I G D D K A R R Y L K K I D Y G N A D P 151
1 150 1 160 1 1 70 1 1 80 1190 1200
TCGACAAGTA ATGGCGATTA CTGGATAGAA GGCAGCCTTG CAATCTCGGC GCAGGAGCAA
S T S N G D Y W I E G S L A I S A Q E Q 171
1210 1220 1230 1240 1250 1260
ATTGCATTTC TCAGGAAGCT CTATCGTAAC GAGCTGCCCT TTCGGGTAGA ACATCAGCGC
I A F L R K L Y R N E L P F R V E H Q R 191
1270 1280 1290 1 300 1310 1320
TTGGTCAAGG ATCTCATGAT TGTGGAAGCC GGTCGCAACT GGATACTGCG TGCAAAGACG
L V K D L M I V E A G R N VV I L R A K T 211
1330 1340 1350 13 60 1370 13 80
GGCTGGGAAG GCCGTATGGG TTGGTGGGTA GGATGGGTTG AGTGGCCGAC TGGCTCCGTA
G W E G R M G W W V G VV V E W P T C S V 231
1390 1400 14 10 14 20 1430 1440
TTCTTCGCAC TGAATATTGA TACGCCAAAC AGAATGGATG ATCTTTTCAA GAGGGAGGCA
F F A L N I D T P N R M D D L F K R E A 251
1450 1460 14 70 14 80 1490 1500
ATCGTGCGGG CAATCCTTCG CTCTATTGAA GCgTTACCGC CCAACCCGGC AGTCAACTCG
I V R A I L R S I E A L P P N P A V N S 271
1510 1520 1530 1 540 1550 1560
GACGCTGCGC 
D A A
GATAAAACCG 
T -
CGCAGCGCCG GTTACTTCAA CGTTAAACAT CgATGAGGgA
275
1570 15 80 1590 1600 1610 1620
AGCGgTGATC GCCGAAGTAT CGACTCAACT ATCGAGAGGT AGTTGGCGTC ATCGAGCGCC
1630 1640 1650 1660 1670 16 80
ATCTCgAACC gACgTTGCTG GCCGTACATT TGTACGGCTC CcGCAgTGgA TGGCGGCCTG
1690 1700 1710 1 720 1730 1740
gAAGCCACAC aAGTCGATAG TTGATTTGCTG GTTACGGTGA CCGTgAAGGC TTGATGAAA
1750 1760 1770 1 780 1790 1800
CAACGCGGGG CACTGTTGCA AATAGT CGGT G GTGATAAACT TgATCATCCC TTTTGCTGA
1810 1820 1830 1 840 1850 1860
TGGAGCTGCA CAT c GAACCC ATT CAAAGGCC GGCATTTTCA GCGTCACATC ATTCTGTGG
1870
GCCGT
1890 1900 1910 1920 1930
137
reading frame would terminate within the next 23 amino acids assuming 
that no other mistakes have been made. That no other mistakes have 
been made is a fair assumption since the region following residue 1040 
is determined from several different gels and is quite clear. The second 
instance is more complex to define unambiguously, since the G residue 
at position 1473 is towards the end of the sequence. This region has 
proved particularly difficult to sequence which from DNA sequence 
analysis could be attributed to a large stemloop structure that can form 
in this region. Using dITP instead of dGTP did not improve sequence 
data significantly. However this particular G residue was quite clearly 
present in the gels showing the coding strand. Also the amino acid 
composition of the protein inferred from the DNA sequence assuming the 
presence of this G residue, agrees well with that determined from the 
protein itself (Holland and Dale, 1984).
The first ATG codon is 21 amino acids upstream of the 
N-terminal amino acid of the mature protein (Holland and Dale, 1984). 
This 21 amino acid sequence presumably corresponds to the signal 
peptide. The finding of the signal peptide is expected since the OXA-2 
beta-lactamase is a periplasmic protein. Further details of the signal 
peptide composition and possible structure are discussed in section 13. 
The Mr of the mature protein starting at amino acid 22, is 29,570 which 
is in close agreement with previously determined values (Dale and Smith, 
1976; Holland and Dale, 1984). Search for a putative ribosome binding 
site showed that there is a TAAGGAAA sequence, which is 
complementary to the 3’ end of the 16 S rRNA subunit seven bases 
upstream of the ATG start codon. This putative ribosome binding site 
TAAGGAAA at position 675 of figure 24, is typical in that it is purine 
rich. The complementary 16S rRNA sequence is UCCUCCU so that 
there is only a 2 base difference from the optimal Shine-Dalgarno 
sequence in the OXA-2 beta-lactamase gene. The spacing between the 
initiation start codon and the ribosome binding site counting from the 
first T residue is 11. This is fairly typical for many genes in E. coli 
such as the genes coding for ribosomal proteins (Post and Nomura, 1980).
A search was made for stemloop structures using the STEMLOOP 
program from the UWGCG package of programs held at the University 
of Edinburgh. It was hoped that a search for stemloop structures would 
reveal a possible terminator. Using a bias for a stem being a minimum 
length of 6, a maximum loop size of 20 and a minimum value for the 
base pairing in the stem as being 12, 52 possible structures were found 
within the published sequence (Dale et al, 1985). Scores for stems were
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given by G=C pairs = 3, A=T = 2 and G-T = 1. The best structure 
obtained as defined by the score for the stem size, was found at 
position 1499-1533 of the sequence of which the possible structure is 
given below in figure 25. The stemloop covers the end of the coding 
region and may well represent a termination sequence.
Figure 25: Possible Terminator Structure Identified from a Search for 
Stemloop Stuctures using the STEMLOOP Program.
Residue C
T
1499 - C G G A C G ' C T G C G C G A T
H i  i i i  I I I  I I I  I I I  I I I  I I I  I I I  I I I  I I I  I I I  I I I  I I I
1533 - G G C C G C G A C G C G C C A
T '
T
A
The strength of the stemloop structure given in figure 4, would 
partly explain the difficulties that were found in sequencing of this 
particular region. No other significant stemloop structures were found in 
the region studied.
Codon usage for the OXA-2 beta-lactamase gene is given in table 
10 in which the number of times each codon is used and the percentage 
frequency is listed. For some amino acids such as glycine, alanine and 
valine, their corresponding codons are recognised by the most abundant 
iso-accepting tRNA species as defined by Post and Nomura (1980) and 
Ikemura (19Sla,b). The frequency for glycine GGY (Y = pyrimidine, R 
= purine) Is 94%, GCR for alanine is 73%, GUR for valine is 50% and 
GAA for glutamic acid is 63%. This codon usage ressembles that of the 
ampC beta-lactamase from E. coli which is a chromosomally mediated 
beta-lactamase (Jaurin and Grundstrom, 1981). Codons that are used in 
the gene coding for the OXA-2 beta-lactamase which are recognised by 
minor iso-accepting tRNA species include CCY for proline at 60% and
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ACR for threonine at 70%. In addition to these codons, two more 
unusual codons are used frequently that are also recognised by minor 
tRNA accepting species. The first instance is AGG for arginine found 
at a frequency of 15% and secondly AUA for isoleucine, at a frequency 
of 28%. The latter is very unusual since the tRNA isoaccepting species 
for this codon is the least abundant of the tRNA population (Ikemura, 
1981a). The significance of the codon usage will be discussed in section 
12.5. The GC content for the published sequence is 50.1% which is 
typical for E. coli DNA and also Salmonella from which this gene was 
originally isolated.
12.4: Sequence Divergence in the OXA-2 Beta-Lactamase Gene
DNA sequencing was completed from a number of clones derived 
from the parent plasmids R46 and pKMlOl of which the latter is a 
deletion mutant of R46. All the clones derived from either parent 
agreed with each other in their DNA sequences until residue 1546,
(figure 24). An Alul clone, A62 derived from the Bam H l/H indlll
fragment of pSU5 (Dale et al, unpublised results), could be read to just
beyond this region as is shown in figure 26. Although the sequence is
of poor quality due to the large distance from the sequencing primer, it 
shows quite clearly that there is a divergence in this sequence from that 
published by Dale et al (1985) beyond residue 1546. This divergence is
also obvious when the pattern of bands is compared between this Alul 
clone and that of the pKMlOl derived clones that are given in the final 
sequence of figure 24. Ali (1986), has sequenced a different clone,
clone A, derived from this region of pSU8. The sequence overlapped 
with residue 1416 to 1546 of figure , after which the two sequences
diverged. However Clone A from pSU8 and the Alul clone from pSU5 
matched as far as could be establised from readings of the sequence and 
matching of the banding pattern. Figure 26 below shows the sequence
divergence.
The divergence is likely to represent the end point of a deletion 
which has occured in the plasmids from which the sequenced clones 
were derived. It is known that the end point of the pKMlOl deletion 
is in this region. However pSU5 has also undergone a deletion event 
during the construction and the end point of that deletion is also found 
in this same region. Until sequence data is available for this region of 
R46 itself it is not possible to tell which deletion has been located, or 
whether the end points are the same in pSU5 and pKMlOl.
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Figure 26: Sequence Divergence of Clones Derived from R46 or
pKMlOl.
(a) Refers to Clone A and (b) refers to a pSU5 Alul clone called A62.
Both these clones have R46 as their parent plasmid. (c) Refers to
sequence derived froma whole range of clones which have pKMlOl as
the parent plasmid.
S e q u e n c e  D i v e r g e n c e  
T
1 5 1 0  1 5 3 0  1 5 4 6
I I I
( a )  CGCTGCGCGA TAAAACCGCG CAGCGCCGGT TACTTCAACG TTAGATCCACT TGTAAAGCC
( b )  CGCTGCGCGA TAAAA-CGCG CAGC--CGGT TA-TT*AATG TTA G -TA C A -T TG*AAA
( c )  CGCTGCGCGA TAAAACCGCG CAGCGCCGGT TACTTCAACG TT AAACATCGA TGAGGGAAG
( a )  TCTTTATTTG CCCATGTTTA TTAAATGGCA TTAGTTTCTA AACGCGTGTC AGCGCCTGGT
( c )  GCGGTGATCG CCGCAAGCTA TCGACTCAAC TATCGAGAGG TCAGTTGCGT CATCGAGCGC
( a )  TTGCCGTTCT CTGGGCTTCG CTGGTGCTTA CGCTGGTTTG TGGTCTTTTT AAGCCTTGCC
( c )  C-ATCTCAAC CGACGTTGCT GGCCTACATT TGTACGGCTC CCGCAGTGGA TGGCGGCCTG
( a )  TTTTACACCA CACTA
( c )  GAAGCCACAC -AGTG
12.5: Discussion
The sequence of the OXA-2 beta-lactamase has now been 
confirmed by Hall and Volker (1987), following sequencing of the OXA-2 
beta-lactamase gene region from pKMlOl. This has revealed several 
interesting features that both corroborate and help to explain results
obtained in this laboratory. Firstly, promotor activity studies carried out 
by Ali (1986) on the OXA-2 beta-lactamase gene in pSU8 have revealed 
that the possible location of promotors is at residues 438-447, 491-507 
and 514-537 of figure 24 which is distant from the proposed
Shine-Dalgarno sequence at position 675 for the start of the translated 
OXA-2 gene. Hall and Volker (1987) have noted that the region of 
DNA from 460-689 can be translated in-frame back to the start of the 
OXA-2 beta-lactamase sequence. Of this in-frame sequence, there are 
two possible translation start ATG codons at positions 461 and 530 whose 
corresponding amino acid sequence matches the start of the aadB gene 
coding for adenlyltransferase which confers kanamycin resistance. The 
promotor sites identified by Ali (1986), at either 438-447 or 514-536, 
could be used to initiate the transcript at these two translation start
sites respectively.
The localisation of the start of the aadB gene in front of other 
resistance genes specifying both trimethoprim and streptomycin /  
spectinomycin, has been discussed in Cameron et al (1986). It appears 
these resistance genes also use the aadB promotor as a result of insertion 
through a "hot spot" into the aadB gene. This "hot spot" may be related 
to the Tn21 hot spot regions which are frequently involved in the 
linkage of mercury, sulphonamide, streptomycin and ampicillin resistance 
genes (section 6.3). Therefore the location of a section of the aadB
gene upstream of the OXA-2 beta-lactamase is a further example of how 
resistance plasmids have evolved. That the initial translation start site 
may occur from aadB, puts into question the nature of the signal 
peptide of the OXA-2 beta-lactamase as given in figure 24. It may be
that OXA-2 beta-lactamase is synthesised as a precursor containing these 
extra 76 amino acids obtained form the aadB gene or alternatively that 
the translation start signal for the OXA-2 beta-lactamase at position 675, 
is much more efficient than that for the adenylyltransferase gene which
must be present to allow expression of the whole gene when it is 
present. The former seems unlikely owing to the large size of the
leader peptide which would in addition contain some of the mature
adenylyltransferase protein sequence. Furthermore it is not certain how
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the secretion system would recognise such a leader peptide. The classic 
nature of the OXA-2 beta-lactamase leader peptide as shown in figure 
24, suggests that the translation start site at position 675 is used
although isolation of precursor protein would be necessary to confirm 
this hypothesis.
The stemloop structure given in figure 25 may appear to be a 
good candidate for a p indepedent terminator but on closer examination 
there appear to be several discrepancies between this stemloop and other 
p independant terminators. To understand these discrepancies, the 
following points have been listed to describe the typical structure of p 
independant terminators (Rosenberg and Court, 1979; Von Hippel et al, 
1984; Platt, 1986).
(i) The p independant terminator has a GC rich dyad symmetry of 
approximately 7-10 bases.
(ii) This dyad symmetry is usually centred 10-20 bases beyond the end 
of the coding region.
(iii) The dyad symmetry permits the formation of intramolecular hairpin 
structures in the RNA transcript that have a minimum loop size of 
three residues. This stemloop can cause the RNA polymerase to stall.
(iv) The RNA transcript carries 4-8 tandem uridine residues directly 
after the stemloop structure which are believed to help the dissociation 
of the RNA-DNA hybrid since rU-dA pairing is very unstable (Platt, 
1986).
Referring back to figure 25, the terminus of the OXA-2 
beta-lactamase gene can be found at residue 1514 which is at the centre 
of the stemloop structure. In addition there is no sequence of tandem 
adenine residues directly after the stemloop that would give the typical 
poly U tail that follows a p independent transcription terminator in the 
RNA transcript. For these reasons it seems very unlikely that this 
stemloop acts as a p independent terminator. A search for alternate 
stemloop structures in the region beyond the end of the OXA-2 
beta-lactamase gene of figure 24, does not reveal any suitable candidates. 
However the information provided by Hall and Volker (1987), has 
provided an alternative explanation. They noted that the start of the 
aadA gene specifying resistance to streptomycin/spcctinomycin starts 36
bases beyond the termination of the OXA-2 beta-lactamase. This
distance is insufficient for the location of a promotor sequence so that 
expression of streptomycin/spectimomycin must be through the original 
aadB promotor located upstream of the OXA-2 beta-lactamase gene. 
Hence the stemloop that forms over the translation stop codon of the
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beta-lactamase gene, may in some way be helping to prevent the 
termination of the transcript and regulating the experssion of the aadA 
gene. The aadA  gene has been localised in close proximity to the bla 
gene on R46 (Brown and Willetts, 1981) but has been deleted in pKMlOl 
(Langer and Walker, 1981). Hence the sequence given in this work 
derived from pKMlOl, contains only a section of the aadA gene.
The codon usage in E. coli genes has been discussed by several 
authors (Gouy and Gautier, 1982; Grosjean and Fiers, 1982; Ikemura, 
1981a,b; Post and Nomura, 1980). The general conclusions are that for 
highly expressed genes such as the ribosomal proteins, the codons used 
tend to be those that are recognised by the most abundant iso-accepting 
tRNA species. Codons for minor tRNA’s are rarely used. To aid the 
efficient expression of genes, Grosjean and Fiers (1982), have shown that 
intermediate binding energies are prefered for codon-anticodon 
interactions. Hence AAC, the codon for asparagine is used preferentially 
to AAU, and GCU the codon for alanine is used in preference to GCC. 
The converse rules appear to be true for weakly expressed genes. Gouy 
and Gautier (1982), have noted that the codon usage of plasmid and 
transposon carried genes is not well adapted to cellular tRNA 
populations. The same conclusion was reached by Ikemura (1981a). The 
codon usage of the OXA-2 beta-lactamase is such that a number of 
codons corresponding to minor tRNA iso-accepting species have been 
used. This fits with the above observations since the OXA-2
beta-lactamase is both plasmid and transposon mediated. Calculation of 
the frequency of optimal codon usage f, as defined by Ikemura (1981b), 
gives a value of 0.53 which is the same as for RTEM beta-lactamase as 
calculated by Ikemura. The f  value for the chromosomal ampC
beta-lactamase of E. coli, calculated from the table of codon frequencies 
given in Jaurin and Grundstrom (1981), is 0.55. These genes do not 
appear to have optimised codon usage as do the genes for ribosomal 
proteins which have f > 0.95. OXA-2 beta-lactamase has been found in 
a number of organisms which include Bordetella bronchiseptica, Proteus 
mirabilis and S. typhimurium (Matthew, 1979). The tRNA population of 
S. typhimurium appears to be similar to that of E. coli (Gouy and
Gautier, 1982), but not much is known about the tRNA populations in 
the other species. Hence no deductions can be made as to how well 
adapted the OXA-2 beta-lactamase gene is for translation in other organisms.
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Section 13: DNA and Amino Acid Sequence Comparisons Between OXA-2
Beta-Lactamase and Penicillin Reactive Proteins 
13.1: Background
The beta-lactamases and penicillin binding proteins form two large 
and diverse groups of enzymes that share an ability to interact with 
beta-lactam antibiotics. For this reason much activity has been put into 
studying similarities of these proteins in both their structure and 
mechanism of action. Tipper and Strominger (1965), suggested that 
beta-lactamases had evolved from penicillin binding proteins. Support for 
this has come from mechanistic studies (Faraci and Pratt, 1983; Hiroto et 
al, 1985) but has been questioned by Spratt (1983), on the basis of lack 
of sequence homolgy. The availability of more data on structure and 
function should help to clarify the evolutionary origins of these proteins.
The Ambler classification of beta-lactamases (Ambler, 1980) is 
based on the similarities in the primary structure. Original comparisons 
showed that four beta-lactamases which are from Gram-positive and 
Gram-negative organisms, shared approximately 20% homology in their 
primary sequence. The availability of the OXA-2 beta-lactamase DNA 
sequence means that the translated DNA sequence can be used to make 
direct comparisons with other beta-lactamase sequences to determine its 
structural class. Prior to the completion of the DNA sequence, the 
available evidence as discussed in section 12.1, was strongly in favour of 
the OXA-2 beta-lactamase being a member of class A. The following 
section discusses the DNA and amino acid homologies found between the 
OXA-2 beta-lactamase and other penicillin reactive proteins. Part of this 
work was carried out at Edinburgh University Molecular Biology 
Department under the supervision of A. Coulson, in order to learn the 
use of the UWGCG (University of Wisconsin Genetics Computer Group)
package of programs. Subsequent use of these computing facilities was 
made using the Joint Academic Network (JANET) via the PAD at the 
University of Surrey.
13.2: DNA Sequence Comparisons Between OXA-2 and Other 
Beta-Lactamases
Preliminary DNA sequence comparisons between TEM and OXA-2
beta-lactamase genes were carried out by Dale et al (1985); no significant 
homology was seen with the TEM beta-lactamase DNA sequence. Using
programs supplied by J. Pustell (Pustell and Kafatos, 1982a,b), further
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comparisons have been made with the DNA sequences of the genes 
coding for B. licheniformis 749/C, E. coli ampC as well as TEM 
beta-lactamases (taken from Ambler, 1980), Jaurin and Grudstrom, 1981; 
Sutcliff, 1978). The comparison programs worked by aligning the two 
sequences and sliding one sequence along the other. Every time a match 
was made, a score was given and recorded. To reduce the amount of 
noise, a minimum stringency was set and sequences that matched were 
given a score along a diagonal. The matrix plots for the above 
comparisons showed no obvious diagonals indicating that no significant 
homology exists in the DNA sequence. This is not unexpected since at 
the level of the DNA sequence, several codons may code for the same 
amino acid. Consequently a greater variation can occur within the
nucleotide sequence without altering the the primary sequence of the 
protein. This is especially true when DNA sequences are compared from
different organisms in which the codon usage may be significantly
different to reflect the cellular tRNA population. Comparison of 
sequences at the nucleotide level requires three times as much
information to be processed than at the protein level and hence a 
corresponding amount of computer time. For the two reasons given 
above and the present interest in study of homology at the level of 
amino acid sequences, further comparisons were limited to the primary 
structure of proteins.
13.3: Amino Acid Comparisons Between OXA-2 and Other Beta-Lactamases
Initial comparisons of the amino acid sequence were carried using 
the programs supplied by J. Pustell (Pustell and Kafatos, 1982a,b) as 
described by Dale et al, (1985). More detailed comparisons were made 
using the UWGCG (University of Winsconsin Genetics Computer Group, 
Devereux et al, 1984) package of programs particularly COMPARE and 
DOTPLOT. These programs are based on the algorithm of Maiziel and 
Lenk (1981), and use a graphics matrix to score the number of matches 
between two sequences. In essence the programs allow a minimal 
number of matches "m" out of "n" to be scored by giving a dot in the 
central coordinate of the match. The two sequences to be compared are 
projected along a horizontal and vertical axis. The search window "n" is 
moved along by one residue along the horizontal direction and the new 
matches are scored. After completing the line, the vertical subsequence 
is dropped by one residue and the process is repeated along the new 
horizontal line. The more similar two proteins are, the more dots are
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Figure 28: Alignment of TEM Beta-Lactamase against the Enzyme from B. licheniformis
using DOTPLOT.
A search window of 6 out of 20 residues was used.
Window: 20 S tr ingency: 6 .0  P o in ts :  251 D ens ity :  13 .43
22-0CT-B5 14: 18
p n b s l .b r f  ck: 2919, 1 to 307
-1__ I -1 -J  ..I. .1 1 - 1 . 1  1 L I  1 I I I I I t  I__ |__|__t _ l __t__t __I —I__I__ i _ J __1__ I__l__I__I__ I__I__I__I__ l l l l l l l l l l l __I__U
■O
n
t3
Cr
"3
o
&ruo
O
CD
cn
r K 1-2
-1— r—1— 1 1— 1— T ~ i — 1 f~| 1—r-T—<—1—i—r
1 4 9
seen on a diagonal.
A choice of moderately stringent parameters for comparison of the 
OXA-2 beta-lactamase with other beta-lactamascs (i.e. 2 matches in a 
window of 3) showed no diagonals. Lowering of the parameters to 6 
matches out of a window of 20 gave three areas of homology when 
OXA-2 beta-lactamase was compared with the TEM enzyme as shown in 
figure 27. These areas correspond to the same regions of homology that 
were given in Dale et al (1985) using the programs of Pustell and
include regions from the signal peptide cleavage site and the active site 
serine residue. Further significance of these matches is discussed in
section 13.5. Following figure 27 is a comparison of TEM beta-lactamase 
with the enzyme from 5. licheniformis 169/C (figure 2) using a search 
window of 6 out of 20 residues. The two sequences share 33% 
homology (Ambler, 1980) which is reflected in the excellent diagonal of 
figure 28. There is an obvious lack of such a diagonal with the 
OXA-2/TEM beta-lactamase comparisons. In an attempt to improve the 
homology between TEM and OXA-2 enzymes, the sequences were
simplified according to table 11. Changes in amino acid sequences are 
often conservative where for example isoleucine may be present instead 
of leucine or valine. It was hoped that simplification would highlight
the presence of any conservative changes.
Table 11: Simplification of amino acid sequences for TEM and OXA-2 
beta-lactamases. Similar amino acids have been grouped together to read 
as a single amino acid.
Amino Acid Related Amino Acids
Gly Gly Pro
Ser Ser Thr
Asp Asp Asn
Glu Glu Gin
His His Arg Lys
lie lie Leu Val Met Ala
Phe Phe Trp Tyr
Cys Cys
Simplification did not improve the degree of homology (results not 
shown). OXA-2 beta-lactamase was then compared to several other class 
A beta-lactamases as well as a class B and one class C enzyme without 
simplification of the amino acid sequence. The proteins used for
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Figure 29: Comparison of the OXA-2 beta-lactamase with other class A 
beta-lactamases. Matches that have been highlighted from the COMPARE 
and DOTPLOT programs are give below using the single letter
assignment for amino acids. Homologies with the active site regions 
have been grouped together at the end of the table. The numbers above
the sequence refer to the amino acid in the nascent beta-lactamase. *
below residues indicates the residues that have been conserved in every 
class A beta-lactamase (Ambler, 1980). BC- beta-lactamase I from B.
cereus, BL- B. licheniformis, SA- S. aureus, RC- R. capsulata.
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comparison were from S. aureus (SA), B. licheniformis 169/C (BL), B. 
cereus I and II (BI and BII), TEM beta-lactamase, E. coli ampC, P. 
aeruginosa Rmsl49 (PSE3) and Rodopseudomonas capsulata SP108 (RC).
The latter two enzymes have been identified as class A beta-lactamases 
(Campbell and Ambler, unpublished results).
The matches in figure 29(L), correspond to the active site serine 
residues of the class A beta-lactamases. The region in the OXA-2
beta-lactamase that shows homology includes serine 72 which also happens 
to be the only serine in the whole sequence that is part of a
Ser-XXX-XXX-Lys peptide. This peptide is characteristic of all the the 
active sites from the serine beta-lactamases and penicillin binding 
proteins (Frere and Joris, 1985). Hence serine 72 in the OXA-2 
beta-lactamase appears to be good candiate for the active site serine. 
The only sequence from the class A beta-lactamases that did not match
up with this sequence was from R. capsulata. Examination of the 
sequence around the active site of this beta-lactamase showed that out a 
20 amino acid segment (i.e. the "window" size used in COMPARE), only 
five matches were seen with the OXA-2 sequence. This was not picked
out since the minimum number of matches allowed was 6 to minimise 
the amount of random matches.
Apart from the active site region, the only other area of known 
function that has shown homology with the OXA-2 beta-lactamase, is the 
signal peptide of TEM beta-lactamase (figure 29 (A)). This region of 
homology covers the signal peptide cleavage site of both proteins. All 
the other matches that have been made on the diagonal, which include
(B), (E), (H) and (J) of figure 29, are short sections that have no
known significance. Interestingly the matching residues do not always
include the highly conserved residues of the class A beta-lactamases 
(marked by * in figure 29). Whether these matches are coincidental or
reflect a more important function, remains to be determined. The 
importance of the homology with the signal peptide sequence and the 
other homologies, will be discussed in section 13.5.
The above section was confined to a discussion of regions that 
show conserved residues on a diagonal. Figure 29 (C), (D), (F), (G), (I) 
and (K) show homologies that are not found on the diagonal of the 
COMPARE and DOTPLOT programs and are therefore unlikely to have 
any significance since large gaps would have to be made in the sequence 
for alignment.
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It is possible to align the sequences of OXA-2 and TEM
beta-lactamasesjto give the maximum degree of homology between the two 
sequences. This was carried out using the Beckman Microgenie package 
with the ALIGN program. However an alignment made this way did 
not include all the information about the homologies between OXA-2 and
the other class A beta-lactamases found in figure 29. Therefore, the
alignment made by the ALIGN program between TEM and OXA-2 was 
coupled with the information from figure 29. For example in figure 29 
(J) there is a good match made with the PSE-3 and OXA-2
beta-lactamases starting at residue 132 in each enzyme. No similiarity
was picked out between TEM and OXA-2 at the equivalent position but
because the sequences of class A enzymes can be aligned with at most 4
- 8 gaps (Ambler, 1980; Campbell and Ambler, unpublished results) it is
possible to use the PSE-3 sequence to find the corresponding region in 
TEM. The homology produced by the ALIGN program was then
manually adjusted to accomodate the information from figure 29 
thereby maximise^ the number of matches. This alignment is shown in 
figure 30 and gives 55 matches (20% homology) of which 18 are with 
the highly conserved residues in the class A beta-lactamases. A further 
18 of these highly conserved residues have not been matched. 38 and 
18 gaps were introduced into the into TEM and OXA-2 sequences 
respectively to produce this alignment. This contrasts with other
alignments for the class A enzymes in which only 4 - 8  gaps need to 
be given to align the sequences (Ambler, 1980).
In conclusion it can be seen that very little homology exists
between the OXA-2 and the class A beta-lactamases. Further
comparisons were made with the class C beta-lactamase of E. coli (Jaurin 
and Grundstrom, 1981), the class B beta-lactamase of B. cereus (Ambler 
et al, 1985) as well as PBP’s la and lb (Broome-Smith et al, 1985b). 
The same degree of stringency was used to compare these sequences but 
few or no diagonals were observed in any of the matches, even in the 
regions corresponding to the active site serine (results not shown).
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Figure 30: Alignment of the Entire OXA-2 Beta-Lactamase Sequence
against that of the Class A Beta-Lactamase TEM as published in Sutcliffe 
(1978). The residues that have been conserved in the class A 
beta-lactamases are marked by *. Residues that are homologous in the 
comparison are marked by |. The alignment was produ ced by matching 
the sections found to be conserved in figure 29 using COMPARE and 
then aligning the intervening residues to give the best homology between 
TEM and OXA-2 beta-lactamases following alignment by the Beckman 
Microgenie program, Align. The lower case letters below the comparison 
indicate where 5 out of 6 residues from six class A sequences are 
homologous (the sequences used include PSE-3 and the R. capsulata 
enzymes Campbell and Ambler, unpublished results).
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13.4: Comparison of the OXA-2 Beta-Lactamase Protein Sequence to the 
NBRF Protein Data Base
The program WORDSEARCH from the UWGCG package is based 
on the algorithm of Wilbur and Lipman (1983). This program was used 
to compare the OXA-2 beta-lactamase to the entire NBRF (1985) protein 
sequence data base held at the Edinburgh Regional Computer Centre.
This data base held the four class A sequences as published in Ambler 
(1980), and the Class C beta-lactamase from E. coli (Jaurin and
Grundstrom, 1981). It was hoped that the homology between the OXA-2 
beta-lactamase and the class A sequences might be sufficient to pick out 
these sequences from the data base. The program differs from 
COMPARE in that the sequences can be aligned, introducing gaps where 
necessary to give the optimal alignment. Using a "word size” of 3 to 
search within a window of 20 and a gap penalty of 2, the best 30
matches to the OXA-2 beta-lactamase were analysed from the related 
program SEGMENTS. The latter program sorted the best matches in 
order of merit taking into account the number of correctly matched 
residues and the number of gaps that needed to be introduced. Table
12 shows some of the best matches with OXA-2 beta-lactamase.
Table 12: The best sequence alignments from the NBRF protein data 
base to the OXA-2 beta-lactamase. The best 9 matches are given below 
with scores given for the number of matches, the number of gaps and 
the overall % homology with the OXA-2 beta-lactamase.
Number Number
Sequence Compared of of %
Homology
Matches Gaps
Nematode Myosin Heavy Chain 44 16 16.0
E. coli Transcription Terminator Rho 43 2 15.6
Aspergillus nidulans Cytochrome b 36 17 13.1
E. coli Diaminopimelate Decarboxylase 35 23 12.7
T7 Protein Kinase 34 14 12.4
T7 Internal Virion Protein C 31 10 11.2
Fruit Fly Actin 8 31 8 11.2
Cowpea Mosaic Virus Genome Polyprotein b 30 8 10.9
Human Histocompatability antigen 27 13 9.8
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None of the best matches featured a beta-lactamase or a penicillin 
binding protein. Surprisingly the best matches were made with
transcription terminator rho protein and the nematode myosin heavy 
chain. This degree of homology is considered low and not significant
when the size of the two proteins is taken into account; the former is 
419 amino acids in length and the latter 1966. Hence the larger the
protein the greater the chance of a match occuring within the sequence. 
In general matches were made with both prokaryotic and eukaryotic
proteins with no particular class of protein featuring significantly. To
verify these results a second program was run by J. Collins to match 
the OXA-2 beta-lactamase with the protein data base (Lyle and Collins, 
unpublished results). The matches made were very similar to those given
in table 12, again with no beta-lactamase featuring in the best of 20. 
This strongly suggests that the OXA-2 beta-lactamase is significantly
different from the other beta-lactamases of known sequence.
13.4: Discussion of Primary Sequence Homologies
The results show that the OXA-2 beta-lactamase is significantly 
different from the sequences of other penicillin reactive proteins. 
Despite the lack of general homology, one small area of homology has 
been consistently picked up in the region of serine 72. This area
matches with the active sites of several class A beta-lactamases and 
therefore suggests that serine 72 in the OXA-2 enzyme is the active site 
serine. Further evidence for this amino acid being the active site 
residue, comes from the observation that it is part of a Ser-xxx-xxx-Lys 
sequence which is characteristic of all the serine penicillin reactive 
proteins that have been studied to date. In addition, serine 72 is 
located towards the N-terminal end which is also true for the active site 
serines of the other class A beta-lactamases. Frere and Joris (1985), 
have expressed concern about using the low degree of homology found 
in a small protein segment from E. coli PBP3 to identify serine 306 as 
the putative active site residue. These authors, by quickly scanning a 
series of protein sequences, have found decapeptides from horse liver
alcohol dehydrogenase and subtilisin which share 50% homology around 
serine 306 of PBP3. Hence they suggest that significance of any 
matches made in this way in the absence of further information has to 
be treated with caution. However sequencing of E. coli PBPla and lb 
has now been completed (Broome-Smith et al, 1985b) and these proteins 
also share a low degree of homology with PBP3 around serine 306.
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Final proof that serine 306 of PBP3 and the analogous residues in 
PBPla and lb are the active site residues, has come from active site 
labelling with 1 AC benzylpenicillin and peptide sequencing (Keck et al, 
1985). Therefore despite the low homology found it is possible to be 
fairly confident that the active site residue of the OXA-2 beta-lactamase 
is serine 72. However absolute proof of this is needed from direct 
peptide labelling. Figure 31 shows an alignment of all the active site 
peptides now identified in the penicillin binding proteins.
The OXA-2 beta-lactamase active site region seems to be much 
more closely related to the class A beta-lactamases than class C enzymes. 
Interestingly the OXA-2 sequence varies from all the other 
beta-lactamases in that it does not have a conserved phenylalanine 5 
residues away from the active site serine. The OXA-2 beta-lactamase 
sequence gives Tyr-x-x-x-Ser-x-x-Lys instead of Phe-x-x-x-Ser-x-x-Lys 
which is a conservative change. No information is yet available on the 
function of this conserved phenylalanine residue and the effect of an
alteration to tyrosine as in the OXA-2 beta-lactamase. A possible future 
experiment would be to study the function of the tyrosine residue and 
the effects it would have on the action of the OXA-2 beta-lactamase if 
it were changed to phenylalanine by site directed mutagenesis.
The area of homology between TEM and OXA-2 enzymes around 
the signal peptide, shows a conserved Phe-Ala-His sequence. In TEM 
beta-lactamase, signal peptidase cleaves after the alanine residue to give 
histidine as the first residue of the mature protein. In OXA-2 
beta-lactamase N-terminal sequencing showed that glutamine was the first 
residue of the sequence (Holland and Dale, 1984). The experiments for 
N-terminal sequencing gave very poor yields and it was suggested that a 
blocked glutamine residue was present (Holland, 1983). However one of 
the initial experiments gave histidine as the N-terminal amino acid 
which coupled to the homology observed in the present work led Dale et 
aU (1985) to suggest that histidine may in fact be the true N-terminal
residue. The study of signal peptide sequences does not show any
sequence conservation around the signal peptide cleavage site although
there appears to be a marked preference for the presence of certain 
amino acids. Austen (1979), noted that signal peptidase preferentially 
cleaves at the carboxyl side chain of small uncharged residues such as 
alanine. Unfortunately this does not help in the above problem since 
both glutamine and histidine are prcceeded by alanine residues. 
Searching the N-terminal sequences of other class A beta-lactamases does 
not resolve the problem either, since they start with a basic residue or
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Figure 31: Alignment of Sequences Around the Active Site Serine for the 
Serine Penicillin Reactive Proteins. The boxed areas represent residues
that occur within the OXA-2 beta-lactamase and match with residues in 
the other sequences. * denotes the active site serine.
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T Q Q T L F E L G
T Q Q T L F E L G
t p q t l f e L g
T P E T L F E  I G
E x o -  S t r e p t o m y c e s
c e l l u l a r
D D - p e p t i d a s e
R61 A I T T T D 0 F R V G
B.  s t r e a t h e r m o  p h i  I us  E K N I D T V L G I [ a
B a c i l l u s  B.  s u b t i l i s  S K N A d | k  I r I  L P I | A  
PBPs
E.  c o l  i 
PBPs
P B P l a
PBP l b
PBP3
PBP5
PBP6
Q V
nd r 0 u i
N R A T Q A 
N R A M Q A 
N R T  I T D V F E  
E Q N A D V[R] R D 
E G N A D E K L D
V G 
G 
G
V S
V S 
I S
V S
V T
N I 
L A 
T V 
L T 
L T
7 ] p  H t E 1 f | a
V L L C G A V
A F S C A A V
A I N S A I L
A L A A G V L
A L T V G V L
A I N S A I L
T L S S A A V
L ( a )
L ( b )
L ( c )
L ( c )
( d )
L ( b)
L ( b )
L ( b)
L ( e )
T F T G V
T F N G V
T F T G
L G G 
L G G
S F S A V V L
M
M M T E Y L L
( f )
( g )
(h) 
(h)
( c )
( i )
( i )
P F L Y T A A M ( j )
P A T  Y | L | T  A *L[ ( j )
P M V V M T (A i j  ( k )
. . J I M  T S Y V I G ( 1 )
K j j M  T S Y V v  G ( 1 )
Reference sources: (a) Dale et al (1985), (b) Ambler (1980), (c) Campbell 
and Ambler, unpublished results, (d) Emanuel et al (1986), (c) Duez et al 
(1987), (f) Jaurin and Grundstom (1981), (g) Lindberg and Nomark
(1986), (h) Knott-Hunzikcr et al (1982b), (i) Waxman et al (1980), (j) 
Broome-Smith et al (1985), (k) Nakamura et al (1983), (1) Broome-Smith et 
al (1983).
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asparagine (Ambler, 1980). Hence no definative judgement can be made 
on the actual N-terminal residue.
The matrix plots constructed from the program COMPARE, do not 
suggest a significant homology between OXA-2 and the class A or C 
beta-lactamases. This is also suggested by the failure to match the 
OXA-2 beta-lactamase sequence to any other beta-lactamase when it was 
compared against the NBRF protein data base. Ambler (1980), grouped 
four beta-lactamases together on the basis of their sequence homology. 
This homology extended throughout the sequence with only a minimum 4 
8 spaces postulated for the optimum alignment. These four 
beta-lactamases shared a total of 20% homology; comparison of individual 
sequences gave from 30-56% homology. The lowest value was between 
the beta-lactamase from the gram positive S. aureus and TEM 
beta-lactamase which originates from a variety of Gram-negative 
organisms. In general the beta-lactamases from Gram-positive organisms 
shared a greater homology than with the Gram-negative beta-lactamases. 
Hence, if the OXA-2 beta-lactamase was a class A enzyme it would be 
expected to show a greater homology with a Gram-negative enzyme than 
a Gram-positive enzyme. The alignment in figure 30 shows that the 
homology is 20% with a total of 56 spaces inserted. This is not much 
better than the 16% chance homology seen for OXA-2 beta-lactamase 
with the myosin heavy chain from the nematode (table 12). It is
tempting to speculate on the above evidence that the OXA-2
beta-lactamase is the first member of a new class.
The original identification of the ampC beta-lactamase as a 
member of a different class of beta-lactamases, was on the basis of the 
lack of any homology being picked out with the class A beta-lactamases 
even in the region of the active site serine (Jaurin and Grundstrom, 
1981). In addition several other features pointed to the ampC enzyme 
being a member of a new class with respect to size, interaction with 
mechanism based inactivators as well as substrates and have been 
discussed in more detail in the introduction section 3.2.3. As yet no 
detailed kinetic studies on the OXA-2 beta-lactamase are available to 
compare with the other classes. However this beta-lactamase has a 
monomeric size similar to that of the class A enzymes and interacts 
with clavulanic acid and BRL36148 in a manner similar to TEM enzyme. 
Therefore it would seem that if OXA-2 beta-lactamase is indeed a 
member of a new class then it is most closely related to the class A
enzymes. As mentioned above, there is a degree of homology between
TEM and OXA-2 beta-lactamases in which 18 residues are strongly
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conserved with all the class A enzymes. This poses the question as to
how much homology is necessary to classify beta-lactamases in the same 
group and at which point the enzyme can be considered to have evolved 
significantly to merit a new and separate classification.
Considering the OXA-2 beta-lactamase sequence further, it has 
already been shown that several residues around the active site have 
been strongly conserved with the notable exception of a phenylalanine 
being replaced by a tyrosine. Little et al (1986b), have shown that 
glutamate 166 of beta-lactamase I from B. cereus may be a good 
candidate for involvement in the active site of this enzyme. This
residue is highly conserved in all the class A beta-lactamases but is not 
found in the OXA-2 beta-lactamase corresponding position in figure 30. 
This residue may not have been picked out because it is possible that 
the assumptions made for this alignment are not valid and have been 
based on a chance homology with other beta-lactamases.
It is possible that the tertiary structure of the OXA-2 
beta-lactamase will be closely related to other serine beta-lactamases from 
evidence provided by Kelly et al (1986), Samraoui et al (1986) and 
Herzberg and Moult (1987). These groups have shown that the class A 
beta-lactamases from B. licheniformis, B. cereus and S. aureus are closely 
related to the Streptomyces R61 DD-peptidase despite the lack of primary 
sequence homology. Duez et al (1987) have now been able to show from
primary sequence homology that the class C ampC enzyme is more
closely related to the DD-peptidase than are the class A enzymes and 
therefore this enzyme is also expected to possess a similar tertiary 
structure. A solution of the tertiary structure of the OXA-2 
beta-lactamase should not only provide an answer to this hypothesis but 
will also help to investigate the evolution of the serine beta-lactamases.
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13.6: Secondary Structure Predictions of the OXA-2 Beta-lactamase
The previous section showed that there is minimal primary
sequence homology between the OXA-2 beta-lactamase and other class A 
beta-lactamases. However the lack of primary sequence homology does 
not necessarily preclude tertiary structural homology as has been 
demonstrated for the class A beta-lactamases of B. cereus and B. 
licheniformis with the Streptomyces R61 DD-peptidase (Kelly et al, 1986; 
Samraoui et al, 1986). Furthermore, Moews et al (1981), have shown that
sequences which have a poor homology in the primary sequence can
show better homology at the level of the predicted secondary structure. 
This was demonstrated for the N-terminal end of the class A 
beta-lactamases and the penicillin binding proteins from B. subtilis and 
B. steareothermophilus. Moews and Knox (1979) and Bunster and Cid 
(1984), have completed secondary structure predictions for the complete
sequences of four class A beta-lactamases; both groups show that the 
secondary structure gives more extensive homology than in the primary 
sequence. Hence the predicted secondary structure can show greater
homology than is apparent from the primary sequence alone. 
Consequently it was hoped that the prediction of secondary structure for
the OXA-2 beta-lactamase would serve a two fold purpose. Firstly to 
provide a good prelude to eventual X-ray crystallography and second, 
hopefully, to reflect a greater degree of homology between the class A 
beta-lactamases than is apparent from the primary sequence.
As yet no method for predicting the secondary structure of 
proteins is completely accurate due to limitations in the knowledge of 
protein folding. Several methods are now available for the prediction of 
protein structure which have been reviewed by Chou and Fasman (1978).
In the following section three methods based on separate criteria have 
been used to predict the secondary structure of the OXA-2
beta-lactamase. Two of these methods, Chou and Fasman (1974, 1979) 
and Garnier et al (1978), were taken from the the Eliopolous package of 
programs held at the Edinburgh Regional Computing Centre. The Chou 
and Fasman method is essentially based on the probability with which
each residue occurs in a particular structure as deduced from 29 solved 
protein structures (Chou and Fasman, 1974). The frequency with which
a particular amino acid "j" occurs within a particular structure k ( k =
helix, sheet or turn) is f<j.k>. Dividing f<j.k> by the average frequency 
of all 20 amino acids occuring in a particular state <fk>, gives the
conformational parameter P<j.k>. The conformational parameter is then
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used as a basis for predicting the secondary structure of proteins 
according to a set of empirical rules as given in Chou and Fasman 
(1974, 1978). Unfortunately these rules are ambigous and require some 
degree of interpretation (Moews and Knox, 1979; Kabsch and Sander, 
1983) which can result in a lower degree of accuracy than obtained by 
the original authors.
The Garnier method is based on the directional information 
statistics and gives a four state prediction. The basic conformational 
parameters are similar to those of Chou and Fasman, but the algorithm 
for their application is different. In essence this method takes into 
account the information that 8 amino acids on either side of amino acid 
j carry about the conformation of j as well as the information that j 
carries about itself. The predictive procedure gives four values as to
the information associated with each residue for each type of structure. 
Whichever value is the greatest predicts the conformation. Hence a 
unique assignment can be made for each residue. Prediction of structure 
for proteins whose structure is known, gives 49% correctly assigned
amino acids. This can be improved to 56% if something is known of
the secondary structure content of the protein from low resolution X-ray 
crystallography or CD spectroscopy. Decision constants which depend on 
the extent of secondary structure, can then be applied to the prediction.
The third method used to predict the structure of the OXA-2
beta-lactamase is based on the "bulk hydrophobicity" of individual amino 
acids (Cid et al, 1982). Taking the a-carbon atom of the amino acid,
the sum of the Nozaki-Tanford free energies of all the amino acids 
within an 0.8nm sphere for each residue in 21 proteins of known
structure, is calculated and an average value of bulk hydrophobic
character is then determined. This bulk hydrophobic character is plotted 
against the amino acid number from which structures are identified from 
the patterns in the profile. For example a helix will generally have a 
polar and a non polar surface with 3.6 residues/turn. Consequently a
periodic structure repeating every three or four residues is expected. 
Beta-sheet with a polar and a non polar surface will be expected to
give an alternating hydrophilic/hydrophobic sequence. Unfortunately this 
method relies on the identification of particular patterns so that
inexperienced users are likely to make errors especially when the profile 
does not fall into a typical pattern. The most suitable way to use this
method is in conjunction with other predictive methods.
The predictions for the secondary structures of class A
beta-lactamases as carried out by Moews and Knox (1979) do not match
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the predictions made by Bunster and Cid (1984) with the authors 
agreeing in 29-65% of the assignments for alpha helix and beta-sheet. 
The first authors used the Chou and Fasman and Garnier methods, 
whereas the latter used the hydrophobicity and Chou and Fasman 
methods. Since these three methods have already been applied to the
class A beta-lactamases, the same methods were used for the OXA-2 
enzyme. In addition, predictions were made for the TEM beta-lactamase 
using the same three methods so that OXA-2 and TEM beta-lactamase 
could be compared directly. The reasoning behind this was that any 
errors in interpretations of the data would be consistent for both 
proteins.
13.7: Structure Prediction for the OXA-2 and TEM Bcta-Lactamases
(i) Garnier Method (G): Since no information was available about 
the secondary structure content of the OXA-2 beta-lactamase, the decision 
constants were set to zero. These are the same constants as used by 
Moews and Knox (1979) for predicting the secondary structure of the 
class A beta-lactamses. Figure 32 shows a plot of the directional 
information for each conformational state in the OXA-2 enzyme; the
state predicted is that which gives the greatest value. The prediction 
for TEM beta-lactamase is identical to that of Moews and Knox (1979), 
since the same program listing as supplied by Garnier, was used. The 
data is not shown.
(ii) Chou and Fasman Method (C-F): The conformational parameters 
obtained from the program were used to predict the structure from the 
empirical rules as given by Chou and Fasman (1974) for helix and sheet 
structure and Chou and Fasman (1978) for beta-turn. A plot of the 
average tetrapeptide potential for helix, sheet and turn was made which 
was then used to decide the conformation at each particular residue.
(iii) Hydrophobicity Method (HDY): The parameters for the bulk 
hydrophobicity of each amino acid were taken from Cid et al (1982), 
and were used to construct a profile for the OXA-2 beta-lactamase. 
This profile was then used to predict the various structural types from 
observing specific patterns.
The predictions given by these three methods are given in figure
33 for TEM and OXA-2 beta-lactamases, in which the primary sequences 
of these two proteins aligned as in figure 30 of section 13.4. The
prediction for each residue is given below the primary sequence as 
either helix, sheet, turn or coil. From these predictions the % content
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of helix and sheet for each protein is given in table 13 below; the 
values have been given are for the mature proteins only.
Table 13: % Content of Helix and Sheet Structure Predicted from Three 
Methods.
OXA-2 Beta-Lactamase TEM Beta-Lactamase
Helix
G C-F HDY Mean
45 35 23 34
G C-F HDY
41 41 37
Mean
(a)(b) 
39 41 32
Sheet 18 16 23 19 19 15 16 16 17 28
The values indicated in (a) and (b) refer to the mean % content of 
each structure type obtained by Moews and Knox (1978) and Bunster 
and Cid (1984) respectively, for TEM beta-lactamase.
It can be seen from table 13, that the % content of helix and
sheet for the TEM beta-lactamase is consistent with the values obtained 
by Moews and Knox (1979). Bunster and Cid (1984), have predicted 
that the % helix is lower and that there is slightly more sheet structure. 
This may be attributed to the generally lower prediction of helix and 
an overprediction of sheet given by the hydrophobicity method of Cid et
al (1982). The best resolution of tertiary structure for a class A
beta-lactamase is available at 0.25nm for S. aureus PCL enzyme (Herzberg 
and Moult, 1987) and gives approximately of 37% helix and 17% sheet
respectively. The same structure shows that there are 8 segments of 
helix and 5 segments of beta-sheet for S. aureus beta-lactamase. Since 
this enzyme shares -20% homology in the primary sequence with TEM 
enzyme (Ambler, 1980) it is predicted that a similar content of secondary 
structure will be found. Using the predictions for TEM beta-lactamase 
in figure 33, if two or more methods have agreed on a particular 
structure then that structure has been assigned. Using the convention 
that a minimum of five residues is needed for a sheet structure and a 
minimum of six for helix (Chou and Fasman, 1978), TEM is predicted to 
have seven helical regions and four segments of sheet. The same
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treatment for the OXA-2 beta-lactamase gives eight segments of helix 
and four segments of sheet.
To estimate the degree of variation between the predictions for a 
particular protein, the number of consistently assigned amino acids can 
be calculated using one prediction as the standard. Let equal the
number of residues in a particular conformational state of the standard 
protein. Then by comparing another prediction, the number of residues 
residues that agree with the standard, can be scored to give Nj. From 
equation 15, the % of consitently assigned amino acids for a particular 
conformation "k" of helix or sheet can be calculated. Therefore using 
each of the methods alternately, the similarity of two predictions against 
each other can be assessed. The same technique has been used to 
compare each of the TEM predictions to the secondary structure as 
obtained for the S. aureus PCI beta-lactamase. A table of these values 
is given in table 14, where in addition the predictions made here by the 
Chou and Fasman method for TEM beta-lactamase are compared to those 
of Moews and Knox (1979).
%k = lOOxNi Equation 15
Nk
Table 14: Comparison of Predictions by Scoring the Number of Consistently Predicted Residues Using Each 
Method in Turn as the Standard and also Comparing each Prediction for TEM to the Secondary Structure of S. 
aureus PCI Beta-Lactamase as Obtained from Herzberg and Moult (1987) and as aligned in figure 33.
%H and %S refer to the number of consistently predicted residues in the helical and extended sheet state 
respectively.
% Correctly Assigned Residues 
Method %H %S
Qxa-2 Beta-lactamase
C-F against G 60 40
HDY against G 44 68
HDY against C-F 43 68
IM Beta-Lactamase
C-F against G 73 42
HDY against G 63 42
HDY against C-F 59 56
G against S. aureus 68 42
C-F against S. aureus 62 20
HDY against S. aureus 54 28
C-F from this study 
against C-F from (a)
72 42
(b) against C-F from (a) 36 65
(b) against G from (a) 29 63
(a) and (b) refer to data from Moews and Knox (1979) and Bunster and Cid (1984) respectively.
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The data from table 14 shows that there is some disagreement 
between the predictive methods used for the conformation of individual 
amino acids. This is not unexpected since the methods use slightly 
different criteria for predicting structure as discussed in the first part 
of this chapter. Interpretation of the data also affects the final 
prediction given as is illustrated for the Chou and Fasman predictions of 
TEM beta-lactamase structure given here and in Moews and Knox (1979). 
72% of the residues were consistent for helix structure and 67% for 
sheet. This percentage is better than when the data of Moews and 
Knox (1979) and Bunster and Cid (1984) were compared for TEM
beta-lactamase (table 14). In that instance only 29-36% of helical
residues were consistently predictedand 64% of residues in beta-sheet
structure. The best indication for the accuracy of prediction comes 
from the comparisons of the TEM beta-lactamase to that of the true
secondary structure of a class A beta-lactamase from S. aureus, since 
class A beta-lactamases are predicted as having the same tertiary 
structure (Samraoui et al, (1986). The number of consistently predicted
residues are between 55 - 68% for alpha helix and 20 - 42% for sheet 
which indicates that these predictions are not completely random.
Although the predictive quality is poor and despite the
differences in published data of secondary structure prediction, it has 
been possible to show extensive similarity between the beta-lactamases on 
the basis of their predictions alone. The next section discusses possible 
homologies bewteen OXA-2 and TEM enzymes.
13.8: Comparison of the Secondary Structure Predictions of the OXA-2 
and TEM Beta-Lactamases
Figure 33 gives the predictions for the OXA-2 and TEM 
beta-lactamases which have been aligned for maximum homology in their 
primary sequence as discussed in the previous chapter. This alignment 
does not reflect any major homology in the predicted secondary sequence 
although sections of possible homology have been boxed in figure 33. A 
well defined region of the beta-lactamases is around their active site 
serine residues which is therefore a good region to study for any
possible homology. Examination of the predicted structure around the 
active site serine of TEM beta-lactamase, shows that it is at the end of 
a helix which is strongly predicted by all three methods used. This is
not the case with the OXA-2 enzyme which is in no well defined 
secondary structure. However predictions for both beta-lactamases hint
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Figure 33: Secondary structure prediction for OXA-2 and TEM
beta-lactamases using three different methods (G - Garnier, C-F - Chou 
and Fasman, HDY - hydrophobicity). The sequences for both proteins 
are shown below aligned as in section 13, figure 5. The predictions 
have been given below where h, s, t and r denote helix, beta-sheet, turn 
and random coil. The actual 2 ’ sequence of S. aureus beta-lactamase 
taken from Herzberg and Moult (1987) is given above the TEM 
prediction and has been aligned with the TEM sequence according to 
Ambler (1980).
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OXA-2 - - -A KTGWEGRMC yV wvgwve ,VPTG SVFFALNIDT PNRMDDLFKR EAIVRAILR
G s s r r r r r r r r t t r r r r r r r t t r r r s s s s t r r r r t t h h h h h h h h h h h h h h h
C- F h h h h h h h r h h s s s s h h h r r r s s s s h h h h h r r r r r r r h h h h h h h h s  s s h s  s
HDY r h h h h h h h h h li h h h h r r r t 11 s s s r s s s s t t t t t r r h h h h h h h h h h h h h h
VA I K
SA GVPK DYK KSGQATYAS * NDVAFV YPGQ SEP IVLV i FT NKDNKSDKPN DKLISETAK
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that there may be a segment of sheet following the active site serine
which would encompass the highly conserved lysine residue. Fine details 
of tertiary structure are available for the S. aureus beta-lactamase 
(Herzberg and Moult, 1987) and show that the active site serine is 
located just before the begining of a helix. Bunster and Cid (1984), 
have found that a charged loop is present just before the active site
serine and is clearly reflected in the hydrophobicity profiles of the class 
A beta-lactamases but is missing from the class C enzymes (results not 
shown). A similar loop has been found in the OXA-2 beta-lactamase 
and is shown in figure 34 alongside the charged loops of TEM, S.
aureus PCI and B. cereus I beta-lactamases. OXA-2 is unusual in that it 
is the only beta-lactamase to contain three basic residues within this 
loop unlike the other beta-lactamases which have a mixture of basic and 
acidic residues. The significance of this potential loop in structure and 
function is yet unknown although from the detailed structure of S. 
aureus enzyme in this region corresponds to a short segment of amino 
acids located just after a /3-sheet and just before the start of the helix.
The next most highly conserved region in the primary sequences 
of OXA-2 and TEM beta-lactamases is the ’LRKL’ at position j 175 
The secondary structure predictions for both enzymes show that this 
sequence is expected to form part of a helix. A helix structure is 
again predicted in S. aureus PCI beta-lactamase. The other regions that 
have been picked out as being conserved from the primary sequence 
alignments of figure 29 are at positions 30 - 45, 50 - 58, 130 - 140 
(using the numbering of native OXA-2 enzyme). The first of these 
after alignment with TEM, shows that a sheet structure is predicted in 
both porteins and corresponds with (31 of S. aureus. The second segment 
at positions 50 - 58 is predicted as possible sheet structure which 
overlaps part of /32 of S. aureus; TEM is predicted as having a helix in
this region. The last segment considered from figure 29 is at position
130 - 140 of the OXA-2 enzyme. This is predicted as having no
defined structure either in TEM or OXA-2. However this same region 
in S. aureus is just before the fi loop and hence may form part of the 
equivalent regions in TEM and OXA-2. Finally two areas of sheet 
followed by helix are predicted at the C—terminal end of proteins. 
This structural motif is echoed in the S. aureus sequence.
Problems were encountered in the prediction of of the signal 
peptide structure for both proteins despite the preservation of a highly 
hydrophobic nature. The Chou and Fasman methods predict that the 
signal peptide is present as beta-sheet. However the Garnier and
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hydrophobicity methods assign several conformations. A similar problem 
has been by Austen (1979), who was able to predict either helix or sheet 
structures for a number of signal peptides. For this reason the 
comparison of the proteins has been confined to the mature proteins.
13.9: Discussion of Secondary Predictions
Unfortunately the secondary structure predictions did not reveal as 
much homology between TEM and OXA-2 beta-lactamases as was hoped.
It was dissappointing that there was a failure to predict the active site 
serine of the OXA-2 beta-lactamase as being at the N-terminal end of a 
helix. The assumption has been made that the best alignment was that 
made in section 13.5 based on primary sequence homologies. It is
possible that alternative alignments may produce a better match in the 
secondary structure. Nevertheless after careful examination of the 
predictions, several regions of possible homology have been boxed in 
figure 33, which suggest that there may be a low degree of homology 
between the two proteins extending throughout the sequence. Whether 
this homology is sufficient to give similar tertiary structures or even if
these predictions show any resemblance to the true structures will depend 
on the solutions of the tertiary structure of both proteins.
Problems were encountered in determining the start and end points 
for the various structural conformations from the Chou and Fasman and 
Hydrophobicity methods. Where possible the rules for helix boundary 
forming and ending residues (Chou and Fasman, 1978) were used to 
determine the possible start and end points of helices. Some discrepancy 
between my Chou and Fasman prediction and that of Moews and Knox
(1979) for TEM beta-lactamase still occured but was not as great as that
between the predictions of Moews and Knox (1979) and Bunster and Cid 
(1984). This underlines the importance of doing a separate prediction 
for the TEM beta-lactamase so that it would be directly comparable with 
the prediction of OXA-2 beta-lactamase.
There are many ways of describing the accuracy of a prediction
only one of which was used to construct table 14. Garnier et al (1978),
suggest that "if two authors were to arrive at exactly the same
prediction, it is likely that they would quote two different numbers to 
express the accuracy of the prediction". Hence great care has to be 
taken when comparing values given by different authors. The method 
used to construct table 14, records only the number of consistently 
predicted residues. It does not take into account the number of residues
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Figure 34: Hydrophobicity Profiles of Various Beta-Lactamases Showing 
the Charged Loop Preceding the Active Site Serine.
6 represents conserved residues and a  represents the active site serine, 
o, + and - represent the charge of each amino acid within the charged 
loop. The numbering system is as for the actual individual mature 
enzymes. ,
Charged Loop
OXA-2 B-L acfam ase
B.licheniformis
B -L acfam ase
S.aureus PC1 
B-Lacamase
12 -
60 65 70
TEM B -Lacfam ase
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•o 14-
85 80 95
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that have been overpredicted in a particular conformation hence only a 
certain type of information is given. The prediction for TEM 
beta-lactamase when compared to the actual secondary structure of the 
PCI enzyme, revealed that especially helix structure was well predicted. 
The best method appeared to be the Garnier and since this prediction
predicts all four states; the figures of 68% for helix and 42% are 
significantly better than the value of 25% expected if this was just due 
to chance. It will be interesting to see how these predictions compare 
with the actual secondary structure of TEM beta-lactamase when data
becomes available.
The structure of the signal peptide has been difficult to predict 
as has been mentioned in the previous section. This complication may 
arise from the fact that the rules of protein folding are based on 
aqueous environments although the signal peptide is used to interact with 
the highly hydrophobic membrane. Furthermore the predictive methods 
have been based and then tested against known tertiary structures. 
Since no information is available on the conformation of signal peptides, 
predictions cannot be made accurately with no data base to work from. 
Studies by Rosenblatt et al (1980), on synthetic signal peptides suggest 
that aqueous environments promote /3-sheet formation whereas helices are 
formed in a nonpolar solvent. Hence the conformation assumed may 
depend on the enviroment of the signal peptide. Emr and Silhavy
(1983), have worked on deletion mutations in the signal peptide of the 
LamB lambda receptor protein. They have found that one particular 
deletion brings proline 9 and glycine 17 side by side. According to the 
rule of protein folding given by Chou and Fasman (1974), this
combination is helix destabilising. Revertants with normal secretion 
patterns have been found. These have a mutation in which proline 9 
has been changed to leucine or glycine 17 to cysteine thereby breaking 
the helix destablising combination. The complexities of signal peptide 
confomation make it more difficult to predict structure. Consequently 
analysis of the predictions have been confined to the mature protein.
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14: Hybridisation of DNA Coding for the OXA-2 Beta-Lactamse with
Plasmids Specifying Other Beta-Lactamase Types 
14.1: Background
The current methods for assessing beta-lactamase type involve 
determining substrate/inhibitor profiles as well as isoelectirc points (Bush 
and Sykes, 1986). However as novel beta-lactamases are being 
continually identified, minor differences in isoelectric points or substrate 
profiles may be overlooked. Contrarily, minor differences may be taken 
as an indication of novel proteins. Therefore interest has been 
developed in the use of DNA probes for identifying beta-lactamase types 
especially in epidemiological surveys. DNA probes have been prepared 
for TEM-1 and OXA-1 beta-lactamase genes (Cooksey et aU 1985; 
Ouellette and Roy, 1986), of the former which comprises a lkb fragment 
from pBR322 that encompasses most of the gene and 200 bases upstream 
of the gene. This fragment was found to hybridise specifically to 
TEM-2 and OXA-2 class plasmids (RP4 and R46 respectively) although
hybridisation to OXA-2 plasmid DNA was in a region 5kb from the
OXA-2 beta-lactamase gene. It is possible that the 200 base segment of 
the probe that does not code for TEM beta-lactamase, contains a part of 
a transposon or insertion sequence that is recognising a similar sequence 
in the R46 plasmid. Alternatively that part of R46 may contain part
of the TEM gene which is no longer functional. Ouellette and Roy
(1986), have made both specific and non specific probes for the OXA-1 
beta-lactamase gene in pTY27 which has been constructed from the
OXA-1 carrying plasmid RGN238. The nonspecific probe which 
contained extra DNA not coding for OXA-1 beta-lactamase, was found to 
hybridise with OXA-2 and PSE type beta-lactamase specifying plasmids. 
To reduce the problem of non specific binding, a synthetic oligomer of
15 nucleotides was synthesised and found to hybridise only to OXA-1 
specifying plasmids. When a larger probe was made, from what appears 
to be entirely OXA-1 coding DNA, it hybridised to DNA from OXA-2 
specifying plasmids in addition to OXA-1 specifying plasmids. The 
latter suggests that there is some relationship between OXA-1 and OXA-2 
beta-lactamases. This relationship is discussed in the following section.
OXA-2 beta-lactamase is a member of the isoxazoyl penicillin
hydrolysing beta-lactamases which include OXA-1 and OXA-3. PSE-2 
also hydrolyses isoxazoyls and has been referred to as OXA-4 (Matthew,
1979). In addition, Medeiros et al (1985), have recently isolated four 
new enzymes which have been called OXA-4 - OXA-7 where this OXA-4
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enzyme is different from PSE-2 beta-lactamase. Despite the increasing 
numbers of enzymes that are being grouped together in the OXA group, 
as yet little is known about the relationships between them at the 
molecular level.
OXA-2 and OXA-3 beta-lactamases are very similar with respect to 
their molecular weight and substrate profiles which has led Dale and 
Smith (1974), to suggest that OXA-3 beta-lactamase may represent a 
partial deletion of the OXA-2 enzyme. Holland and Dale (1985), have 
tested this hypothesis by determining the cross reactivity of antibodies 
raised against the OXA-2 enzyme with other beta-lactamases. Cross 
reactivity was seen only with the OXA-3 enzyme although much higher 
concentrations of poly clonal antibody were required for the reaction to 
be seen than for OXA-2 beta-lactamase. This could be interpreted in 
the context of the OXA-3 beta-lactamase being a deletion mutant of 
OXA-2 where some antigenic determinants had been lost in the deletion 
therefore requiring more antibody for a reaction to be seen. It was 
hoped that the use of DNA probes would aid the study of the 
relationships between various beta-lactamases.
14.2: Verification of Beta-Lactamase Types from E. call strains
The final aim was to prepare a DNA probe specific for the 
OXA-2 beta-lactamase gene and use it to probe plasmids known to 
specify various beta-lactamases. Before preparing the plasmid DNA, the 
E. coli strains were grown up and tested for the type of beta-lactamase 
activity present.
E. coli strains were taken from the culture collection held in this 
laboratory and are listed in detail with source references in section 7.1, 
table 1. Table 15 below gives brief details of the strains used, plasmids 
and beta-lactamase types specified.
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Table 15: Plasmid Mediated Beta-Lactamascs.
Host Strain Plasmid Enzyme
E. coli RGN238 OXA-1
pSU8 OXA-2
R46 OXA-2
R51B OXA-3
R55 OXA-3
R+* TEM-1
RP1 TEM-2
RP11 PSE-1
R151 PSE-2
Rmsl49 PSE-3
pMG19 PSE-4
p453 SHY-1
R997 HMS-1
Aeromonas hydrophilia oxacillin
hydrolysing
* Beecham Pharmaceuticals enteropathogcnic strain, serotype 091HK7
10ml crude cell extracts of each beta-lactamase strain were 
prepared from L-broth containing 10/xg/ml ampicillin as described in
section 8.2.5. The crude cell extract was applied directly to LKB 
ampholine PAG plates pH 3.5 - 9.5 which were subjected to isoelectric 
focusing as described in section 8.2.9.' Beta-lactamase activity was
visualised by placing Whatmann 3MM paper soaked in 500/^g/ml 
nitrocefin in 0.05M phosphate buffer pH 7.5, over the polyacrylamide 
plate and watching the appearence of red bands. After 10 minutes the 
colour change was photographed and recorded. The pi of the bands was 
recorded by running broad range pi markers (Sigma) on the gel. The 
part of the gel containing the markers was cut off before staining with 
nitrocefin, and was stained separately with Coomassie blue. The position 
of the marker proteins was then used to determine the pi of the 
beta-lactamases. All the beta-lactamases migrated to their predicted p i’s 
as given in Matthew (1979), apart from OXA-3 beta-lactamase specified
by R51B. The pi of this protein was 5.5 (plate 4) as opposed to the 
value of 7.1 expected for this beta-lactamase (Matthew, 1979) which 
suggests that this beta-lactamase is not OXA-3. It is possible that the
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c u l t u r e  h a d  b e e n  m i s - l a b e l l e d .  A n o t h e r  c u l t u r e  w a s  u s e d  c a r r y i n g  R55;  
i s o e l e c t r i c  f o c u s i n g  s h o w e d  t h a t  t h e  p i  o f  th e  b e t a - l a c t a m a s e  f r o m  th e  
c r u d e  ce l l  e x t r a c t  w a s  7.1 ( r e s u l t s  n o t  s h o w n )  w h i c h  w a s  u sed  in 
s u b s e q u e n t  D N A  m a n i p u l a t i o n s .
P l a t e  4: I .E.F.  o f  C u d e  Cel l  E x t r a c t s  f r o m  E. coli  C a r r y i n g  D i f f e r e n t  
B e t a - L a c t a m a s e s  on  a B r o a d  R a n g e  Gel ,  p i  3.5 - 9.5.
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14.3: Hybridisation of the BamYil - HindWl Fragment from pSU8 to
Plasmids Carrying Beta-Lactamase Genes
The OXA-2 beta-lactamase from R46 has been subcloned into pSU8 
as described in section 6.5. The coding part of the gene (approximately 
0.9kb), is located within the 2.7kb BamYll - Hittdlll (B/H) fragment 
which was isolated and used in the subsequent hybridisation experiments. 
Plasmid DNA from the various beta-lactamase producing strains was
prepared using the method of Birnboim and Doly (1979) and transferred 
to nitrocellulose by Southern blotting (Southern, 1975). However before 
the DNA was transferred to nitrocellulose filters, the plasmids were 
digested with BamYll since the average size was >20kb and large 
fragments of DNA do not transfer efficiently from agarose to
nitrocellulose.
pSU8 was prepared from a large scale plasmid preparation using 
the cleared lysate method (section 8.3.2). This plasmid was then digested 
with BamYll and Hindlll after which the 2.7kb fragment was isolated
from a low melting temperature agarose gel. 0.3 - 0.8/ig of this DNA 
was labelled with a-^^P-dATP by nick translation; unincorporated label 
was removed by purifying the DNA on short spun columns (Maniatis et
aU 1982). DNA labelled in this way routinely gave activities of 0.5 - 
1.0 x 106 c.p .m as estimated by cerenkov counting and was used directly 
to probe the filters containing the digested plasmid DNA. All the 
methods used in this section have been described in detail in sections 
8.3 - 8.4.
In the first experiment, the probe was left to hybridise with the 
nitrocellulose filter for 18 hours at 68* C after which any unbound 
material was removed by washing the filter at the same temperature.
The filter was exposed to X-ray film for 2 days before developing. A 
photograph of this autoradiogram is given in plate 5. The position of 
these bands was measured and correlated to the position of the bands in 
plasmid digests as recorded before their transfer to the nitrocellulose 
(plate 6).
From plate 5 it is obvious that hybridisation has occured to TEM, 
PSE, SHV as well as OXA typre plasmids and therefore the BamYll - 
Hindlll probe is not specific for OXA type plasmids. No hybridisation 
was observed for the OXA-3 type plasmid which was most likely due to 
the very low concentrations of plasmid DNA.
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P l a t e  5: A u t o r a d i o g r a m  S h o w i n g  t h e  H y b r i d i s a t i o n  o f  p S U 8  D e r i v e d  
B a m Y l l  - H i n d l l l  P b o b e  w i t h  V a r i o u s  P l a s m i d s  t h a t  h a v e  b e e n  D i g e s t e d  
w i t h  B a m Y ll .
A B C D E F G H  I J K L
P h o t o g r a p h  o f  t h e  a u t o r a d i g r a m  e x p o s e d  f o r  2 d a y s  f o l l o w i n g  
h y b r i d i s a t i o n  o f  t h e  B a m Y ll  - H i n d l l l  f r a g m e n t  a t  68* C to  v a r i o u s  
p l a s m i d s .  T r a c k s  A; B a m Y ll  - H i n d l l l  d i g e s t  o f  pSU8 .  T h e  r e m a i n i n g  
t r a c k s  c o n t a i n  B a m Y ll  d ig es t s  o f  t h e  p l a s m i d s  w h e r e  t h e  p l a s m i d  n a m e s  
a r e  n o t  g i v e n  b u t  r a t h e r  t h e  b e t a - l a c t a m a s e  s p e c i f i e d .  B; O X A - 2  (p S U 8  
u n c u t ) ,  C; PSE- 1 ,  D; PSE-2 ,  E; PSE-3 ,  F;  PSE-4 ,  G ; S H V - 1 ,  H;  O X A - 1 ,  I; 
O X A - 3 ,  J; T E M - 1 ,  K ;  T E M - 2 ,  L; O X A - 2  ( p S U 8  cu t ) .
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P l a t e  6: U V  P h o t o g r a p h  o f  t h e  B a m Y ll  D i g e s t  o f  P l a s m i d s  S p e c i f y i n g  
V a r i o u s  B e t a - L a c t a m a s c s  a n d  th e  I n d i v i d u a l  B a n d s  t h a t  H y b r i d i s e  w i t h  
t h e  B a m Y ll  - H i n d l l l  F r a g m e n t  f r o m  pSU 8.
A B C D E F G H I J K L
I I I I I I I I I I  I | I I
P h o t o g r a p h  o f  a 1% a g a r o s e  gel  s t a i n e d  w i t h  e t h i d i u m  b r o m i d e .  T r a c k s  
c o n t a i n  B a m Y ll  d i g e s t e d  p l a s m i d  D N A  i s o l a t e d  f r o m  s e v e r a l  b e t a - l a c t a m a s e  
p r o d u c i n g  s t r a i n s .  T h e  ce l l u lo s e  s h e e t  c o v e r i n g  t h e  p h o t o g r a p h  g i v e s  t h e  
p o s i t i o n  o f  t h e  b a n d s  t h a t  h a v e  h y b r i d i s e d  w i t h  t h e  p r o b e  D N A  as 
d e t e r m i n e d  f r o m  p l a t e  5. T h e  e n d  t r a c k s  c o n t a i n  l a m b d a  x H i n d l l l  
m a r k e r s .  T r a c k s  A; B a m Y ll  - H i n d l l l  d i g e s t  o f  p SU 8 .  T h e  r e m a i n i n g  
t r a c k s  c o n t a i n  B a m Y ll  d i g e s t s  o f  t h e  p l a s m i d s  w h e r e  t h e  p l a s m i d  n a m e s  
a r e  n o t  g i v e n  b u t  r a t h e r  th e  b e t a - l a c t a m a s e  s p e c i f i e d .  B; O X A - 2  ( p S U 8  
u n c u t ) ,  C; PSE-1 ,  D; PSE-2 ,  E; PSE-3 ,  F;  PSE- 4 ,  G ; S H V - 1 ,  H;  O X A - 1 ,  I; 
O X A - 3 ,  J; T E M - 1 ,  K;  T E M - 2 ,  L; O X A - 2  ( p S U 8  cu t) .
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Since the probe binds to several plasmid types, the experiment
was repeated by raising the stringency of the hybridisation reaction. 
14% formamide was added to the hybridisation buffer which was 
incubated at 68’ C for 18 hours. The effect of the formamide was to 
lower the melting temperature of the DNA by 0.7* C for every i%
formamide added (Maniatis et al, 1982) so that the T m of the probe was
lowered by by ~10’ C. Plate 7 shows the autoradiogram from the
experiment carried out at the higher stringency. This autoradiogram was 
over exposed so that the bands are more clearly visible than in plate 5. 
Again the probe hybridised with PSE-1, PSE-3, PSE-4, SHV-1, OXA-1 and 
OXA-2 type plasmids. Comparison of the experiments carried out at low 
stringency with those carried out at the higher stringency showed that in 
the latter no detectable hybridisation of the probe was seen to PSE-1 or 
TEM-1. On the other hand PSE-3, PSE-4 and SHV-1 showed bands at a 
higher stringency that were not detected at the low stringency. This is 
most likely a consequence of the over exposure of the film at the high 
stringency where very weak bands were not previously seen but have 
now been emphasised.
Despite the more selective binding of the BaniRl - H indlll probe 
at the higher stringency, it is quite clear that this probe is not totally 
selective for the OXA-2 beta-lactamase gene. A similar non selective 
binding was observed by Ouellette and Roy (1986) with a probe made 
for the OXA-1 beta-lactamase gene. It is quite likely that the DNA in 
the probes not coding for the specific genes, is recognising other 
sequences within these large multi resistant specifying plasmids such as 
the inverted repeats of the insertion sequences and transposons. To 
exclude this possibility, DNA probes were constructed from entirely 
within the coding sequence of the OXA-2 beta-lactamase gene.
14.4: Preparation of Specific Single Stranded DNA Probes from Within 
the Coding Sequence of the OXA-2 Beta-Lactamase Gene
One of the simplest methods to construct specific DNA probes is 
to synthesise oligomers of approximately 17-30 nucleotides and end label 
with 32p a  danger of using small oligomers as probes is that they 
will only be targeted against a small section of the gene and 
consequently may fail to pick up homologies. At the time of this study, 
no DNA synthesiser was available so that alternative approaches were 
used to generate specific probes. The first of these involved scanning 
the DNA sequence of the OXA-2 beta-lactamase gene (Dale et al, 1985)
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P l a t e  7: A u t o r a d i o g r a m  S h o w i n g  t h e  H y b r i d i s a t i o n  o f  p S U 8  d e r i v e d
B a m H l  - H i n d l l l  w i t h  V a r i o u s  P l a s m i d s  a t  H i g h  S t r i n g e n c y .
i i i i i i
H y b r i d i s a t i o n  w a s  f o r  18 h o u r s  a t  68° C in  b u f f e r  c o n t a i n i n g  14% 
f o r m a m i d e .  A u t o r a d i o g r a p h y  w a s  f o r  5 da y s .  T r a c k s : -  B a m H l  d ig e s t s  o f  
p l a s m i d s  s p e c i f y i n g  A: S H V - 1 ,  B: PSE-4 ,  C: PSE-3 ,  D: PS E- 2 ,  E: PSE-1 ,  F: 
p S U 8  ( O X A - 2 ) ,  G: T E M - 2 ,  H: O X A - 1 ,  I: T E M - 1 ,  J: p S U 8  ( p u r i f i e d  a n d  
u n c u t ) .
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for any suitable restriction sites that could be used to generate specific 
fragments. The search was carried out using the programs developed by 
Staden (1982) and adapted by K. Indge to run on the PRIME computor
at Surrey University. Restriction sites deemed as being suitable were 
sites that were unique, coming from entirely within the coding region of 
the mature protein and were recognised by readily available restriction 
endonucleases. The only suitable unique site found in this search was 
for Fspl (TGCTGCA) located at position 747 of figure 24 section 12. In 
addition the search showed that there were two H ind i sites 
(GTPyTPuAC) at positions 985 and 1492 which were also within the
coding region of the gene. The Hincll site at position 985 is also
recognised by Hpal but H in d i was used preferentially in conjunction
with Fspl since two probes could be made that covered both the 5’ and
3* region of the coding sequence i.e. from position 747-985 and 985-1492. 
To verify the position of these restriction sites, the BamYll - H indlll 
was mapped.
14.4.1: Restriction Mapping of dSU5 and pSU8
Plasmids pSU5 and pSU8 both contain the BamHl - Hindlll (B/H) 
fragment that specifies the OXA-2 beta-lactamase. These plasmids were
purified by the cleared lysate method (section 8.3.2) and digested with 
BamHl and Hindlll. The 2.7kb fragment was then isolated from either 
plasmid using low temperature melting agarose as described in section
8.3.4. Fspl, H ind i and EcoRl were used for restriction mapping of this 
fragment. Plate 8 shows a photograph of the digests taken under uv 
after separation on 1.2% agarose. The position of the bands was
measured against the position of the molecular weight standards of X x 
H indlll and 4>X174 x Hae III. Table 16 shows the the size of the 
fragments from the various digests.
The restriction mapping was carried out on a number of occasions 
and in each case partial digestion by Fspl and H ind i was obtained 
despite using the restriction enzymes in 20 fold excess of the 
recommended use as well as doubling the incubation time. The
restriction map given in figure 35 was compiled from the information in 
table 16 with an extra 0.05kb fragment proposed to account for the 
banding pattern seen. This is the only possible order of sites that will 
account for all the fragment sizes seen and corresponds exactly with the 
restriction fragments predicted from the DNA sequence (Dale et al, 1985).
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T a b l e  16: R e s t r i c t i o n  m a p p i n g  o f  t h e  B a m H l  - H i n d l l l  ( B / H )  f r a g m e n t  
s p e c i f y i n g  t h e  O X A - 2  b e t a - l a c t a m a s e .  F r a g m e n t  s izes  w e r e  d e t e r m i n e d  
f r o m  l a m b d a  x H i n d l l l  a n d  <4>X174 x H at’I I I  d ig es t s .  F s p l  (F) ,  H i n d i
(N )  a n d  E c o R I  (E).
D i g e s t  F r a g m e n t  S i z e / k b
1 ( B / H )  2.8
2 ( B / H ) x E  1.7, 1.0
3 ( B / H ) x F  2.7, 2.2, 1.4, 1.3, 0.9, 0.46
4 ( B / H ) x N  2.7, 2.1, 1.6, 1.05, 0.58, 0.51
5 ( B / H ) x F x E  1.0, 0.9, 0.46, 0.3
6 ( B / H ) x N x F  2.7, 2.2, 2.1, 1.6, 1.4, 1.3, 1.05, 0.9, 0.46
P l a t e  8: R e s t r i c t i o n  D i g e s t s  o f  t h e  B a m Y ll  - H i n d l l l  f r a g m e n t  f r o m  pS U8.
M 2 3gt54 6 g s l
1.2% a g a r o s e  gel  p h o t o g r a p h e d  u n d e r  u v  a f t e r  s t a i n i n g  w i t h  e t h i d i u m  
b r o m i d e .  T r a c k  N o ’s c o r r e s p o n d  to t h e  d ig e s t s  in  t a b l e  16 a b o v e .  X a n d  
<I> r e f e r  to s t a n d a r d  D N A  m o l e c u a l r  w e i g h t  m a r k e r s ;  X x H i n d l l l  a n d  
4 X 1 7 4  x h a e I II  r e s p e c t i v e l y .
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14.4.2: Construction of Clones Using F so l /H indi
The approach used was to clone the specific fragments into the
Ml 3 recombination system which could then be used to make single
stranded DNA probes. To obtain the appropriate clones, the entire pSU8
plasmid was digested with Fspl and Hincll in preference to the B/H
fragment, to minimise any loss of small fragments of DNA. Since extra 
sites exist for Fspl and Hincll in pSU8 (results not shown), some of the 
clones generated will not contain the correct fragments. These can be 
quickly identified by measuring the size of the insert and rapid 
sequencing of M13 s.s.DNA using the chain terminating method (Sanger 
et aU 1980), to identify the correct clones. The digested plasmid was 
phenol extracted and ethanol precipitated before redissolving in TE 
buffer. M13mpl8 cut with Smal was used as the cloning vector since 
both Fspl and Hincll generate blunt ends. The cut vector was
phosphatase treated and then ligated with the insert using T4 ligase. 
(All these procedures have been outlined in sections 8.3). The ligated
vector was then used to transform E. coli JM101; clones were selected 
using the white/blue beta-galactosidase selection system (Messing and
Vieira, 1982).
Thirty six clones were selected and grown as described in section
8.3.4. RF DNA was prepared from these clones using the small scale
plasmid preparation system of Birnboim and Doly (1979). Insert sizes 
were estimated by digesting the RF DNA with BamHl and Kpnl since 
these two sites are located on either side of the Smal site of M13mpl8 
into which the fragments had been cloned. Table 17 gives the insert 
sizes of the fragments which should give a good indication of which 
clones contain the correct insert.
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Table 17: Insert Sizes of Fragments Cloned into M13mpl8 from an Fspl - 
Hincll Digest of pSU8.
Clone Size/bp Clone Size/bp Clone Size/bp Clone Size/bp
FH 1* 850 FH 10* 950 FH 19 1450 FH 28 700
FH 2 850 FH 11* 700 FH 20* 450 FH 29* 700
FH 3* - FH 12* - FH 21* 600 FH 30 -
FH 4* 450 FH 13* 510 FH 22 600 FH 31* -
FH 5* 750 FH 14* 1200 FH 23* 1000 FH 32* 700
FH 6 1500 FH 15* 510 FH 24* 870 FH 33 1400
FH 7* 550 FH 16* 1500 FH 25 850 FH 34* 850
FH 8* 850 FH 17* 1000 FH 26 1500 FH 35* 850
FH 9* 700 FH 18 800 FH 27 _ FH 36 _
In instances were the sizes have not been given, there has been either 
no insert or the clone has failed to grow. * indicates the clones that 
have been sequenced to date. Some of the clones which have been 
indicated as not having an insert were sequenced since single stranded 
DNA had been prepared before loss of the insert occured.
The expected size of the Fspl - Hincll fragment to the nearest 10 
bases is 240 and 510 bases for the Hincll - Hincll insert. From the 36 
FH clones only numbers 4, 7, 13, 15 and 20 had inserts near the desired 
range and hence were the first sequenced but no fragments of 240 bases 
were seen. Sequence data showed that FH 4, 7 and 20 contained DNA 
that did not match with the coding region of OXA-2 beta-lactamase and 
hence were not studied further. FH 13 and FH 15 with fragment sizes 
of 510 bases, were predicted to represent the Hincll - Hincll fragment. 
However DNA sequencing showed that the fragments were identical and 
started at an Fspl site i.e. FI of figure 35 reading in towards the £coRI 
site. Extension of this sequence showed that it corresponded exactly 
with the published DNA sequence of the OXA-2 beta-lactamase (Dale et 
al, 1985) until residue 985 of figure 24 in sectiom 12.3. The sequence 
divergence occurs exactly in the middle of the Hincll site as if Hincll 
had cut the DNA and a second insert was ligated in tandem at this site 
during the blunt end ligation reaction. Interestingly the sequence 
divergence starts with GCA- which is the expected start sequence of a 
clone begining from an Fspl site.
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Figure 36: DNA Sequence of FH 13 and FH 15 Clones.
The start of the insert is underlined as is the start of the sequence 
divergence.
lO  20  30  40  50  6 0
CCCC GCAAGAAGGC ACGTAGAACG TTCTGACTGG AGGAAGTTTT TCAGCGAATT TCAAGCCAAA
70 80 90 100 H O  120
GCACGATAGT TGTGGCAGAC GAACGCCAAG CGGATCGTGC CATGTTGTTT TTGATCCTGT
130  140  150 160  170  180
GCGATCGAAG AAACGCTACT CGCCTGCATC GACATTCAAG ATACCTCATA CACTTTTTGC
190 2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
ACTTGATGCA GGCGCTGTTC GTGATGAGTT CCAGATTTTT CGATGGGACG GCGTTGCATG
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  ^  3 0 0
ATCGTCCTGT CGTTGAGGAC CCGGCTAGGC TGGCGGGGTT GCCTTACTGG TTAGCAGAAT
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
GAATCACCGA TACGCGAGCG AACGTGAAGC GACTGCTGCT GCAAAACGTC TGCGACCTGA
3 70  3 80 3 90  4 0 0  4 1 0
GCAACAACAT GAATGGTCTT CGgTTTCCGT GTTTCGtAAA GTCTGgAAaC GcG
Both DNA sequencing and restriction mapping of the OXA-2 
beta-lactamase gene have shown that an EcoKl site is located
approximately 50 residues downstream of the Hincll site. No evidence 
of an EcoKl site exists in the sequence determined so far. The most 
probable explanation for this sequence divergence is that Fspl and Hincll 
generate blunt end cuts so that during ligation an extra fragment has 
been added in tandem to give FH 13 and FH 15.
To date 24 out of the 36 FH clones have been sequenced, and all
start at an Fspl or Hincll site apart from FH 31 which contained no 
insert. FH 8, 10, 34 and 35 are identical and start at the FI site 
(figure 35) reading towards the BamHl site. These clones contain inserts 
that are predicted as being 850-950 bases long from restriction mapping
(table 17) and have been used to extend the DNA sequence of the B/H
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fragment as given in figure 24, section 12.3. Clone FH 1, starts at an 
Fspl site and matches with a HaeIII clone (Dale, unpublished results) 
that was constructed only from within the B/H fragment. This suggests 
that FH 1 starts at an Fspl site within the B/H fragment other than 
the FI site of figure 35 i.e. at F2, reading towards the BamHl site. 
The DNA sequence of this fragment is not given here. All the other 
clones sequenced (table 17), do not appear to start within the B/H 
fragment and so were not studied any further. It is interesting that of 
all the clones sequenced none have started at N1 or N2 (figure 35) of 
the B/H fragment.
Due to the the problems described above, different cloning 
strategies were adopted to isolate the elusive Fspl/H incll fragment. 
These have been outlined below in table 18.
Table 18: Cloning Strategies Adopted to Isolate the Fspl - Hincll
Fragment.
Clone Description
FH Fspl/Hincll double digest of pSU8 cloned into Smal of 
mpl8.
Fspl/Hincll double digest of B/H fragment from pSU8 cloned 
into Smal of mpl8.
Fspl/EcoRl double digest of B/H fragment from pSU8 cloned 
into Smal/EcoRl digest of mpl8.
Fspl/EcoRl using new enzymes double digest of B/H fragment 
from pSU5 cloned into Smal/EcoRl cut mpl8.
The first clones to be made after the FH clone series were the F 
clones which were prepared from the B/H fragment only, to avoid 
picking up any extraneous DNA from the rest of the pSU8 plasmid. 
Sequencing of 12 F clones revealed that they all contained the same 
insert as FH 13 and FH 15, the sequence of which is given in figure 
36. That all 12 clones should contain the same double insert seems very 
unlikely. Since the sequence divergence of these clones occurs at the
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Hincll site, the E clones were made using EcoRl which has a site 
located some 50 bases downstream of the Hincll site. Of the 24 clones 
picked 12 were sequenced and again showed exactly the same insert as 
FH 13 and FH 15. At this point it was considered possible that pSU8 
contained an insert in the B/H fragment which was being picked up in 
the clones. To avoid this possibility, the B/H fragment from pSU5 was 
used to construct the Y clones. In addition fresh enzymes were used so 
that no cross contamination of Hincll could be considered in the enzyme 
stocks. The results again showed that the Y clones were carrying the 
same insert as in FH 13 and FH 15. As a last resort, a final strategy 
was used in which the B/H fragment of pSU5 was cut with Fspl and 
FcoRI. The fragment digest was run out on a 1.2% agarose gel with an 
aim to isolating the appropriate fragment using NA45 paper (section 
8.3.5). Unfortunately owing to the small size of the fragment and the 
several steps taken to isolate it, no transformants were obtained. The 
discussion of these rather unusual results is given in section 14.4.4.
14.4.3: DNA Probe Constructed from an Alu I Clone
Owing to the problems experienced in the construction of specific 
DNA probes using Fspl and Hincll, another system was used. This 
method utilised a clone A71, made by S. Wall (Dale et al, 1985) from a 
HindlXX- fragment of pSU5 which contained the OXA-2 beta-lactamase 
gene. This fragment was then digested with Alul and fragments were 
cloned into the Smal site of the polylinker in M13mp8. DNA 
sequencing placed this clone as starting at residue 1065 and finishing at 
residue 1218 of the DNA sequence in figure 24, section 12.3. This 
fragment covers residues 127-177 of the amino acid sequence and hence 
is located entirely within the mature protein coding region.
Single stranded DNA probes were synthesised by a method adapted 
from Burke (1984) which is fully explained in section 8.4.4. In essence 
this procedure consists of annealing the universal Ml 3 sequencing primer 
to the M13 Alul clone A71, and extending the primer past the insert
DNA with the Klenow fragment of DNA polymerase I. By adding
a _32p_dATP to the reaction, all A residues become labelled to give DNA 
with a very high specific activity. Addition of all four cold nucleotides 
as a chase reaction ensures that the DNA sequence is extended well
beyond the insert. This newly sythesiscd DNA is cut with EcoRl which 
has a site just beyond the end of the insert. The A71 insert has been 
cloned into the Smal site of the M l3 polylinker site. Cutting at the
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EcoRl site gives an extra 2 bases at the 3’ end of the insert in 
addition to the 58 bases located at the 5’ end which starts with the 
universal primer so that the total length of the insert is 215 bases. 
After cutting with EcoRl, rapid denaturing of the DNA with sodium 
hydroxide followed by separation on 1.2% agarose, enables the labelled 
single stranded DNA to be separated. However due to the small size of 
single stranded DNA it is not easily visualised by ethidium bromide 
staining. Five minute direct autoradiography of the gel clearly shows 
the probe DNA which runs just behind the bromophenol blue dye front. 
The DNA can then be isolated by running into NA45 paper as described 
in section 8.3.5. Probes made in this way were routinely 3 x 10^ - 2 x 
106 c.p .m. as estimated by Cerenkov counting.
Plasmids from various beta-lactamase specifying strains were 
digested with BamYll and then run out on agarose gels. The DNA from 
the gels was then transferred to nitrocellulose filters as previously
described (section 8.4.1), before being probed with the A71 single 
stranded DNA. The hybridisation experiments were carried out for 18 
hours at 6 8 'C before washing to remove unbound material. The filters 
were dried and exposed to X-ray fim overnight at -70’ C using 
intensifying screens. After developing the film, heavy bands were seen 
for the pSU8 plasmid DNA. No other bands were seen except for a 
possible faint band in the OXA-3 plasmid type track. A five day
exposure of the same filter showed much more definite bands for the 
OXA-3 type plasmid but also weak bands for TEM-1 and PSE-3 type 
plasmids (plate 9). Hybridisation to the uncut pSU8 plasmid showed 
several bands which indicates some covalently closed circular DNA and
nicked circular DNA is present in addition to the linear DNA. The 
bands present for TEM-1 and PSE-3 type plasmids correspond to definite 
bands in the uv photograph of the agarose gel gel prior to Southern 
transfer (plate 9a). The OXA-3 type plasmid shows a more intense band 
than either TEM-1 or PSE-3 although no DNA is visible from the uv 
photograph at the corresponding position. (Subsequent digests of the 
OXA-3 type plasmid have used more DNA and show a weak band at 
the same position).
That . the A71 probe should hybridise weakly to the TEM-1 and 
PSE-3 type plasmids was surprising. The experiment was repeated but
the hybridisation conditions were less stringent at 48* C. At the lower 
temperature it was expected that less probe would be washed off and 
that these bands would be stronger. However the X-ray film showed 
that no bands were visible in the TEM-1 and PSE-3 type plasmids
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P l a t e  9: H y b r i d i s a t i o n  o f  a S p e c i f i c  D N A  P r o b e  to P l a s m i d s  S p e c i f y i n g  
V a r i o u s  B e t a - L a c t a m a s e s .
A b o v e  (a)  is a u v  p h o t o g r a p h  o f  B a m H l  d i g e s t s  o f  p l a s m i d s  c o d i n g  f o r  
v a r i o u s  b e t a - l a c t a m a s e s  a f t e r  s e p a r a t i o n  on  a g a r o s e  a n d  s t a i n i n g  w i t h  
e t h i d i u m  b r o m i d e .  T r a c k s  A a n d  N  r e f e r  to M r m a r k e r s  o f  X x H i n d l l l  
a n d  <bX174 x H a e l l l  r e s p e c t i v e l y .  T h e  p l a s m i d  ty p e s  a r e  B; O X A - 3 ,  C; 
PS E-1 ,  D; PSE-2 ,  E;  PS E-4 ,  F;  S H V - 1 ,  G;  O X A - 1 ,  H;  T E M - 1 ,  I; T E M - 2 ,  J; 
p S U 8 ,  K ;  p S U 8  u n c u t ,  L;  PSE-3 ,  M; HMS-1.  (b)  F o l l o w i n g  h y b r i d i s a t i o n  
w i t h  t h e  s p e c i f i c  A lu l  p r o b e  to  t h e s e  p l a s m i d s  ( m e t h o d s  in  te x t ) ,  a f i v e  
d a y  e x p o s u r e  o f  X - r a y  f i l m  s h o w e d  t h e  p l a s m i d  t y p e s  to w h i c h  t h e  
p r o b e  h y b r i d i s e d .  T h e  c o r r e s p o n d i n g  b a n d s  t h a t  h a v e  l i t  u p  a r e  
i l l u s t r a t e d  in  p l a t e  9 (a)  o n  t h e  p e r s p e x  shee t .
ft(b)
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although the OXA-3 type plasmid band remained (results not shown).
Further experiments were also carried out but again hybridisation to
TEM-1 and PSE-3 type plasmids could not be repeated. This suggests 
that non specific binding was observed in the first experiment.
A control experiment was carried out to ensure that the extra 58
bases of the A71 probe coming from the polylinker site and the
universal probe were not causing binding to the OXA-3 type plasmid. 
Extension of the primer was carried out in the normal way except that 
the DNA was cut with both BamHl and EcoRl. Both of these sites are 
located on either side of the Smal site into which the A71 insert had 
been cloned so that at most four extra bases were left at the 5’ end 
and 2 bases at the 3’ end which do not code for the OXA-2
beta-lactamase gene. The probe was treated in the same way except that 
it was now double stranded and had to be boiled before introduction 
into the hybridisation bag. The results again showed that the OXA-2 
beta-lactamase bound to only OXA-2 or OXA-3 type plasmids. The
conclusion of these results is that A71 is a specific probe for the
OXA-2 beta-lactamase and OXA-3 type plasmids indicating that some 
similarity must exist between these two plasmids presumably within the 
beta-lactamase genes.
In case the original observation of cross reactivity between the
OXA-2 beta-lactamase A71 probe and TEM-1 type plasmid was genuine,
checks were made using the programs of Pustell and Kafatos (1982a,b) to 
search for regions of homology between A71 and the TEM-1
beta-lactamase DNA sequence published by Sutcliff (1978). Only eight 
short sections of the TEM-1 gene sequence showed homology to the A71 
DNA probe. The best region gave 9 out of 10 matches but considering 
that the proportion of mismatched bases in other regions is far greater,
it is unlikely that the short stretches of homology would hybridise under
stringent conditions (Bonner et al, 1973). Hence A71 appears to
hybridise to a region other than the beta-lactamase gene in the TEM-1 
type plasmid.
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14.5: Discussion: Fspl - Hincll Probes
In an attempt to isolate specific DNA probes from an FspI/HincII 
digest of pSU8 or the B/H fragment, one particular clone was 
continually selected. This clone contained the correct DNA sequence 
until the Hincll site at which point there was a sequence divergence 
(figure 36). At first it seemed likely that this was caused by two 
fragments ligating in tandem during the blunt end ligation step.
However different cloning strategies suggest that this is unlikely since 
the same clones were obtained when ZscoRI was used instead of Hincll. 
Alternative explanations are examined below.
The first possibility is that an insertion or a deletion has 
occurred within the OXA-2 beta-lactamase gene. This seems unlikely 
since pSU8 was prepared from E. coli grown in the presence of 20^g/ml 
ampicillin in which normal growth was observed. If an insertion or
deletion had occured, loss of beta-lactamase activity would be expected 
and hence no cell growth. In addition no evidence was seen for an 
insertion or deletion in the the BamYll - H indlll fragment of pSU8 
which had the usual 2.7kb size on restriction mapping. However as a
precaution the Y series of clones were constructed from pSU5 but still 
gave the unusual clone. Therefore on the evidence available, an 
insertion or deletion can be discounted as giving rise to the sequence 
divergence in these clones. Another possibility to be considered is that
the sequence published in Dale et al (1985) is incorrect and the sequence 
obtained in figure 36 is the actual sequence of the OXA-2 
beta-lactamase gene. Again this does not seem likely since the OXA-2 
beta-lactamase DNA sequence was obtained from a number clones 
originating from plasmids R46, pKMlOl and pSU8 which all agreed in 
overlapping segments of the sequence. Secondly, if  the sequence of 
figure 36 is translated, then 3 in frame stop codons occur within the 
first 33 bases after the sequence divergence. This would give a mature
protein of 81 amino acids which is far to small to account for the Mr
obtained by physical methods.
Having discounted the most obvious explanations for this sequence 
divergence, other possibilities need to be considered. What is of
particular interest is that the sequence divergence comes exactly at the 
point of the Hincll site and that the diverging sequence starts with an 
Fspl site. As mentioned earlier the obvious explanation is that two 
fragments have been ligated in tandem but that this should occur
persistantly even when EcoRl was used instead of Hincll is very
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suspicious. Since the sequence divergence occurs at the Hincll site, this 
enzyme was replaced with EcoRl which cuts beyond the Hincll site to 
generate the E clones. The same sequence divergence was obtained in 
these clones so that in making the Y clones new enzyme stocks were 
used to rule out any possibility of Hincll contamination. Unfortunately 
this did not improve the situation giving rise to the same series of
clones.
Leaving aside the issue of why these clones are consistently made, 
it is worthwhile considering where this extraneous DNA comes from.
The total insert size in these clones from restriction mapping is 510 
bases, of which 238 bases agree with the DNA sequence of the OXA-2 
beta-lactamase gene and 272 bases do not (calling this piece of DNA 
fragment X). Since the B/H fragment used to construct the F, E and 
Y clones gave this extraneous sequence, it seems likely that this sequence 
is to be found within this fragment. Restriction mapping on this 
fragment has shown that there are two Fspl sites (FI, F2) and two
Hincll sites (Nl, N2) in figure 35. The sequence extending in both 
directions from FI, Nl and N2 has been well characterised whereas the 
sequence around F2 has only been characterised towards the BamHl site. 
The extraneous piece of DNA appears to start at an Fspl site which is 
definitely not FI since the sequence of fragment X does not match the 
given sequence around this site. Therefore the only candidate for 
fragment X is from F2 reading towards the EcoRl site. Even so this 
seems unlikely because if the fragment X were to start at F2 reading 
towards the EcoRl, site restriction mapping predicts the size of the
fragment as being 900 bases by terminating at the FI site (figure 35). 
Furthermore the DNA sequence of 749 bases out of the 900 is now 
available for the F1-F2 fragment with only approximately 150 bases 
missing before the F2 site. There is no sequence homology between this 
sequence and that of the fragment X. The only other possible source
of DNA is a contaminant in the B/H fragment picked up during
isolation on low melting agarose ie from the vector M13mpl8. The 
complete sequence of this M13mp8 is available but no stretch of 
sequence was found that is homologous with the sequence of fragment
X. There is always a small possibility that some non specific DNA is 
contaminating either the plasmid or vector stocks and is being picked 
out in these clones. Perhaps the sequence of DNA starting at Fspl and
ending at Hincll or EcoRl is not viable when cloned into M13mpl8. 
Therefore a strong selection pressure is formed for these unusual clones.
Since the ultimate goal was to make a specific clone that could
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be used to probe other beta-lactamase specifying plasmids, a new cloning 
strategy was adopted.
14.6: Discussion of the Interaction of Probes that are Specific and 
Non-Specific for OXA Type Plasmids
The probe made from the 2.7kb B/H fragment of pSU8 hybridised 
with plasmids other than the OXA-2 beta-lactamase carrying plasmids. It 
carries approximately 1.3kb at the 5’ end and 0.56kb at the 3’ end that 
does not code for the OXA-2 beta-lactamase (figure 35). This 
observation is not unique since Ouellette and Roy (1986), showed that a 
2.1kb BamHl - H indlll fragment carrying the OXA-1 beta-lactamase gene 
in addition to extra DNA at both ends of the sequence, hybridised with 
plasmids harbouring genes coding for OXA-2, OXA-3 and PSE-1 - 4 
beta-lactamases. R46 which carries the gene for the OXA-2 
beta-lactamase is similar to many other multiresistance plasmids in that it 
carries genes coding for resistance to sulphonamide, 
spectinomycin/streptomycin and tetracycline. This linkage of
beta-lactamase resistance genes along with sulphonamide and 
spectinomycin/streptomycin is very common amongst resistance plasmids 
and has been commented on in section 6.3. Tanaka et al (1983a,b) have 
proposed that this common linkage of genes has evolved from an ancient 
mercury transposon. The OXA-2 beta-lactamase gene on pSU8 which was 
originally derived from R46, has not yet been shown to exist on a 
transposon although recent evidence shows that R46 contains two 
insertion sequences IS46, that enclose the tetracycline gene (Brown et al, 
1984; Yamamoto et al, 1984). Although the OXA-2 beta-lactamase does 
not appear to be transposon mediated in R46, another plasmid R1767, 
has been found that does have this gene on a transposon which, in 
addition, carries resistance to mercury and sulphonamide. It may be 
possible that the OXA-2 beta-lactamase gene from R46 is part of a 
non-functional transposon. If this is the case then it is highly probable 
that the extra DNA in the B/H fragment may carry such regions in the 
DNA sequence that hybridise to related regions in other multiresistance 
plasmids known to possess insertion sequences and/or transposons.
Recent papers have shown how rearrangements of R46 may bring 
sequences normally far apart into close proximity. Dodd and Bennett 
(1986), have found that R46 encodes a resolvase gene and recognition 
site, some 12kb from the beta-lactamase gene. The functions of this site 
specific recombination system are interchangable with that of Tn3
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although they cannot transpose as Tn3. pKMlOl is a deletion derivative 
of R46 which has probably been generated by adjacent deletions of the 
IS46 element recombination system. A similar deletion has probably
occurred in the construction of pSU5 so that a different section of 
DNA has been brought into close proximity of the beta-lactamase gene. 
Hence various mechanisms are in operation on R46 which make it seem 
likely that the B/H fragment of pSU8 (which was derived from pSU5) 
contains a DNA sequence homologous to regions in other plasmids.
Evidence is now emerging that there may be a ’hotspot’ for 
recombination in the vicinity of the OXA-2 beta-lactamase gene on R46. 
The latest evidence suggests that the OXA-2 beta-lactamase is using the
promotor of the aadB gene which is no longer functional in R46 
(section 12.5). OXA-1 also appears to be using the same aadB promotor 
(Ouellette et al, 1987), which would explain why hybridisation occured 
between the B/H fragment and the OXA-1 specifying plasmid; both these 
plasmids are carrying remnants of a non-fuctional gene. The simple
explanation of these results is that the bla genes have inserted within
the aadB gene at a recombinational hotspot. If this recombination was 
transposon mediated, then the transposition functions have been lost from 
R46 since no transposition of the OXA-2 beta-lactamase is seen. 
However some stretches of DNA that are involved in this recombination
process are likely to remain and therefore it is not surprising that 
probes carrying any of this DNA will recognise similar regions in other 
plasmids. For this reason, it is apparent that probes for specific genes
need to come entirely from the coding region of their respective genes.
A71 was used as a probe specific for the OXA-2 beta-lactamase
although weak hybridisation to OXA-3 type plasmids was seen. This
interaction is not surprising since Dale and Smith (1974), have proposed
that the OXA-3 beta-lactamase is a deletion mutant of the OXA-2 
enzyme. Holland and Dale (1985), have subsequently shown that
antibodies raised against OXA-2 inhibit the OXA-3 enzyme albeit less 
efficiently. Therefore the evidence suggests that partial sequence 
homology may exist between the two proteins.
Hybridisation was observed on one occasion with TEM-1 and PSE-3 
type plasmids. However this observation was never repeated in any 
subsequent hybridisation experiments. If this was a true observation,
then the A71 probe does not hybridise within the TEM-1 beta-lactamase
gene as deduced from DNA homology studies of the probe and bla gene 
sequence. Hybridisation must be at some other site.
The specific DNA probe of Ouellette and Roy (1986) which
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appears to be from entirely within the the OXA-1 gene, hybridised 
weakly with OXA-2 type plasmids. No sequence data has been given
for this probe and it has not been compared with the DNA sequence of 
the OXA-2 beta-lactamase gene to ensure that hybridisation occurs within 
the gene. In the present studies no interaction was seen between the 
A71 probe and RGN238, the OXA-1 enzyme type plasmid. It may be 
possible that that the EcoRV/Bglll fragment of Ouellette and Roy (1986), 
contains DNA that does not code for the OXA-1 enzyme.
Finally A71 can be used as a probe for OXA-2 and OX A-3 
beta-lactamases although in the latter case proof is needed that the probe
does hybridise to the OXA-3 enzyme gene and not with some other part
of the plasmid sequence. Probes are becoming more useful for the
epidemiological studies of resistance genes, a fact that has been stressed 
by Jacoby (1985). Hybridisation studies can also be used to analyse 
common ancestry between related proteins at the molecular level. This 
has been done for the genes specifying tetracycline resistance where 
hybridisation has shown that five classes of genes exist (Marshall el al,
1983). Schlaes et al (1986), have also used DNA probes to demonstrate 
the distinctiveness of a novel beta-lactamase OHIO-1. Therefore specific 
DNA probes are beginning to play an increasingly more important role
in the identification and charaterisation of novel beta-lactamases. 
Preliminary investigations have been started using total cellular DNA 
from various organisms in dot blots to probe for OXA-2 beta-lactamase
genes with the A71 probe. So far results have shown that A71
hybridises to strains carrying R46 or pSU8 plasmids. Hence A71 may 
prove to be useful in searching for OXA-2 type plasmids.
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Section 15: Purification of the OXA-2 Beta-Lactamase bv Affinity
Chromatography 
15.1: Background
Purification of the OXA-2 beta-lactamase from large volumes can
take from 1-2 weeks using the method of Holland and Dale (1984).
This is a time consuming process involving several steps; any purification 
protocol that can shorten the time required for purification would be 
extremely useful. The purification protocol published by Holland and
Dale (1984), has other disadvantages apart from the length of time taken 
to purify the protein; some of the purification stages use buffers that
contain chloride ions which are known to inhibit the OXA type 
beta-lactamases (Dale and Smith, 1971b). Similarly the ammonium 
sulphate precipitation steps at 60% may overcome the buffering capacity 
and lower the pH of the solution (R. Todd, personal communication). 
Low pH is likely to cause enzyme inactivation as shown by direct
activity studies (Dale and Smith, 1971a). Similarly Holland (1983), has
demonstrated the acid lability of the OXA-2 beta-lactamase by isoelectric 
focusing; beta-lactamse loaded at pH 5 or lower does not focus.
Attempts have been made to exploit the binding of the OXA-2
beta-lactamase to cibacron blue dyes (Monoghan et al, 1982) for rapid 
purification by blue sepharose affin ity  chromatography. However, this 
procedure is costly both in terms of affinity  matrix and penicillin 
substrate which is required to elute the bound enzyme. A rapid method 
for the purification of serine beta-lactamases has been published by 
Cartwright and Waley (1984), using single step affinity  chromatography. 
The method exploits the ability of boronic and boric acids to
specifically inhibit serine beta-lactamases from both class A and C 
(Kiener and Waley, 1977; Beesley et al, 1983). m-Aminophenylboronic 
acid (m-apba) is liganded to a hydrophilic spacer arm via the amino 
group to give an L-type affinity column. m-Apba liganded to a more 
hydrophobic arm gives a B-type column and is used for beta-lactamases 
that have a low affinity  for boronic acids. The metallo enzymes from 
B. cerens and P. maltophilia can not be purified on these types of 
affin ity  column and are not inhibited by boronic or boric acids 
(Cartwright and Waley, 1984).
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15.2: Purification of the OXA-2 Beta-Lactamase on an L-Boronic Acid
Column
L-type affinity  columns were made as described in section 8.2.7. 
The only change to the method published by Cartwright and Waley 
(1984), was that sodium acetate replaced sodium chloride in the elution 
buffer. The substitution was made to limit the exposure of the 
beta-lactamase to chloride ions. A crude cell extract of E. coli 
containing OXA-2 beta-lactamase was available from a 400 1 batch
fermentation stored at -20* C (section 11.3). A portion of this extract 
was thawed and dialysed against 0.02M triethanolamine-hydrochloride/0.5M 
sodium acetate pH 7.0 at 4*C. This was applied to to an L-type 
column and washed in the same buffer until the OD readings of the 
eluent were zero. The beta-lactamase was eluted with 0.5M borate/0.5M 
sodium acetate pH 7.0. The position of the protein peaks was 
determined from the absorbance at 280nm and enzyme activity was 
located rapidly by the nitrocefin microtitre test. Active fractions were 
then assayed accurately against benzylpenicillin using the 
spectrophotometric assay as described in section 8.2.3. Those containing 
most enzyme activity were pooled. Protein concentrations were measured 
by the Bradford method (Bradford, 1976) using bovine serum albumin as 
the standard. Table 19 shows the purification obtained for the OXA-2 
beta-lactamase where 45% of enzyme activity was recovered in the pooled 
fractions.
Table 19: Purification of the OXA-2 Beta-Lactamase from Crude Cell 
Extract on an L-Boronic Acid Affinity Column.
Total Specific
Fraction Volume Protein Enzyme Enzyme
Activity Activity
(mg) (^moles/min) (^moles/min/mg)
Puri­
fication
(ml)
Crude
Cell 30.0 822 852 1.04 1
Extract
Pooled
Enzyme 32.5 
Fractions
34 373 10.97 10.5
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SDS-polyacrylamide gel electrophoresis of the purified 
beta-lactamase revealed that there were still many predominantly high 
molecular weight protein bands present in the affinity  chromatography 
purified enzyme. This is not unexpected since the purification factor 
was very low. This experiment was repeated with partially purified 
protein that had been batch eluted from DEAE-cellulose as described in
Holland and Dale (1984). The specific activity of this partially purified 
protein for benzylpenicillin was 13.7/imoles/min/mg of protein. Further 
purification on the L-type affinity  column gave enzyme with specific 
activity of 116/£moles/min/mg of protein with only 6% of the enzyme 
activity loaded onto the column being lost. The total purification in 
this instance was 112 which is significantly better than that observed 
for protein purified only by affinity  chromatography. The elution
profile from L-type affinity  columns is shown in figure 37 for partially 
purified OXA-2 beta-lactamase; SDS-polyacrylamide gel electrophoresis 
showed only a single band for the OXA-2 beta-lactamase. These results
show that OXA-2 beta-lactamase binds specifically to L-type columns and 
is eluted with borate and high salt. Partially purified beta-lactamase is 
more efficiently purified with nearly all the activity being retained. 
Isoelectric focusing of OXA-2 beta-lactamase prepared in this manner 
gives a pi of 8.6 and several satellite bands as is characteristic of this 
enzyme.
The affinity  column had been constructed and tested prior to any 
inhibition studies with borate and boronic acids. Some preliminary 
measurements were made to investigate the inhibitor effects of borate 
ions on this beta-lactamase. Amoxycillin at 1.68mM and 0.84mM was 
used as the substrate in 0.02M triethanolamine-hydrochloride/0.05M sodium 
acetate pH 7.0. The enzyme (which was dialysed against 0.05M sodium
phosphate pH 7.5 buffer prior to use) was kept constant at l ln M  and 
borate ion concentration was varied in the assay from 7.75mM to 31mM. 
Assays at each inhibitor concentration were repeated in duplicate or 
triplicate at 30' C. No change was seen to the enzyme activity under 
the conditions tested. The experiment was repeated using a different 
buffer to exclude any possibility of the triethanolamine buffer 
components affecting the enzyme activity. Cephaloridine 0.46mM was 
used as the reporter substrate in 0.025M sodium phopshatc buffer pH 7.4 
with the enzyme concentration at 56nM. The borate ion concentration 
was varied from 0.5 - lOmM but again the enzyme activity did not 
appear to be inhibited. Hence borate ions did not appear to have any 
effect on this beta-lactamase under the conditions tested. Attempts were
1 9 9
D - D  D  ( p Z / u j u i / s ^ j u n ) A i l A  I 1 D V  3 H A Z N 3
LD O
made to use m-apba in similar experiments but the high absorbance 
readings meant that the enzyme activity could not be assayed directly.
15.3: Discussion
The OXA-2 beta-lactamase binds to an L-type affin ity  column and 
is specifically eluted with borate ions. This is characteristic of the 
serine beta-lactamases (Cartwright and Waley, 1984), which further 
corroborates the evidence from homology studies that the OXA-2 enzyme 
is indeed a serine enzyme. However, purification cannot be achieved in 
a single step from crude cell extract, several impurities being co-eluted 
with the beta-lactamase. This is perhaps not too surprising since boronic 
acids are known to interact with other serine enzymes such as the serine 
protease subtilisin, (Philipp and Bender, 1971). Specific binding of serine 
enzymes other than the beta-lactamase may have occurred which were 
then eluted by the borate buffer. In addition, boronic acid affinity 
columns are known to bind proteins through hydrophobic interactions (C. 
Longstaff, personal communication). The extent to which hydrophobic 
binding has played a part, is uncertain and has not been tested for.
56% of the total enzyme activity was lost during purification and 
cannot be accounted for by loss during washing of the column since a 
negligible amount of activity was found in the wash from the column. 
Further purification of partially purified beta-lactamase on the affinity 
column results in a net loss of only 6% activity. If the loss of enzyme 
activity on the column was due to hydrophobic binding, I would expect 
a similar loss of enzyme from the partially purified protein. Clearly 
this does not appear to be the case and a possible explanation is that 
serine proteases in the crude cell extract may be concentrated on the 
L-type affinity  column, co-eluting with the beta-lactamase and causing 
degradation and loss of enzyme.
The source of the crude cell extract was from a 400 1 batch 
fermentation performed in 1982 at the Porton Microbial Products and 
Production Laboratory. The extract had been stored at -20* C so that 
the age of the extract may have affected the purification efficiency of 
the column. The specific enzyme activity of OXA-2 beta-lactamase in 
the crude cell extract as recorded in 1982 by Holland (1983), was 1.19 
units/min/mg of protein which is comparable to the figure given in 
table 19 of 1.04 units/min/mg recorded in 1986. Therefore the OXA-2 
enzyme does not appear to have suffered any degradation during storage.
Despite the problems associated with purification of OXA-2
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beta-lactamase from crude cell extracts, affin ity  chromatography of 
DEAE-cellulose purified enzyme results in a homogenous preparation shown 
by SDS-polyacrylamide gel electrophoresis that has a final enzyme 
activity of 116 units/min/mg of protein. This value is comparable to 
that obtained by Dale and Smith (1974), of 146 units/min/mg. Using 
the L-type affinity  column can therefore reduce the purification to 
essentially a two step process; ion exchange chromatography followed by 
affin ity  chromatography and hence cuts down purification times 
significantly.
Borate ions inhibit a variety of class A and C beta-lactamases 
with Kj’s ranging from 0.37 - 5.0mM (Cartwight and Waley, 1984).
Therefore it is surprising that no evidence of inhibition was seen when 
borate ions upto 33mM were used. The OXA-2 beta-lactamase appears to 
be a serine enzyme as demonstrated in sections 12 and 13 and hence 
there is no obvious reason why inhibition was not seen. Ideally the 
kinetics of this beta-lactamase need to be more thoroughly studied using 
boronic acids and boric acids to inhibit the enzyme.
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Section 16: Conclusions
The results presented here show new evidence concerning both the 
physical and molecular characteristics of the OXA-2 beta-lactamase as 
well as confirming and expanding several observations made previously 
by other authors. The dimeric nature of the OXA-2 beta-lactamase was
first proposed by Dale and Smith (1976), but doubt had been expressed
as to the validity of this observation (Holland and Dale, 1984), after the 
failure to crosslink with dimethyl suberimidate and also due to the 
inexact relationship of the Mr as determined by gel filtration and 
SDS-polyacrylamide gel electrophoresis. Determination of the molecular 
weight by ultracentrifugation has served to prove that this enzyme is not 
only dimeric but also aggregates at high protein concentrations. This 
aggregation has been seen with with other beta-lactamases (Braswell et al, 
1986) but is more prominent for the OXA-2 enzyme.
The DNA sequence from which the amino acid sequence has been
translated has proved invaluable in characterising the OXA-2
beta-lactamase. Comparisons with other beta-lactamases at the primary 
sequence level have shown that it is different, although more detailed
analysis has shown that this enzyme is more closely related to the class 
A than the class C enzymes. Alignments were made with TEM 
beta-lactamase where the sequence matched at several highly conserved 
residues. However to attain this alignment many more gaps had to be 
introduced than is normal for the class A proteins. Hence this raised 
the question as to how much similarity is necessary to classify a protein 
in the same group. I believe the OXA-2 beta-lactamase is the first 
member of a new group that has only recently separated on the
evolutionary tree from the class A beta-lactamases i.e. a cousin of the 
class A group. As such the properties of this protein are expected to 
be very similar to the class A enzymes, a fact that is borne out by the 
interaction of the OXA-2 enzyme with clavulanic acid. The evidence 
presented strongly suggests that several forms of inhibited enzyme exist 
as with the TEM beta-lactamase (Charnas et al, 1978). Preliminary
investigations also suggest that the novel beta-lactamase inhibitor
BRL36148 has a similar mode of interaction in that there are several 
forms of inhibited enzyme.
Previously the OXA-2 beta-lactamase was assumed to be a serine 
enzyme since there was no evidence to suggest the contrary. However 
the current work presents the first evidence that this protein is indeed a 
serine beta-lactamase. The best proof comes from the DNA sequence
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from which the amino acid sequence has been derived: the OXA-2
enzyme has a serine at position 72 that is homologous to the active site 
serine of the other beta-lactamases. The sequence around serine 72 is 
very characteristic of the active site residues of other serine
penicillin-reactive proteins in that they all possess the sequence 
ser-xxx-xxx-lys (Frere and Joris, 1985). Furthermore the interaction of 
this beta-lactamase with clavulanic acid strongly suggests that it is a 
serine protein. Finally the interaction with phenylboronic acid columns 
is also indicative of a serine active site (Cartwright and Waley, 1984) 
although no inhibition was seen when borate ions were added to the 
assay mix.
A specific DNA probe has been made for the OXA-2 
beta-lactamase using a new method. This probe can be used in 
identifying other OXA-2 beta-lactamase specifying plasmids as well as 
studying the distribution of the gene. Furthermore, cross hybridisation 
was seen with the OXA-3 beta-lactamse carrying plasmid which verifies 
the earlier observation by Holland and Dale (1985) that the OXA-3 
beta-lactamase is related to the OXA-2 enzyme. The non specific probe
has confirmed observations of Cooksey et al (1985) and Ouellette and
Roy (1986), that many sequences within the large multiresistance plasmids 
are common. It is likely that this non-specific probe is picking up 
homologies with the aad B gene which is now believed to be the 
promotor from which the OXA-2 beta-lactamase is expressed 
(Mossakowska et al, 1988).
Finally, the secondary structure predictions only showed a poor 
homology, which is insufficient to conclude with certainty that the 
tertiary structures of OXA-2 and class A beta-lactamases will be the 
same. However this analysis may prove useful for the resolution of the 
tertiary structure. The attempts to crystallise the OXA-2 beta-lactamase 
have not been successful but have provided the starting conditions from 
which future crystallisation experiments may be tried.
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Section 17: Future Perspectives
17.1: Mechanistic Studies: Proof of the Acvl Enzyme Mechanism of 
Action
The results presented in this work have given the first evidence 
that the OXA-2 beta-lactamase is a serine enzyme. This has been
determined from amino acid homologies (section 13), although Frere and 
Joris (1985), have expressed concern over the use of such indirect 
methods to identify the active site serine. Consequently for absolute 
proof of the assignation of serine 72 as the active site residue, it is
necessary to label this residue, isolate the labelled peptide and sequence 
it. This has been achieved for a number of serine penicillin reactive
proteins using substrates or inhibitors. Clavulanic acid and BRL36148 
(section 10, appendix A) have not been useful for identifying the active 
site serine of the OXA-2 beta-lactamase so alternative inhibitors need to 
be tried. The most suitable inhibitor for this may be
6/3-bromopenicillanic acid, which is a mechanism based inactivator that 
interacts with the active site serines of class A and class G
beta-lactamases (Loosemore et al, 1980; Orlek et al, 1979). The inhibition 
of the enzyme is at a unique residue and gives rise to a chromophore 
that can be used to follow the labelled peptide (Loosemore et al, 1980).
As an alternative to using inhibitors, it may be possible to use 
substrates to trap the acyl enzyme intermediate. Loosemore et al (1980) 
have successfully used a "slow substrate" cefoxitin (kcat /K m = 6 M"^s'^), 
to trap the acyl-enzyme of the TEM beta-lacatamase. Investigation of 
the kinetic parameters for the OXA-2 beta-lactamase with various 
substrates could help to identify a suitably "slow" substrate with which
it may then be possible to trap the acyl-enzyme. Such investigations 
should again help to reveal the relationship of this enzyme with the 
class A and C beta-lactamases.
17.2: Investigation of the Specificity of the OXA-2 beta-lactamase
The name of this beta-lactamase is derived from its ability to 
hydrolyse oxacillin more rapidly then benzylpenicillin (Dale and Smith, 
1974). These measurements have been made on the basis of Vmax and 
further study of the specificity of this enzyme would need to be made 
on the basis of kcat/K m (Fersht, 1982). Any differences seen in the 
specificity of this beta-lactamase for different substrates, particularly 
oxacillin, may be due to one or more key residues near or within the
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active site that interact specifically with that particular substrate. 
Ideally, these amino acids would need to be identified by X-ray
crystallography. However, in the absence of suitable crystals an
alternative method to investigate key residues involved in substrate 
specificity needs to be used. The method that has been considered and 
for which some preliminary investigations have been made is to generate 
a series of mutants and screen for altered substrate specificty using a 
differential screen. For example, if  screening was to be carried out for 
normal activity against ampicillin but loss of activity agaist oxacillin, 
replica plating onto agar containing ampicillin or oxacillin of mutants 
transformed into E. coli, should enable a large number of clones to be 
screened. The main problem with this system is that E. coli is not 
susceptible to oxacillin (Rolinson, 1985), since it does not readily 
penetrate the outer membrane. Some experiments have been conducted 
with cell wall mutants or EDTA treated cells but have not proved 
promising for improving the susceptibility to oxacillin. However this 
problem has now been largely overcome with the availability of 
Streptomyces lividans transformed with a plasmid that expresses the 
OXA-2 beta-lactamase (Ali and Dale, 1986). Streptomyces are 
Gram-positive organisms and so do not present a membrane barrier to
oxacillin.
Since it is not possible to target any particular residues from 
previous knowledge of the binding interactions within the active site, 
random point mutations can be generated by the method described in
Shortle and Nathans (1978). In essence a gap is introduced in the DNA 
after nicking with a restriction enzyme and extending the nick to 
generate a short stretch of single stranded DNA. Treatment with 
bisulphite converts the exposed cytosines to uracil so that after 
mutagenesis the gap is filled, maintaining the altered nucleotide sequence. 
Further examples of generating mutants using other mutagens such as 
nitrous acid have been reviewed in Zimmerman (1977) and Shortle et 
aU 1980). There is some precedent for this approach where Hedge and 
Spratt (1985) were able to screen for mutations in PBP 3 that had an 
altered specificity for cefoxitin. It was found that four point mutations 
were all that were needed to enable PBP 3 to be resistant to cefoxitin.
2 0 6
17.3: Relationship of the OXA-2 Beta-Lactamase with Other OXA Type
Enzymes
Evidence so far suggests that the OXA-2 beta-lactamase is related 
to the OXA-3 enzyme (Holland and Dale, 1985; section 14). The A71 
probe constructed from the OXA-2 beta-lactamase gene has been shown 
to interact with the OXA-3 specifying plasmid, R55. There is as yet no 
proof that the interaction is within the bla gene of R55 and therefore 
it is necessary to clone this gene and check that A71 hybridises with
this DNA specifically. Dale and Smith (1974), have suggested that the 
OXA-3 beta-lactamase may be a deletion mutant of the OXA-2 enzyme. 
The simplest way prove this would be to clone the gene coding for the
OXA-3 beta-lactamase in Ml 3 and sequence the gene. In the absence of
the DNA sequence it may be possible to study the homology between the 
two beta-lactamases by making a family of oligonucleotide probes 
spanning the whole of the OXA-2 beta-lactamase coding sequence. In 
this way it should be possible to identify which probes hybridise with 
the OXA-3 beta-lactamase gene and therefore identify which sections of 
the two enzymes are related if at all.
Several groups are close to or have finished the DNA sequence of 
the OXA-1 beta-lactamase gene (eg Ouellette et aU 1987) which can then 
be used to study the relationship with the OXA-2 enzyme. In addition 
to the beta-lactamases already mentioned, several new OXA type enzymes 
(OXA-4-7), have been reported by Medeiros et al (1985) and Phillipon et 
al, (1986). Of these only OXA-6 appears to resemble OXA-2 and OXA-3 
beta-lactamases, the others appearing to be similar to the OXA-1 type of 
enzyme. Probing the DNA of these new types of plasmid with the 
family of probes from the OXA-2 beta-lactamase gene should further
help to reveal the relationships between these proteins.
17.4: Structure of the OXA-2 Beta-Lactamase
Proteins from the class A and class C beta-lactamases have now 
been crystallised and preliminary X-ray crystallography data is available 
(detailed in section 3.5). Since the OXA-2 beta-lactamse is the first 
member of a new class of serine enzyme, it is highly desirable to solve 
the structure of this protein and compare it with that of the other 
penicillin reactive proteins. Section 11.2, has given the details of initial 
conditions for crystallisation. For success, a much more intensive effort 
needs to be made using freshly prepared protein. Apart from solving
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the crystal structure, further experiments probing the physical properties 
of this beta-lactamase would be of interest and are outlined below.
The class A beta-lactamases are monomeric but show a weak
interaction of which the dimeric system of the OXA-2 enzyme may be 
an extension. The monomers in this enzyme appear to be tightly 
associated since it has not been possible to make heterodimers using the 
monomers of the OXA-2 and OXA-3 beta-lactamases by conventional 
methods (Dale and Smith, 1976). Future experiments to investigate the
nature to the subunit interaction on enzyme activity could employ 
chemical reagents such urea and guanidinium-hydrochloride. Robey and 
Schachman (1985), have separated the subunits of aspartate 
transcarbamylase by denaturing the enzyme and chemically labelling with
succinic anhydride; the enzyme was reconstructed by diluting out the 
denaturant to get refolding of the protein. Unfortunately after 
treatment of the OXA-2 beta-lactamase with either urea or 
guanidium-hydrochloride, the enzyme cannot be renatured (Dale and 
Smith, 1976). Consequently systems using these reagents cannot be used 
for this enzyme. Another technique that could be used to study the 
dimeric nature of this beta-lactamase is to introduce mutations into
subunit interface. This has been successfully employed for tyrosyl-tRNA 
synthetase; altering phe 164 to aspartate or glycine induces the reversible 
dissociation of the enzyme into inactive monomers (Ward et al, 1987). 
Unfortunately, the identification of the most suitable residues to alter in 
the OXA-2 beta-lactamase will require some prior knowledge of the 
amino acids in the subunit interface.
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APPENDIX
A.l: Investigation oF the Interaction Between BRL36148 and OXA-2 
Beta-Lactamase
The nature of the interaction between the OXA-2 Beta-lactamase 
and the Beecham compound BRL36148, was investigated at Beecham 
Pharmaceuticals Brockham Park, as part of this CASE award. 
Beta-lactamase of specific activity 95 units/mg of protein giving one 
band on SDS-polyacrylamide gel electrophoresis was used in all the 
following experiments. All the calculations have been made on the 
assumption that the enzyme consists of two identical subunits of Mr  
32,000 containing one independant catalytic site per subunit.
BRL36148 was prepared as a racemic mixture of which only one 
form was active as deduced from inhibition studies using one isomer. 
In the following experiments racemic mixtures were used unless otherwise 
specified and calculations were made on the basis of only one isomer 
being active with the other isomer not contributing to the reaction.
A.2: Stochiometrv of the inhibition
To determine the stoichiometry of the inhibition between OXA-2 
beta-lactamase and BRL36148, enzyme was incubated with various 
concentrations of inhibitor to give enzyme/inhibitor ratios from 0-3 (table 
A.l). After incubation of the enzyme with inhibitor in 0.05M sodium 
phosphate buffer pH 7.5 at 30* C for 10 minutes, 15^1 of the reaction 
mixture was removed and assayed directly against 2.5ml of 0.5mg/ml 
ampicllin or amoxycillin. Residual enzyme activity was measured on a 
Perkin-Elmer Lambda 7 spectrophotometer and results were calculated as 
the % activity remaining against control reactions that contained no 
inhibitor. By extrapolation to zero activity remaining, versus molar ratio 
of inhibitor to enzyme (Figure A.l), the molar ratio of inhibitor to give 
total inactivation was 1.53. This value is a mean calculated from three 
separate experiments and indicates that some turnover of the inhibitor 
may occur before full inactivation is achieved.
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Table A.l: Typical Reactions used to Investigate the Stoichiometry of 
Interaction. The final molar ratio is given for that of the active 
isomer.
(Enzyme) (BRL36148) Final(Enzyme) Final(BRL36148) Molar Ratio
//*M /HM After Mixing After Mixing E/I
/jiM //*M
4 0 2 0 1 0
4 2.4 2 0.6 1 0.3
4 4.8 2 1.2 1 0.6
4 7.2 2 1.8 1 0.9
4 11.2 2 2.8 1 1.4
4 14.4 2 3.6 1:1.8
Figure A.l: Stoichiometry of Inhibition.
I
_ /  .
100
80-
6 0 -
<n
4 0 -
i_J
20 -
1-2 1-60-4 0-8
Molar r a t i o  o f  in h ib i tor
Three independent experiments were carried out where the remaining 
activity was measured after 10 minutes incubation at 30’ C with various 
molar ratios of BRL36148.
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A.3: Return of Activity After Inactivation bv BRL36148
The return of activity after enzyme inactivation with various 
inhibitor concentrations was observed over a 48 hour period. 1.5/xM
enzyme was incubated at 30* C in 0.05 M sodium phosphate buffer pH
7.4 with 0, 0.5, 1, 1.5, 2, and 3 molar excess of inhibitor. 15fil aliquots
were withdrawn at various time intervals and assayed against 2.0ml of 
0.5mg/ml ampicillin. The assays were designed so that the inhibitor 
concentration did not affect hydrolysis of the substrate. These results
have been plotted in figure A.2 where return of activity has been 
expressed as % activity remaining, using the value of the reaction 
containing no inhibitor as 100%.
Results showed that no return of activity occured in the first 5 
hours; after 24 hours an increase in activity of approximately 14% was
observed for the enzyme/inhibitor ratios of 1:1 and 1:1.5. No return of
activity was seen for the enzyme/inhibitor ratios of 1:2 and 1:3 even
after 48 hours. At these higher concentrations this inhibition appears to 
be permanent, the native enzyme beginning to lose activity. It was not
possible to measure the half-life of the enzyme inhibitor complex without 
loss of enzyme activity due to enzyme instability.
A.4: Effect of Hvdroxvlamine on the Enzvmc-Inhibitor Complex
Reactivation of the enzyme-inhibitor complex was attempted on 
several occasions. It was found that any activity present in
hydroxylamine treated samples was a result of hydroxylamine hydrolysis 
of substrate and not due to reactivation of the enzyme inhibitor
complex. This suggests that the probable covalent bond between OXA-2
beta-lactamase and BRL36148 is not accessible to this nucleophile.
• A.5: Rate of Inactivation of the OXA-2 Beta-Lactamase bv BRL36148
The rate of inactivation of OXA-2 beta-lactamase by BRL36148 
was investigated. Previous work showed that the rate of inactivation by 
BRL36148 was second order. A direct method to determine the second
order rate constant was complicated because the1 enzyme was fully 
inactivated in the time taken to mix the the enzyme with inhibitor and 
introduce it into the assay mixture. Therefore an indirect method was 
used where the inactivation rate was measured in the presence of 
substrate. This method has been used previously by Knott-Hunziker et
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al (1980), to calculate the second order inactivation constant for the 
interaction of B. cereus I beta-lactamase with 6 0-bromopenicillanic acid.
Conditions were chosen in which the substrate was in great excess so 
that the decrease in the amount of substrate during the reaction could 
be taken as negligible. K m for amoxicillin was determined from a 
single progress curve according to the method of Waley (1981) and was 
calculated as 15.5/^M. The rates of hydrolysis of amoxicillin were 
measured in the presence (vj) and in the absence of inactivator (vq) and 
were compared by calculating the ln(v]/v0) against time (figure A.3). 
This was carried out at at various inhibitor concentrations which were 
in molar excess over the enzyme (the conditions of the reaction are
futher detailed in A.9 of this section). Slopes of the lines were used to 
determine the pseudo first order rate constant, k0bs, for inactivation
according to equation (A.l) (Kitz and Wilson, 1962; Knott-Hunziker et al, 
(1980); Arisawa and Then, 1983). Scheme A.l describes the process 
which has been used to determine this equation.
Scheme A.l
E + S ^ = ^  E S  >E + P
ki
E +. I ------ ** El
E, S, P, and I represent the enzyme, substrate, product and inactivator 
where the concentration of the inactivator is considered as being 
constant since it is in excess of the enzyme. ES is the Michaelis
complex and kj is the inactivation constant.
ln(v]/v0) = „  k. Km [i].t Equation A.l
Km + |s!
This linear relationship suggests that the slope is proportional to 
the inhibitor concentration and is shown in figure A.3. The second 
order rate constant kj, for the inactivation of the OXA-2 beta-lactamase 
can be determined from the slope of figure A.3, .
(Kitz and Wilson, 1962; Arisawa and Then, 1983)
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The second order inactivation constant calculated from figure A.3, 
gives a value of 3.12/iM sec"*.
Figure A.3: Inactivation Constant for the Inactivation of OXA-2
Beta-Lactamase with BRL36148.
0 -0 6
0 - 0 5
l_JQJ
£  0 - 0 4
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0-60-2 0-3 0-70-4 0-5
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A.6: Nature of the Interaction of OXA-2 Beta-Lactamase with BRL36148
The absorbance maxima of BRL36148 before reaction with enzyme 
is at 310nm. Initial experiments with the active isomer mixed in a 1:1 
ratio with OXA-2 beta-lactamase showed that the spectrum of the 
inhibited complex did not change over a 110 minute period. The 
difference spectrum between native and inactivated enzyme showed two 
peaks at 252nm and 358nm. This experiment was repeated since the
contribution of small unbound molecules to the spectrum of inactivated
enzyme was not known.
A 263/d solution of a racemic mixture of BRL36148 (1.6mM) was 
incubated in 0.05M sodium phosphate buffer pH 7.5 with 263/d of
200/iM OXA-2 beta-lactamase. The molar ratio of active enantiomer to 
enzyme was 1:4. This sample was incubated for 20 minutes at 30* C 
after which 25/d was removed and assayed for enzyme activity. 
Unbound molecules were separated from the inhibited enzyme at 4*C by 
loading the remaining incubation mixture on a Sephadex G15 column 
(27xl.5)cm. The enzyme was eluted at a flow rate of 27ml/min in 
phosphate buffer and collected in a 400ml volume. Since the enzyme 
was inactive, the protein peak was followed at 280nm. A control sample 
was treated similarly except that enzyme was incubated with buffer only.
The spectrum of the inhibited enzyme was compared with the
spectrum of the uninhibited enzyme (figure A.4). The difference
spectrum showed two absorbance maxima (figure A.4); a broad peak at
379nm and a peak at 252.8nm. Since the molar extintion coefficient of
OXA-2 beta-lactamase is known, the concentration of the inhibited
enzyme can be determined from the absorbtion at 281nm (interaction of 
BRL36148 with this enzyme does not appear to affect the absorbance at 
281nm). Assuming that for each active site one inhibitor molecule is 
bound, the amount of inhibitor bound to the enzyme can be calculated. 
On this assumption the molar extinction coefficient of the absorbance 
peaks of figure A.4 can be determined (table A.2).
21 5
Figure A.4: Absorbance Spectrum of Native and Inactivated OXA-2
Beta-Lactamase.
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Table A.2: Determination of the Ratio of the Extinction coefficient
calculated for the peaks in the differnce spectrum of inhibited OXA-2 
beta-lactamase
Wavelength Absorbance Calculated molar Ratio of
extinction coefficient two peaks
/nm  /units /M“l cm"*
379.6 0.020
252.8 0.055
A.7: Isoelectric Focusing of Native Enzyme and Enzvme Inactivated bv
BRL36148
Analysis of BRL36148 inactivated OXA-2 beta lactamase was
carried out as described in section A.10. I.E.F. patterns of native
enzyme, fully inactivated enzyme and inactivated enzyme after 1 minute 
at 0* C with BRL36148 were followed at pH 3.5 - 9.5. The distribution 
of bands was followed by activity and protein staining. Unfortunately 
due to the large number of satellite bands no distinct bands were seen
with the nitrocefin stained gel. However, the protein stain (plate A.l) 
showed quite clearly that a number of new bands were present in the
inactivated enzyme. Figure A.5 shows the relative amounts of each band 
after drying of protein stained plates and measuring the amount of each 
band with an LKB ultrascan laser densitometer.
The most obvious result is that the two main bands in the native
enzyme at pi 8.35 and 8.3, dissappear in the inactivated enzyme and a
whole new set appear at pi 7.85 to 7.0. The pi of the native enzyme
is somewhat lower than the expected pi of 8.6. This may be partly due 
to the fact the the resolving power of this particular gel appeared to be 
poorer at the basic end as evidenced by the position of the marker
proteins. An extended pH range gel (pH 7.5 to 10.5) was prepared.
Analysis of native and inactivated enzyme showed that native enzyme
gave two bands when stained with nitrocefin (no activity was seen for
inactivated enzyme). The position of the active enzyme bands was 
confirmed by protein staining. However, these bands were no longer 
present in the inactivated enzyme; at least four new bands could be seen 
(plate A.2).
1712
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Plate A. l:  Isolectric Focusing in a Broad Range Gel.
T r a c k s : -  A: N a t i v e  e n z y m e ,  B: E n z y m e  i n c u b a t e d  f o r  1 m i n u t e  a t  O '  C 
w i t h  B R L 3 6 1 4 8 ,  C: F u l l y  I n a c t i v a t e d  E n z y m e .
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Figure A.5: Relative Amounts of Each Band Found in Tracks A and C 
of Plate A.l.
Tracks A and C were scanned with a laser densitometer and the sum of 
all the peaks was taken for each track. The % of the total height was 
then calculated for every separate peak which was then plotted at the 
relative position that it was found.
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pi of bands
Native enzyme 8.4, 8.2
Inactivated enzyme 8.1, 7.9, 7.8, 7.6
Any bands with a pi below 7.5 were not resolved. The quality 
of the ’homemade* gel was poor such that the bands were thick and 
indistinct, making the interpretation of the results d ifficult. However, it 
is quite clear that the pattern of bands in the inactivated enzyme is 
significantly different. Hydroxylamine does not regenerate any of the 
original bands, confirming earlier results.
Reaction of BRL36148 with OXA-2 beta-lactamase may result in 
the addition of a carboxy group which would cause a reduction in the 
overall pi of the enzyme. If after binding to the active site serine 
residue the inhibitor cross reacted with other amino groups in the active 
site such as a lysine e-amino group, a decrease in the pi could occur. 
U nfortunately due to the large number of satellite bands, probably as a 
result of loss of amido groups from asparagine and glutamine, it is not 
easy to determine the number of inactive enzyme species. However, 
more bands are present in inactivated enzyme samples than in native 
enzyme which is indicative that more than one species of inactive 
enzyme exists.
A.8: Discussion
BRL36148 is an inhibitor of OXA-2 beta-lactamase w ith an 
inhibition stoichiometry of 1:1.53. The enzyme-inhibitor complex is stable 
with no return of activity seen over the first five hours; a fter 24 hours 
a slow return of activity begins but even after 48 hours a full return 
of the enzyme activity has not occurred. No return of activity is 
observed with enzyme inhibitor ratios of 1:2 or 1:3, presumably because 
any enzyme released reacts with the inhibitor which is present in excess, 
to give permanent inactivation of the enzyme. That there appears to be 
some turnover of inhibitor is unim portant when considering the 
physiological conditions in a cell. To be effective in v/vo, the inhibitor 
need only occupy the beta-lactamase long enough to allow access of the 
antibiotic to the target enzymes. That no return of activity has been 
seen after 5 hours suggests that BRL36148 is a good inactivator.
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P l a t e  A.Z: I s o e l e c t r i c  F o c u s i n g  of  B R L 3 6 1 4 3  I n a c t i v a t e d
OXA- 2  i j - L a c t a m a s e
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h y d r o x y l a m i n e  t r e a t m e n t
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The kinetics of inactivation give a second order rate constant of 
3.12/aM sec”* which is greater than the second order rate constant for 
inactivation of TEM beta-lactamase by 6-acetylmethylene penicillanic acid 
at 0.61 fiM sec“l (Arisawa and Then, 1983) and for 6-/3-bromopenicillanic 
acid at 2.12/iM sec-* (Knott-Hunziker et al, 1980). The method used to 
determine the second order inactivation constant was indirect in that the 
rate of inactivation was followed in the presence of substrate. The 
inhibitor concentration was used in excess of the enzyme so that the 
concentration could be regarded as constant. However, in these 
experiments the inhibitor concentration was only in a 5-24 molar excess 
over the enzyme such that the reduction in the inhibitor concentration 
would be significant. Attempts to use very high concentrations of 
inhibitor were complicated due to the rapidity with which the 
inactivation occurred. The enzyme concentrations were lowered to 2.5nM 
in an attempt to increase the molar ratio of inactivator to enzyme. No 
attempts were made to use lower enzyme concentrations since very dilute 
enzyme solutions of OXA-2 beta-lactamase are not stable (Holland, 1983; 
this work, unpublished results). In retrospect it would have been better 
to repeat these experiments at different substrate concentrations to verify 
that an inversely proportional relationship exists between k0bs and the 
substrate concentration as predicted in equation A.I.
That substrate protects the enzyme from inactivation, supports the 
fact that BRL36148 interacts at the active site of this beta-lactamase. 
This is not unexpected since BRL36148 has a structure similar to 
substrate. The determined rate constant for inactivation shows that 
BRL36148 interacts with OXA-2 beta-lactamase at a comparable rate to 
that of 6/3-bromopenicillanic acid and beta-lactamase I (Knott-Hunziker et 
al, 1980).
Various types of inhibitors have been shown to inactivate 
beta-lactamase with the generation of an enzyme chromophore (reviewed 
in Cartwright and Waley, 1983). Clavulanic acid inactivated-TEM  
beta-lactamase shows an increased absorbance at 280nm (Charnas et al, 
1978). The olivanic acids produce a chromophore absorbing at 248nm 
and 264nm on inactivation of the same enzyme (Easton and Knowles, 
1982) which is consistent with the formation of a pyrroline. In the 
case of 6 /3-bromopenicillanic acid, a chromophore is formed on 
inactivation of B. cereus I beta-lactamasc which has a Xmax at 326nm. 
This has been shown to be a dihyrothiazine intermediate (Cohen and 
Pratt, 1980; Orlek et «/, 1979). In the present study, inactivation of 
OXA-2 beta-lactamase by BRL36148 results in the formation of a
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chromophore with absorbance maxima at 253nm and 379nm which is 
distinct from those described for other beta-lactam inhibitors. When the 
uv spectrum of inactivated beta-lactamase present in an excess of 
inhibitor was recorded, the results showed that the absorbance maxima 
were at 252 and 358nm, the latter peak being very flat. Removal of 
unbound molecules by gel filtration showed that the absorbance peak in 
this region shifted to a Xmax of 379nm. Since the stoichiometry of 
inhibition is greater than one, turnover of the inhibitor is occurring. 
The products of hydrolysis may therefore interfere with the absorbance 
spectrum of the enzyme which has not been separated from the products 
which would account for this shift. The chemical nature of this 
product has yet to be defined.
The isoelectric focusing results have been complicated by the 
presence of satellite bands making it d ifficu lt to determine the number 
of inactivated enzyme species present. The evidence would suggest that 
there may be more than one inactive enzyme species which has also 
been observed for the interaction of clavulanic acid with TEM 
beta-lactamase (Charnas et aU 1978).
These observations can be used to describe a preliminary mode of 
interaction of BRL36148 with OXA-2 beta-lactamase. Some hydrolysis of 
the inactivator occurs because the turnover number is greater than one 
which could also account for the gradual return of activity observed 
over a 48 hour period. Hydroxylamine did not cause any return of 
activity which may be a consequence of the active site geometry being 
unfavourable to the entry of this nucleophile.
The I.E.F. evidence suggests that more than one inactive enzyme 
species exists but this evidence is weak due to the complicated banding 
patterns given by the OXA-2 beta-lactamase. Ideally, proof of a 
branched pathway would come from measuring the kcat of the reaction 
as well as the reactivation rate, kreact. If the kcat is larger than 
^react’ a branched pathway must be presumed. In this way the 
branched pathways of penicillanic acid sulphone and 
6-(methoxymethylene)penicillanic acid were, demonstrated (Kemal and 
Knowles, 1981; Brenner and Knowles, 1984).
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Methods
A.9: Inactivation oF OXA-2 Beta-Lactamase bv BRL36148
(1) The K m of amoxicillin was determined from a single progress curve 
as described by Waley, 1981).
(2) Amoxicillin was made up in 0.05 M sodium phosphate buffer pH 7.5 
and was used at a fina l, concentration of 500/iM in the inactivation 
assays which were performed at 30* C. The inactivator was added as
indicated in table A.l, where BRL36148 was a mixture of both isomers.
(3) The inhibition of the OXA-2 beta-lactamase by BRL36148 was 
measured by the rate of hydrolysis in the presence and the absence of 
inactivator. 1.98ml of 500fiM substrate containing various concentrations 
of inhibitor was prewarmed to 30* C. The reaction was started by
adding 20/il of OXA-2 beta-lactamase and the progress of the reaction 
followed at 250nm. The rate of reaction at each inhibitor concentration
was measured in triplicate or quadruplet to give an average value for
ln(vj/v0).
(4) For each time point along the progress curve, ln(v]/v0) was 
determined and was plotted against time. The slope of the line gave 
the pseudo first order rate constant for each inhibitor concentration.
(5) From the slope of the plot ^obs against the inhibitor concentration, 
the second order rate constant was calculated.
Final Concentration 
of Inactivator//*M
Final Concentration Ratio
of Enzyme /  pM  I:E
Actual Inhibitor
Concentration
Added//*M
0.0125
0.025
0.090
0.125
0.190
0.250
0.375
0.600
0.0025
0.0025
0.010
0.025
0.025
0.025
0.025
0.050
5:1
10:1
9:1
5:1
7.6:1
10:1
15:1
24:1
0.025
0.050
0.180
0.250
0.380
0.500
0.750
1.200
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A.10: Isoelectric Focusing of native and inactivated OXA-2
Beta-Lactamase
(1) Commercially prepared LKB plates pH 3.5-9.5 were used as described 
in LKB leaflet 1804 "Instruction for LKB Ampholine PAG plates". Gels 
of pH 7.5-10.5 were prepared as described in LKB application note, 
March 29th, 1973. Samples run on these plates were treated as for the 
broad range pH plate except that the enzyme concentration was 75^M 
and the Inactivator was at 300/iM.
(2) Samples were prepared as indicated below and applied to the gel in 
duplicate so that half the plate could be stained with Coomassie blue 
and the other half with nitrocefin. Samples that were to be tested with 
nitrocefin were diluted 20 fold.
(i) 50/rM OXA-2 beta-lactamase + sodium phosphate buffer incubated 
for 20 mins at 30* C.
(ii) 50ptM OXA-2 enzyme + 100/iM BRL36148 incubated for lm in 
0* C
(iii) 50/iM OXA-2 enzyme + 100/xM BRL36148 incubated for 20 
minutes at 30* C
(3) Staining with nitrocefin was carried out by immersing Whatman No 1 
paper in 500/ig/ml nitrocefin dissolved in 0.3M sodium phosphate buffer 
pH 7.3. The paper was laid on the gel and appearance of bands was 
observed.
(4) The protein stained gel was dried between cellulose sheets under 
vacuum. The dried gel was subjected to densitometry using an LKB 
Bromma 2202 Ultrascan laser densitometer.
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ABBREVIATIONS
m-Apba m-Amino Phenyl Boronic Acid
DMSO Dimethylsulphoxide
DTT Dithiothreitol
EDTA Ethylenediamine Tetra Acetic Acid
HPLC High Performance Liquid Chromatography
IEF Isoelectric Focusing
IPTG Isopropyl-|3-D-thiogalactopyranoside
Mr Relative Molecular Mass
ddNTP Dideoxynucleoside Triphosphate
dNTP Deoxynucleoside Triphosphate
PAG Polyacrylamide Gel Electrophoresis
PBP Penicillin Binding Protein
PCMB p-Chloromercuricbenoate
PEG Polyethylene Glycol
SDS Sodium Dodecyl Sulphate
SSC Saline Sodium Citrate
TBE Tris-Borate-EDTA
TE Tris-EDTA
TEMED N,N,N’,N’-Tetramethylenediamine
TLC Thin Layer Chromatography
Tris (Tris{hydroxymethyl})
X-Gal 5-Bromo-4-chloro-3-indolyl-(3-galactoside
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